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Abstract

The purpose of this study was to examine the effects of tryptophan, the amino
acid precursor to serotonin, on neuropsychological performance. A dietary method of
tryptophan manipulation was employed to temporarily raise, lower, or maintain
circulating levels of tryptophan within the body, allowing the resulting cognitive and
affective sequelae to be measured. A total of 73 participants (50 females, 23 males)
completed this mixed-design, double-blind study. Participants were quasi-randomly
assigned to one of three tryptophan conditions (augmented, depleted or balanced) and
were provided with breakfast, lunch and a snack. A comprehensive neuropsychological
test battery was administered 1.5 hours after completion of lunch. Analyses were
conducted on each gender separately. No significant results were found for females. For
the males, however, significant between-group differences were found for the Rey-O
delayed recall, with those in the Depletion group scoring significantly higher than those
in the Balanced or Augmented conditions. Males in the Augmented condition also
performed better than those in the Balanced or Depleted condition on the speed
component of the Ruff 2 & 7 Selective Attention Test. With regards to affect, males in
the Augmented group demonstrated a near-significant difference on the PANAS positive
affect scale on the fourth PANAS administration compared to those in the Depleted
group. These differences in positive affect levels seem to be primarily driven by the
trend in excitement levels between males in the Augmented and Depleted conditions over
time. Results of this study support the hypothesis that dietary manipulations aimed at
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altering tryptophan levels had an effect on some cognitive tests and positive affect, at
least with regards to males.
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Effects of tryptophan manipulation on neuropsychological performance
Human behaviour is continuously influenced by factors stemming from the
external environment and from internal systems. The reaction to these stimuli is
mediated by the central nervous system (CNS), in part through chemical messengers
known as neurotransmitters (see Appendix A for glossary of terms). Of all the
neurotransmitters in the mammalian CNS, serotonin, one of the main metabolic products
of tryptophan, has received a great deal of interest within the literature. In particular, the
focus of most research studies on serotonin has been on the association between the
neurotransmitter and mood (Benkelfat, Ellenbogen, Dean, Palmour, & Young, 1994;
Flory, Manuck, Matthews & Muldoon, 2004; Heninger, Delgado, Charney, Price &
Aghajanian, 1992; Smith, Pihl, Young, & Ervin, 1987; S. N. Young, Smith, Pihl, &
Ervin, 1985). However, a growing body of evidence suggests that serotonin also plays a
role in many cognitive functions (e.g., Lieberman, 2003). Given that serotonin and it’s
precursor (tryptophan) are derived from foods that are consumed (Sirek & Sirek, 1970),
there is growing support for the notion that diet can produce reliable effects on
tryptophan levels and thus, on cognitive performance (e.g., Dye, Lluch & Blundell,
2000), presumably through the serotonergic pathway (one of the major pathways
resulting from tryptophan metabolism). In order to examine this notion, the
neurochemistry behind tryptophan entering the body and becoming converted to
serotonin will first be reviewed. Following this review, the role of serotonin innervation,
function, and the neuroanatomical structures related to the serotonergic system, as well as
those related to the other pathways of tryptophan metabolism, will be discussed. Finally,
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this paper will examine the methods by which tryptophan levels can be manipulated.
This study will investigate the effects of tryptophan on neuropsychological performance.
Neurochemistry Review
In order to fully understand the ways in which tryptophan can exert its influence
on cognitive and affective responses to stimuli in the environment, it is first necessary to
understand the neurochemical bases of serotonin synthesis via tryptophan metabolism.
The entire process begins with the ingestion of nutrients that are metabolized in order to
provide the necessary amino acids for neurotransmitter synthesis to occur. Thus, the first
step in this process begins with the amino acids.
The Amino Acids
Three of the main components in the mammalian central nervous system (CNS) –
peptides, amines, and non-essential amino acids (Wurtman, Hefti & Melamed, 1981) –
are heavily dependent upon the ingestion and/or creation of amino acids. Amino acids
are critical to proper nutrition and are the building blocks of both proteins and peptides.
Although proteins are essential macronutrients responsible for the growth and
development of the body, including bones, skin, muscle and blood, as well as for the
repair of tissues (Blass, 1994), it is the peptides that are a major component of the
mammalian CNS. Peptides are the chemical messengers of the CNS and are broadly
distributed throughout the nervous system (Brownstein, 1994).
When amino acids are broken down, amines are the resulting product. Amines,
which comprise the second main component of the CNS, are involved in the production
of neurotransmitters. Based on their structure, amines are the building blocks of either
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the catecholamines (e.g., epinephrine, norepinephrine, or dopamine) or the indolamine
serotonin (Pinel, 2006). Serotonin in an example of a monoamine, meaning it is
synthesized from a single amino acid. Compared to amino acids, monoamines are a
group of small-molecule neurotransmitters that are produced by cell bodies that are
mainly located in the brain stem (Pinel, 2006). Neurotransmitters are released more
diffusely from monoamines than from amino acids as their axons are highly branched
with many varicosities (i.e., swellings along the axon of the presynaptic neuron that
release neurotransmitters), enabling more widespread release of neurotransmitters into
the extracellular space (Bunin & Wightman, 1999) serving a neuromodulatory function.
The third main component of the mammalian CNS is that of the non-essential
amino acids. There are twenty standard amino acids, of which twelve are classified as
non-essential; the remaining eight are comprised of essential amino acids. The title of
“essential” versus “non-essential” relates not to the importance of a given amino acid, as
all are crucial for optimal health, but rather it relates to the means by which the body
obtains the amino acids. Non-essential amino acids, such as glutamine, can be
synthesized by the human body from essential amino acids or via the catabolism of
proteins. Essential amino acids such as tryptophan, however, cannot be produced by the
body and thus they must be obtained through the ingestion of food (Wurtman, et al.,
1981). The distinction between the eight essential amino acids (isoleucine, leucine,
lysine, methionine, phenylalanine, threonin, tryptophan, and valine) (V. R. Young, 1994)
and the three semi-essential amino acids (histidine, tyrosine, and arginine) is that the
latter can be synthesized by the adult human body but not by infants and growing
children whose metabolic pathways are in the process of development (V. R. Young,
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1994). Both essential and non-essential amino acids are the major constituents involved
in the creation of proteins (Barondes, 1974; Blass, 1994).
Although not strictly one of the three essential components of the mammalian
CNS, essential amino acids play a major role in neurotransmitter synthesis. Based upon
their chemical composition, essential amino acids can be classified into the aromatic
amino acids (tryptophan, tyrosine, phenylalanine and histidine), the branched-chain
amino acids (leucine, isoleucine, and valine), and the other amino acids (threonine and
methionine) (Cooper, Bloom & Roth, 1996; Paul & Southgate, 1978; Wurtman et al.,
1981). All three groups are examples of ‘large neutral amino acids’ (LNAAs), a term
used to describe amino acids that compete with each other for uptake into the brain and
subsequent neurotransmitter synthesis (Curzon, 1985; Wurtman et al., 2003). Brain
levels of neurotransmitters will change depending on the levels of the precursor(s) in the
blood plasma, as will changes in blood plasma levels of competing LNAAs (Fernstrom &
Wurtman, 1972). Ultimately, however, it is the transport systems of the blood-brain
barrier that determine which transmitters will gain access to the brain.
The Blood-brain Barrier
The blood-brain barrier is comprised of capillary endothelia with tight junctions
between cells that create a continuous membrane separating the brain from circulating
blood and preventing many harmful or toxic substances from gaining access to the brain
(Betz, Goldstein & Katzman, 1994; Brightman, Reese & Feder, 1970; Oldendorf, 1976;
Pinel, 2006). According to Oldendorf, there are two ways in which molecules can cross
the blood-brain barrier: 1) lipid-mediation, through which lipid-soluble molecules can
easily pass; and 2) carrier-transport systems, in which special transport carriers are
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needed to carry the molecules through the blood-brain barrier. As LNAAs are not lipidsoluble (Betz et al., 1994), Pardridge and others (Pardridge & Oldendorf, 1977;
Wurtman, et al., 2003) posit that there is a special transport system for LNAAs that
enables them to cross the blood-brain barrier. As many of the LNAAs serve as
neurotransmitter precursors, they must compete with each other for access to the carrier
molecules (Pardridge & Oldendorf, 1977). Thus, those LNAAs with the highest blood
plasma concentrations are most likely to gain access to the carrier molecules, enabling
them to cross the blood-brain barrier and thus to alter the levels of brain neurotransmitters
(Cooper et al., 1996). Essential amino acids that serve as precursors to catecholamines or
indolamine are readily admitted via the leucine-preferring system (L-system), whereas
the alanine-system (A-system) serves to limit entry of the non-essential amino acids and
actively transports them out of the brain (Betz et al., 1994; Oldendorf, 1971). In other
words, the essential amino acids are rapidly and broadly swept into the brain from the
blood, whereas the non-essential amino acids are not as readily exchanged (Oldendorf,
1971). It is for this reason that Pardridge and Oldendorf (1977) state that “… the bloodbrain barrier amino acid transport probably is the limiting factor in determining
availability of amino acids in the brain” (p. 8). Thus, even though the essential amino
acids can cross the blood-brain barrier with greater ease, they must compete for access to
the carrier systems. It is this function, in addition to the ratio of each amino acid, which
serves to limit the synthesis of neurotransmitters.
Tryptophan:LNAA Ratios
An additional factor that influences the rate of amino acids crossing the bloodbrain barrier is the ratio of each amino acid and whether or not there is competition with
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other molecules for carrier transport. For example, tryptophan is the least abundant of the
amino acids (Paul & Southgate, 1978; Wurtman, 1970; Wurtman & Fernstrom, 1972;
Wurtman et al., 1981). As mentioned previously, the LNAAs (which include tryptophan)
compete with each other for access to the blood-brain barrier transport molecules. Thus,
the other LNAAs gain access to transport carriers and cross the blood-brain barrier in
greater volumes than tryptophan simply because they are more abundant. The reasons for
the greater abundance of the other LNAAs as compared to tryptophan are at least threefold. First, although the main source of tryptophan is from dietary protein (Munro, 1974),
tryptophan comprises only a fraction of the total amino acid content of most dietary
protein (approximately 1 to 1.6% compared to 25% for the LNAAs) (Wurtman, 1970).
For this reason, the ingestion of protein greatly increases levels of the LNAAs, thereby
maintaining the lowered tryptophan:LNAA ratio. Second, half of all tryptophan that is
ingested is excreted in the urine without being converted into serotonin (Sirek & Sirek,
1970). Finally, tryptophan is the only LNAA that is metabolized by the liver into
kynurenine, which in turn is used in the synthesis of niacin; a key function of niacin is the
metabolism of carbohydrates. Since enzymes found in the liver can also break
tryptophan into smaller proteins, the actions of the liver result in less tryptophan being
available for systemic circulation (Brown, 1980).
Thus, it is clear that there are many factors at work to maintain the
tryptophan:LNAA ratio. According to Fernstrom and Faller (1978), “… competition
among tryptophan and other large neutral amino acids in blood is a very important, and
perhaps dominant, determinant of tryptophan uptake into the brain” (p. 1537). There are,
however, two ways in which the ratio of tryptophan to LNAAs can be altered, which in
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turn will alter the rate of transport of the different amino acids across the blood-brain
barrier. The first method of raising plasma tryptophan levels is by ingesting greater
quantities of tryptophan-containing foods or supplements. Although this might seem like
a good technique in principle, it is in fact a poor method of altering the tryptophan levels.
This is because ingesting dietary protein, albeit the main source of tryptophan, also raises
the levels of LNAAs competing for transport across the blood-brain barrier. For
example, consuming a meal that contains 10% protein will raise tryptophan in levels that
are proportionate to the raise in LNAAs (Fernstrom & Faller, 1978; Fernstrom &
Wurtman, 1972). Thus, brain tryptophan levels will actually decrease due to increased
competition from the other LNAAs that utilize the same transport carrier (Blass, 1994).
According to Teff, Young, and Blundell (1989), even 4% protein in an otherwise proteinfree meal will prevent a rise in tryptophan levels compared to that of the LNAAs, while
an amino acid mixture (100 g) that does not contain tryptophan will effectively reduce
tryptophan plasma levels by 70 to 90% (S. N. Young, Ervin, Pihl & Finn, 1989). Thus, it
is clear that simply raising tryptophan levels will not suffice in adequately altering the
tryptophan:LNAA ratio.
The alternative method, which appears to be the most rapid and most effective
means of altering the tryptophan:LNAA ratio, is by lowering levels of the other LNAAs
through the ingestion of carbohydrates (i.e., “carb-loading”). The consumption of
carbohydrates results in an increase in insulin levels, which in turn lowers plasma levels
of the LNAAs by drawing them into the surrounding tissue (Wurtman et al., 1981).
Tryptophan, however, is impervious to this effect, presumably because approximately 70
to 80% of plasma tryptophan is albumin-bound which prevents its penetration into
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peripheral cells (Blum et al., 1992; Lyons & Truswell, 1988; McMenamy, Lund &
Oncley, 1957). Thus, ingesting carbohydrates essentially clears the way for tryptophan to
travel to the blood-brain barrier and gain priority access to the carrier transport molecules
which deliver it into the brain where it can be synthesized into serotonin.
Serotonin Synthesis
All neurotransmitters are synthesized from precursors that are stored as tissue
proteins until needed. The essential amino acid tryptophan serves as the precursor for the
indolamine serotonin (5-hydroxytryptamine, 5-HT), a neurotransmitter found throughout
the brain and body. Originally discovered due to its effects on smooth muscle
contraction, serotonin was simultaneously yet independently discovered by Ersparmer
(1940) in Italy and by Rapport, Green and Page (1948) in Cleveland, USA. Both groups
noticed that following blood clotting a substance was found within the serum that
appeared to cause vasoconstriction. The “tonic” effect of the serum substance was
eventually termed “serotonin” and was subsequently found to have a wide array of effects
on the body (Sirek & Sirek, 1970).
As shown in Figure 1, serotonin is created via a three-step process, starting with
the precursor tryptophan. Through the utilization of a single oxygen atom, the ratelimiting enzyme tryptophan hydroxylase (which is only found in cells that produce 5-HT)
converts tryptophan into 5-hydroxytryptophan (5-HTP) (Frazer & Hensler, 1994; Sirek &
Sirek, 1970). Serotonin is almost immediately synthesized once tryptophan is converted
to 5-HTP (Cooper et al., 1996) through the action of the aromatic amino acid
decarboxylase, an enzyme that removes a carboxyl group (Sirek & Sirek, 1970). The
resultant 5-HT is eventually degraded by monoamine oxidase through the removal of an

Tryptophan

9

amine group (Sirek & Sirek, 1970). The main product generated through the catabolism
of 5-HT is 5-hydroxyindole acetic acid (5-HIAA), which is excreted through the urine
(Frazer & Hensler, 1994). It is estimated that the average human expels between 1 and
10 mg of 5-HIAA per day (Sirek & Sirek, 1970). As aromatic amino acid decarboxylase
is not normally saturated in the human brain, levels of 5-HT can thus be boosted either
through increasing 5-HTP itself (e.g., via supplementation), or by increasing tryptophan
(e.g., via the ingestion of carbohydrates) which will in turn increase levels of 5-HTP, and
thus of 5-HT (Frazer & Hensler, 1994). Furthermore, although 5-HTP is only found in
trace amounts in the brain (Frazer & Hensler, 1994), it is lipid-soluble (unlike
tryptophan), and is therefore able to cross the blood-brain barrier without a carrier
transport. In this way, 5-HTP can act directly to increase brain serotonin levels (Murray,
1998). It is important to note, however, that of the approximate 10 mg of 5-HT found in
an adult male (Sirek & Sirek, 1970), only about 1-2% of that total amount is found in the
brain. Within the brain, however, the pineal gland acts as the factory for producing 5-HT
as it contains the enzymes necessary to convert tryptophan into 5-HT (Frazer & Hensler,
1994). The metabolic activity of the pineal gland, which is located outside of the bloodbrain barrier, is directly influenced by external factors such as light from the environment
(via sympathetic innervation) that regulate the daily rhythmic cycle of 5-HT synthesis
(Cooper et al., 1996).
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Figure 1. Flow chart depicting the enzymes responsible for converting tryptophan into
serotonin (5-HT).

5-Hydroxyindole
TryptophanAcetic Acid
(5-HIAA)
+ tryptophan hydroxylase
5-Hydroxytryptophan (5-HTP)

+ 5-hydroxytryptophan decarboxylase
5-Hydroxytryptamine (5-HT)

+ monoamine oxidase (MAO)
5-Hydroxyindole Acetic Acid
(5-HIAA)
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In order for tryptophan, 5-HTP, or any other precursor to successfully change the
rate of neurotransmitter synthesis, however, five conditions must be met: 1) food
consumption must produce equivalent increases in the amount of neurotransmitter
precursors in the plasma levels; in other words, there must be no mechanism working to
keep plasma levels within a strictly controlled and constant range; 2) a mechanism must
be in place to enable the precursor access to the brain via the blood-brain barrier; 3)
raising plasma levels of the precursor must be able to further saturate transport carriers so
as to increase the amount of a given precursor gaining access to the brain (i.e., transport
carriers must maintain a sub-threshold level of saturation); 4) there must be a low affinity
between the enzyme and the precursor, resulting in poor binding and inefficient catalysis;
the precursor will act as the rate-limiting factor in the genesis of the neurotransmitter; and
5) the enzyme must be free of significant inhibitory feedback from the creation of its
product (i.e., it must not “turn itself off” after producing a specific amount of its
neurotransmitter) (Wurtman et al., 1981). With regards to these conditions, Carlsson and
Lindqvist (1978) have found that the enzyme tryptophan hydroxylase is only 50 to 75%
saturated with tryptophan, indicating that the enzyme is not normally saturated in the
mammalian brain (Cooper et al., 1996; Curzon & Knott, 1974; Frazer & Hensler, 1994;
Gessa & Tagliamonte, 1974; S. N. Young, 1993). Further, Lovenberg, Jequier, and
Sjoerdsma (1968) posit that there is no evidence to suggest that 5-HT inhibits tryptophan
hydroxylase, thereby decreasing its own rate of production. Of note, Gallager and
Aghajanian (1976) did find evidence that the rate of firing of 5-HT neurons in the raphe
nuclei slows after the administration of large doses of tryptophan, resulting in decreased
release, and perhaps decreased generation, of 5-HT. However, since such instances do
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not normally occur without external manipulation, it appears that there is minimal
feedback control of 5-HT synthesis under normal conditions. Thus, according to Spring
(1986), tryptophan meets all five conditions for ensuring successful alteration of the rate
of serotonin synthesis.
Up until this point, we have discussed the process of metabolism by which the
amino acid tryptophan gets converted into serotonin, the indolamine neurotransmitter
involved in many different functions throughout the brain and body. This next section
will detail the routes of serotonin innervation within the brain and will discuss the
specific neuroanatomical structures innervated by these pathways that are implicated in
various cognitive functions. There is, however, a gap in this literature that cannot fully
be bridged as not enough is currently known about the effects of tryptophan manipulation
on neuroanatomical function. A better understanding of these pathways would enable
more precise and accurate predictions about the role of tryptophan on specific
neuroanatomical structures and functions.
Serotonin Innervation and Functional Neuroanatomy
Serotonergic neurons have diffuse branching axons innervating much of the CNS
(Frazer & Hensler, 1994; Tork, 1990). The majority of their somas can be found along
the brainstem midline, especially in the raphe nuclei of the brainstem, the pons and
medulla (Cooper et al., 1996; Frazer & Hensler, 1994). These latter nuclei act as
“variable ratio sensors” (Wurtman et al., 1981, p. 323) by keeping the rest of the brain
informed about the body’s metabolic status. This information is in turn used to help
determine which actions should be carried out next (e.g., deciding which foods should be
consumed at the next meal). In more general terms, serotonin receptors are located
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throughout the brain and spinal cord (e.g., the amygdala, hippocampus, hypothalamus,
and substantia nigra, as well as all layers of the cerebral cortices) (Graeff, 1997; Molliver,
1987; Palacios, Waebar, Hoyer & Mengod, 1990), with each area being responsive to
certain types of input and nonresponsive to others. Forebrain regions in control of
physiological functions are the termination points for ascending projections, while the
spinal cord is the end terminal for descending projections (Tork, 1990). Until its release
into the synapse via exocytotic mechanisms (Sanders-Bush & Martin, 1982), vesicles in
the terminal buttons of the pre-synaptic neuron store the serotonin molecules. The rate of
release is determined by the rate of firing of serotonergic cells (Frazer & Hensler, 1994).
Once released, the activity of 5-HT is terminated via reuptake at the serotonergic
terminals. Generally speaking, the serotonergic pathways emerge from the dorsal and the
medial raphe nuclei and project to various neuroanatomical structures (Takagi, Shiosaka,
Tohyama, Semba & Sakanaka, 1980). The routes of serotonergic innervation throughout
the brain, however, are extensive, influencing several different and, in many cases,
overlapping neuroanatomical structures and functions. The specific contributions of
these structures to cognitive functioning are the focus of this next section.
Memory and Learning. Many different regions of the brain are involved in
different types of memory. The most well-known of these structures is the hippocampus,
a pair of seahorse-shaped structures that line the inner fold of each side of the temporal
lobes (Lezak, Howieson & Loring, 2004). The ventral hippocampus receives
serotonergic innervation from dorsal raphe projections, whereas the dorsal hippocampus
receives serotonergic innervation from the medial raphe nuclei (Graeff, 1997; Molliver,
1987; Steckler & Sahgal, 1995). The hippocampus plays a major role in normal learning
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and retention, quickly associating and integrating information from multiple cortical
areas (Eichenbaum & Cohen, 2001). Serving as an index of where each memory is
stored in the neocortex (Schacter, Norman, & Koutstaal, 1998), the hippocampus encodes
information about events and the context in which they occurred, as well as the thoughts
and emotions that were triggered by them. These multiple pieces of information (i.e.,
“new” memories) are then consolidated and stored in the neocortex as “older” memories
(Fuster, 1995). The hippocampus plays a particular role in spatial memory as the
perceptual and memory systems are closely linked (Zola & Squire, 2000).
The dorsomedial nucleus of the thalamus is also implicated in memory. It has
significant reciprocal pathways to the prefrontal cortex (Graff-Radford, 2003), as well as
receptive pathways with the amygdala, temporal cortex, hypothalamus and interthalamic
nuclei (Afifi & Bergman, 1998). The dorsomedial nucleus of the thalamus receives
serotonergic innervation via dorsal raphe projections (Cooper et al., 1996; Steckler &
Sahgal, 1995). Damage to these projections or to the dorsomedial thalamic nucleus
would presumably result in decreased availability of serotonin which would result in
functional impairments in memory.
The neostriatum, part of the basal ganglia, is also involved in memory. More
specifically, it is involved in procedural memory (Fuster, 1995), and it also plays a role in
devising novel solutions to new situations (Saint-Cyr & Taylor, 1992). The neostriatum
and the basal ganglia both receive serotonergic innervation via dorsal raphe projections
(Cooper et al., 1996; Graeff, 1997; Steckler & Sahgal, 1995).
Several components of the limbic system, which is comprised of numerous
structures including the amygdala, the cingulate gyrus, and the hippocampus
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(Markowitsch, 2000), are also involved in learning and memory. The limbic system,
which is spread through the brain stem (e.g., reticular activation system) and the cortex
(e.g., olfactory bulb of the frontal cortex) (Lezak et al., 2004), are involved in memory,
emotions, and motivation (Damasio, 1994; Markowitsch, 2000). The limbic system
receives serotonergic innervation from both dorsal and medial raphe projections (Cooper
et al., 1996; Graeff, 1997; Steckler & Sahgal, 1995). The mammillary bodies and the
fornix, two other limbic components which are located within the posterior part of the
hypothalamus, aid in the retention and consolidation of memories. The fornix connects
the hippocampal areas of the forebrain with those of the mammillothalamic regions of the
limbic system (Markowitsch, 2000); damage to the mammillary bodies impairs memory
processing (Tanaka, Miyazawa, Akaoka & Yamanda, 1997). The amygdala, a small
almond-shaped structure found deep in the anterior portion of the temporal lobe, is also
involved in memory formation and consolidation by way of object recognition (Mishkin
& Appenzeller, 1987) and by providing an emotional component to memories (Doty,
1990). It has extensive connections with many areas of the brain, including the nuclei in
the brain stem, cerebral cortex, hypothalamus, thalamus, hippocampus, and basal ganglia
(Lezak et al., 2004).
Lastly, the cerebellum, which is attached to the brainstem at the base of the brain,
plays a role in memory and learning through its non-motor connections to the thalamus
and via input received from the frontal, partietal and superior temporal cortices
(Schmahmann & Sherman, 1998). In this way, the cerebellum influences learning and
memory in general (Nyberg, 1998), as well as working memory (Desmond, Gabrieli,
Wagner, Ginier, & Glover, 1997). Temporal, parietal, frontal and cerebellar cortices, as
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well as all layers of the cerebral cortex, receive the majority of their serotonergic
innervation from the dorsal raphe nuclei (Graeff, 1997; Molliver, 1987).
Overall, the literature on serotonergic influences on memory are inconsistent as
Riedel, Eikmans, Heldens and Schmitt (2005) found that citalopram, a selective serotonin
reuptake inhibitor (SSRI), results in impairments in delayed memory recall, whereas
others have found that increased levels of serotonin improved memory and learning (e.g.,
Luciana, Burgund, Berman & Hanson, 2001; Park et al., 1994).
Attention. As with memory, many different neuroanatomical structures are
employed in the process of arousal and attending to stimuli. The reticular formation is a
network of reciprocal nerve fibers connecting the lowest part of the brainstem (the
medulla oblongata) to all major cortical tracts. The reticular formation contains the
reticular activating system which is involved in attention through its arousal of the
cerebral cortex (Mesulam, 2000). The reticular activating system is responsible for
alertness and for maintaining wakefulness (Mirsky, 1989). Lesions to this system result
in disturbances in sleep and general responsivity (Lezak et al., 2004). Serotonergic
innervation is mainly received from dorsal raphe projections (Steckler & Sahgal, 1995).
The thalamus also plays a role in attention (Corbetta, Miezin, Dobmeyer,
Shulman & Petersen, 1991) by way of its connections with the reticular activating system
(Steriade, Jones & Llinas, 1990). The thalamus, a pair of small, oval-shaped structures
lying along both sides of the third ventricle within the forebrain and above the
hypothalamus, is known as the “relay station” of the limbic system and of the brain as a
whole as it is involved in many different functions and has extensive reciprocal and
topographically organized cortical connections, including pathways to the premotor,
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prefrontal, temporal and parietal cortices (Kolb & Whishaw, 1996; Sherman & Koch,
1998). The role of the thalamus in attention is illustrated by reductions in awareness to
stimuli on the side opposite the damaged thalamus (Heilman, Watson, & Valenstein,
2003). As with the dorsomedial nucleus, the thalamus receives serotonergic innervation
via dorsal raphe projections (Cooper et al., 1996; Steckler & Sahgal, 1995).
Components of the limbic system also play a role in attention. The ability to
attend to stimuli is influenced by the amygdala (Eichenbaum & Cohen, 2001), but also by
the cingulate cortex, a structure located deep within the brain above the corpus callosum.
The amygdala has projections that terminate in the anterior portion of the cingulate
cortex, influencing attention (Chelazzi & Corbetta, 2000), whereas the posterior portion
is, in part, innervated by the hippocampus, thereby also implicating it in memory
functions (Mesulam, 2000). Serotonergic innervation to the amygdala is via dorsal raphe
projections (Steckler & Sahgal, 1995), whereas the cingulate cortex receives its
innervation from medial raphe projections.
The cerebellum is also known to play a role in attention (Middleton & Strick,
2000a), and lesions to the white matter of the intercerebral conduction pathways that link
the two hemispheres results in impairments in attention (Filley, 2001). As mentioned
previously, the cerebellum is innervated by dorsal raphe projections (Cooper et al., 1996),
whereas both the dorsal and the medial raphe projections are likely involved in
innervating the white matter (Cooper et al., 1996; Graeff, 1997; Steckler & Sahgal,
1995).
Taken together, increasing serotonin would be expected to improve attention
(Lieberman, Falco & Slade, 2002) through an effect on the reticular activation system,
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resulting in increased arousal and vigilance. However, greater levels of serotonin may
also impede certain aspects of attention (e.g. auditory and visual attention; Schmitt et al.,
2000) and vigilance (Riedel et al., 2005) presumably by way of an inhibitory effect on the
amygdala, the thalamic nuclei or cerebellar structures.
Executive Functioning. The term ‘executive functioning’ is a catch-all phrase
pertaining to most higher-level cognitive functions, including such diverse functions as
planning, cognitive flexibility, and abstract reasoning, among others. Thus, it is not
surprising that, as with memory and attention, many different neuroanatomical structures
are involved in these diverse functions. For example, several researchers have found that
the cerebellum, though primarily thought of for its motor control, plays a role in abstract
reasoning (Middleton & Strick, 2000a), planning (Dow, 1998), set-shifting (Le, Pardo, &
Hu, 1998), and information processing speed (Botez, Gravel, Attig, & Vezina, 1985), as
well as in more language-based functions such as linguistic processing (Leiner, Leiner, &
Dow, 1989), and word generation (Raichle, 2000). It does this through its non-motor
pathways. Lesions to these pathways would presumably decrease the amount of
serotonin available to the structures innervated by these cerebellar pathways and,
although it has been found that information processing slows as a result (e.g., Botez et al.,
1985), it is unclear whether any effects on these cognitive processes result from decreases
in brain tryptophan (and thus, presumably, serotonin) (e.g., Fischer, Colombani,
Langhans & Wenk, 2002; Hughes et al., 2003; Luciana et al., 2001; Rogers et al., 1999;
Schmitt et al., 2000).
Each of the three main areas of the frontal cortex (premotor, motor and prefrontal
cortices) is differentially innervated, albeit with some overlap. The premotor cortex,
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which is responsible for selecting a movement, receives input from the prefrontal cortex
and parietal areas, whereas the motor cortex, which is responsible for carrying out a
movement, projects to the basal ganglia and red nucleus (involved in motor
coordination). The prefrontal cortex, which receives its input from the parietal and
temporal lobes, projects to the cingulate cortex, the basal ganglia, the amygdala and the
hypothalamus (Kolb & Whishaw, 1996); this area is involved in the control of executive
functions. The frontal cortex is innervated by both medial and dorsal raphe projections
(Graeff, 1997). On a simplistic level, the frontal cortex is considered the primary
location of executive functioning, although it is known that input into these functions are
provided by most neuroanatomical structures in the brain (Lezak et al., 2004). Lesions to
the frontal lobes tend to produce deficits in “reciprocal relationships between the major
functional system” (Lezak et al., 2004, p. 78). This includes the limbic, sensory, motor
and executive systems, resulting in deficits of integrating such varied constructs as
memory, attention, drive, motivation, social behaviour and motor function (Barrash,
Tranel & Anderson, 2000; Damasio & Van Hoesen, 1983; Lezak et al., 2004).
The basal ganglia, a bundle of nuclei comprised of the caudate, putamen and
globus pallidus, as well as the amygdala, subthalamic nucleus and substantia nigra, sits at
the base of the cerebral hemispheres. The caudate nucleus and putamen receive direct
input from the cerebral cortex, whereas the substantia nigra and the globus pallidus
project to the cerebral cortex via the thalamus (Lezak et al., 2004). Reductions in
cognitive flexibility (i.e., the ability to change cognitive strategies to meet new demands)
are noted after damage to the basal ganglia (Lawrence, Sahakian, Rogers, Hodge, &
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Robbins, 1999). Collectively, these regions are innervated by serotonergic projections
from the dorsal raphe nuclei (Graeff, 1997; Steckler & Sahgal, 1995).
Overall, certain aspects of executive functioning, such as novel solution
generation, have been found to improve with increased serotonin levels (Kurup & Kurup,
2003), whereas other functions, such as verbal fluency and strategy planning, have been
found to improve with decreasing serotonin levels (Park et al., 1994; Schmitt et al.,
2000). It is thus unclear from the literature the exact ways in which increases or
decreases in serotonin levels (as assessed via tryptophan manipulation) affect cerebellar,
basal gangliar, and frontal cortical functioning.
Emotional Regulation. Many different neuroanatomical structures are involved in
the processing, production and memory of emotionally-charged stimuli. The
hypothalamus, which is located just above the brain stem but below the thalamus,
influences the activity of the pituitary gland in order to control and coordinate such
activities of the endocrine and autonomic nervous systems as circadian rhythms, hunger,
thirst, fatigue and body temperature (Pinel, 2003; Rolls, 1999). Protective emotional
reactions such as fear or rage are also controlled by this structure (Lezak et al., 2004).
According to Flynn, Cummings and Tomiyasu (1988), depending on the location of the
hypothalamic damage, a myriad of symptoms may emerge, such as obesity or reductions
in drive or responsivity. Alterations in mood have also been implicated in damage to
hypothalamic pathways (Andreasen, 2001). Serotonergic innervation to the medial and
periventricular hypothalamus is received by dorsal raphe projections (Graeff, 1997;
Steckler & Sahgal, 1995), whereas the lateral hypothalamus receives medial raphe
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projections (Graeff, 1997; Molliver, 1987). Thus, damage to these pathways would
presumably reduce the amount of serotonin available to the hypothalamus.
Through its role as a relay station for the limbic system, the thalamus exerts an
influence on emotional responding. It has been found that damage to the thalamus results
in apathy, emotional flattening and reductions in drive (O’Connor, Verfaellie, & Cermak,
1995). The cingulate cortex, part of the limbic system, has also been implicated in
emotional responding (Rolls, 1999). As stated above, the thalamus and the cingulate
cortex are innervated by dorsal and medial raphe projections, respectively (Graeff, 1997;
Steckler & Sahgal, 1995).
The amygdala, which is also a component of the limbic system involved in
emotional behaviour, has extensive innervation from the hypothalamus and is implicated
in emotional responding (Lezak et al., 2004), processing and learning (Bechara, Damasio,
Damasio, & Lee, 1999). Through its connection to the ventral hippocampus, the
amygdala also plays a role in memories of emotional events (Pinel, 2003). Lesions to the
amygdala dampen the expression of emotional states and aggressive behaviour
(Aggleton, 1993; Brodal, 1981). Amygdalar lesions would also presumably decrease
availability of serotonin in the brain, and it has been found that decreases in tryptophan,
the precursor to serotonin, results in increased levels of aggression (Cleare & Bond,
1995; Pihl et al., 1995). The amygdala receives serotonergic innervation from dorsal
raphe projections (Graeff, 1997; Steckler & Sahgal, 1995).
The basal ganglia are also implicated in emotional experiences, as it has been
documented that bilateral damage to these structures results in flattening of emotional
expression (Bhatia & Marsden, 1994). Damage to the circuitry of the non-motor
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pathways of the basal ganglia are also implicated in several psychiatric disorders,
including depression (e.g., Middleton & Strick, 2000b). As mentioned above,
serotonergic innervation to the basal ganglia is via dorsal raphe projections (Graeff, 1997;
Steckler & Sahgal, 1995).
Fine Motor Control. The last area of functional neuroanatomy to be discussed in
this section pertains to motor control. The pons, which literally means “bridge”, is a
small structure on the brainstem above the medulla that is responsible for carrying
sensory signal up to the thalamus, and for sending signals down from the cortex. It
serves as a major pathway between the cerebellum and the cerebral cortex (Lezak et al.,
2004). Together, the pons and cerebellum are responsible for kinesthetic and postural
control, fine-tuning motor impulses from the cerebral cortex (Lezak et al., 2004). These
areas are innervated by dorsal raphe projections (Steckler & Sahgal, 1995). Damage to
either area results in difficulty with coordination and fine motor control (Barlow, 2002;
Caplan, 2001). It has been reported within the literature that increased serotonin results
in problems of motor coordination (e.g., Luciana et al., 2001) and slowed motor response
time (e.g., Markus et al., 1998). Increased levels of serotonin may thus exert an
inhibitory effect upon the pons and cerebellum, thereby reducing motor speed and
response times (e.g., Luciana et al., 2001; Markus et al., 1998).
Serotonin, Mood and Cognitive Performance
As mentioned earlier, much of the research on 5-HT has focused on the role of
serotonin in mental disorders and physiological disturbances. Indeed, serotonin has been
implicated in many different disorders, such as depression (e.g., Sobczak et al., 2002),
attention-deficit hyperactivity disorder (e.g., Barrickman, Noyes, Kuperman, Schumacher
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& Verda, 1991), and sleep, arousal and insomnia (e.g., Lieberman et al., 1983), among
others. Of the numerous disturbances in which 5-HT has been implicated, however,
depression is a disorder commonly dealt with by clinical psychologists (Ormel, et al.,
1994). Thus, it comes as no surprise that there is a growing literature on the effects of
depression on cognitive performance. For instance, it has been reported that depression
can result in lower scores on measures of executive functioning (e.g., Rogers et al., 2004;
Veiel, 1997; but see Mitchell & Phillips, 2007), memory (e.g., Austin, Mitchell &
Goodwin, 2001), working memory (e.g., Harvey et al., 2004), speed of processing and
motor performance (e.g., Gualtieri, Johnson & Benedict, 2006; Sobin & Sackeim, 1997),
intelligence (e.g., Hartlage, Alloy, Vazquez & Dykman, 1993) and attention (e.g., Porter,
Gallagher, Thompson & Young, 2003). The mechanism behind this relationship between
cognition and depression, however, is still somewhat unclear. It can be surmised that
since depression is associated with reductions in serotonin levels (Frazer & Hensler,
1994), it could be that lower levels of tryptophan (or its metabolite, 5-HTP) are crossing
the blood-brain barrier, resulting in lower levels of serotonin production and activity.
This could in turn directly affect the neuroanatomical structures that are known to play a
role in a given cognitive function. For instance, it has been reported in the literature that
reductions in hippocampal volume are frequently noted in those suffering from
depression (e.g., Campbell, Marriott, Nahmias & MacQueen, 2004; Videbech &
Ravnkilde, 2004; but see Vythilingam, et al., 2004). Cortisol levels are often found to be
elevated in those suffering from depression (e.g., Monteleone, 2001), and chronic
elevation of cortisol is known to both reduce hippocampal activity and increase
hippocampal atrophy (McAuley et al., 2009). Furthermore, stress is known to inhibit
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hippocampal neurogenesis, a process that normally occurs throughout the lifespan, and to
reduce dendritic branching (Jacobs, van Praag & Gage, 2000). Reductions in dendritic
branching, as well as atrophy within the hippocampus, would both result in decreased
hippocampal volume. Thus, it could be that the lowered levels of serotonin, such as are
found in those with depressions (e.g., Wichers & Maes, 2002), affect memory via direct
effect on the hippocampus (and possibly other neuroanatomical structures involved in
this cognitive process).
According to Cook (1991), there is growing evidence to support such interactions
between serotonin, mood and cognitive performance. These processes likely occur in the
limbic system (described above), areas of the brain heavily innervated by serotonergic
projections. Further evidence of the relationship between serotonin and cognitive
performance lies within the hippocampus, a structure known to play a major role in longterm memory (LTM). As described above, if the serotonergic pathways projecting to the
hippocampus are compromised, or if there is a change in the amount or rate of firing of
serotonergic cells, hippocampal functioning could be altered as a result. The thalamus,
which receives serotonergic projections from the dorsal raphe nuclei, is known to play a
role in attention (Corbetta et al., 1991) and thus, alterations in the activity of this pathway
or region could result in disruptions in information processing due to poor attention.
Taken together, the discussions in the previous two sections on functional
neuroanatomy and the relationship between mood, serotonin and cognition provide
evidence that many cognitive and affective processes are, in fact, affected by serotonin
and the serotonergic pathways known to affect neuroanatomical structures.
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Relationship between Serotonin, Depression and Antidepressants
As discussed above, depression is one of the most commonly seen psychological
disorders dealt with by clinicians. One way in which depression is treated is via
pharmacological intervention with antidepressant medications. There are three main
classes of antidepressant medications used in the treatment of depression. The oldest
class is known as the tricyclic antidepressants and they exert their effects by blocking the
reuptake of serotonin and norepinephrine. These actions on the serotonergic system are
thought to regulate mood (Murray, 1998). Monoamine oxidase inhibitors (MAOIs) work
by decreasing the rate at which the MAO enzyme breaks down monoamine
neurotransmitters, thus increasing the availability of serotonin, dopamine, epinephrine
and norepinephrine in the synapse. A third class of medication is known as the serotonin
reuptake inhibitors. These drugs exert their influence by nonselectively inhibiting the
uptake of serotonin and other monoamines, thereby increasing their concentrations in the
synapse. The selective serotonin reuptake inhibitors (SSRIs), however, only block the
reabsorption of serotonin, thus making them of the greatest interest here. Since the SSRIs
work by blocking the reuptake of serotonin into presynaptic neurons, greater amounts of
serotonin are available in the synapse (Murray, 1998). This increase in serotonin
availability increases the inhibitory activity of presynaptic receptors, thereby decreasing
the firing rate of the serotonergic neuron (Blier & de Montigny, 1994; Nutt et al., 1999).
This negative feedback mechanism results in an initial inhibition of the firing rate of the
raphe nuclei. After this initial inhibitory period, the concentration of serotonin in the
synapse begins to increase over the course of several weeks until serotonin levels reach
therapeutic levels within the cortex (Nutt et al., 1999). There is documentation within
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the literature that SSRIs are an effective treatment for depression (e.g., Kraft, Slager,
McGrath & Hamilton, 2005; Pallanti, & Sandner, 2007; Rossi, Barraco & Donda, 2004;
Zohar, & Westenberg, 2000; but see Hotopf & Barbui, 2004; Kirsch, Moore, Scoboria, &
Nicholls, 2002) as they have generally been found to improve negative mood states in
both normal, non-depressed persons, and in patients with depression (e.g., BargeSchaapveld, Nicolson, van der Hoop, & DeVries, 1995; Barton, et al., 2008; Bell,
Abrams, Nutt, 2001; Delgado et al., 1990). Of interest, however, is that there is research
documenting the efficacy of serotonergic precursors, such as 5-HTP, as being equal to
those of SSRIs in treating depression. For instance, Poldinger, Calanchini and Schwarz
(1991) conducted a clinical trial wherein patients diagnosed with depression where given
either 100mg of 5-HTP three times a day, or 50mg of the SSRI fluvoxamine three times a
day for a period of six weeks. At the end of the six-week trial, 5-HTP was not only found
to be as effective as the SSRI at treating depressive symptoms, but it also produced fewer
side effects. These results echo those of van Praag (1981) who similarly found in his
study that daily doses of 200mg of 5-HTP were as effective as the tricyclic antidepressant
clomipramine at alleviating symptoms, again with fewer side effects. Further support for
these findings comes from the literature on acute tryptophan depletion and SSRI use. For
instance, Delgado and colleagues (1990) induced acute tryptophan depletion in a group of
patients diagnosed with depression who were being successfully treated with SSRIs. Of
the 21 patients in this study, two-thirds of them experienced a relapse in their depressive
symptoms following tryptophan depletion. Upon consuming a normal meal, it took
between 24 and 48 hours for remission to return. The authors found that free plasma
tryptophan levels were negatively correlated with depression scores during the depletion,
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with more tryptophan in the plasma resulting in lesser degrees of depression. These
results have been replicated in the literature by several other researchers (e.g., Booij, Van
der Does, Haffmans, & Riedel, 2005; Nutt et al., 1999; O’Reardon et al., 2004) which,
when taken together with the literature on SSRIs, indicates that reductions in serotonergic
activity may be implicated in depressive symptoms in certain groups of people (Cooper et
al, 1996).
The relationship between serotonin and depression, however, is far from clear as
there is documentation within the literature that selective serotonin reuptake enhancers
(SSREs) such as tianeptine, which act to increase the reuptake of serotonin at the
synapse, also result in improvements in symptoms of depression (Defrance, Marey &
Kamoun, 1988; Mennini, Mocaer & Garattini, 1987). Thus, although it is unclear
whether increases or decreases in serotonergic activity have greater implications for the
treatment of depression, it does appear that serotonin is in some way involved in
depressive symptoms.
Effects of Other Tryptophan Metabolites on Brain Function
There is also growing evidence, however, that other metabolites of tryptophan
affect neuroanatomical function and thus, cognitive performance. Such metabolites are
created when tryptophan circulating in the bloodstream passes through the liver, which
can result in one of four possible outcomes: 1) tryptophan is returned, unchanged, into the
bloodstream for use elsewhere in the body; 2) liver enzymes break tryptophan down into
smaller proteins; 3) tryptophan gets converted into 5-HTP; or 4) tryptophan is converted
into kynurenine (Murray, 1998). As kynurenine is a convulsant responsible for proper
muscle function, an excess of kynurenine can result in damage to the muscles. Normally,
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the liver produces greater quantities of kynurenine (used in the production of niacin) than
5-HTP. However, heightened or chronic stress can upset the balance even more by
decreasing the supply of the enzyme necessary to produce 5-HTP, resulting in even less
5-HTP being produced and thus lowering the production of 5-HT in the brain (Murray,
1998). Kynurenic acid, which is produced by the kynurenine pathway and released by
astrocytes, is critical for memory and learning (Potter, 2009). This is because the
hippocampus is heavily innervated by glutamatergic neurons and glutamatergic
neurotransmission is mediated by NMDA (N-methyl-D-aspartate) receptors. Kynurenic
acid acts as an NMDA receptor antagonist, meaning that it reduces the chances that the
calcium ion channel (which is controlled by NMDA) will open. The opening of this
channel is essential for long-term potentiation (i.e., the protracted increase in
communication that occurs between the pre- and the post-synaptic neuron when they are
stimulated at the same time) (Carlson, 2007), which is, in turn, thought to be a major
underlying mechanism in learning and memory (Bliss & Collingridge, 1993). Thus,
greater amounts of kynurenine result in less 5-HTP in the brain, leading to less serotonin
production in the brain, but more kynurenic acid, an NMDA antagonist the makes it less
likely that long-term potentiation will occur. Together, these processes reduce both
learning and memory within the hippocampus.
The NMDA receptors are also thought to play a role in developmental neural
plasticity (Cooper et al., 1996). These receptors have agonist receptor sites for glutamate
and for glycine, both of which must be activated if the ion channel is to open (Dingledine
& McBain, 1994). However, kynurenic acid by-products, such as quinolinic acid, act as
antagonists of the glycine receptor site (Dingledine & McBain, 1994), working to
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decrease the chances of the NMDA-regulated ion channel opening, and thereby
decreasing the likelihood of long-term potentiation occurring. Quinolinic acid is an
excitatory neurotoxin, meaning that it binds to a neuron and causes damage or cell death
due to its stimulation. In this way, quinolinic acid may play a role in neurotoxicity
induced by NMDA (Cooper et al., 1996). Quinolinic acid has also been implicated in
neurodegeneration within the rat hippocampus, resulting in cognitive impairment
(O’Neill, Morgan, & Brioni, 1998). Fortunately, glial cells release kynurenate, a byproduct of kynurenine, to serve a neuroprotective role within the brain (Cooper et al.,
1996). It can thus be seen that the different by-products of tryptophan metabolism have
differing effects on the neurochemistry of the brain. Quinolinic acid, a neurotoxin, may
produce memory impairments, whereas kynurenate works to protect the brain from these
neurotoxic effects. If there is an imbalance in these neurochemicals, the chances of longterm potentiation and thus learning and long-term memory, may be decreased.
Lastly, there is some evidence that melatonin, another tryptophan metabolite,
plays a role in cognitive functioning. Melatonin is created in the pineal gland, which
houses all the necessary enzymes to turn tryptophan into serotonin; serotonin is then
converted into melatonin (Frazer & Hensler, 1994). Aside from its role in circadian
rhythms, melatonin has been implicated in the inhibition of long-term potentiation in the
rat hippocampus (Soto-Moyano et al., 2006) and in deficits in learning and memory in
mice (Larson et al., 2006). Thus, if there are alterations in the amount of tryptophan
reaching the brain, a ripple effect could be seen wherein less serotonin is created,
resulting in less melatonin, which in turn could lead to decreased performance on
learning and memory tasks.
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Taken together, it is clear within the literature that there are many different
pathways in which tryptophan can affect the neurochemical balance in the brain which
may in turn produce changes in cognitive performance by way of influencing
neuroanatomical functioning.

Effects of Tryptophan Augmentation or Depletion
on Neuropsychological Performance
Amino Acid Protocol
One method of assessing the effects of tryptophan metabolites on affect and
cognitive performance is via acute tryptophan depletion. As discussed previously,
depletion works by decreasing the tryptophan:LNAA ratio, resulting in marked decreases
of tryptophan compared to the LNAAs competing for transport across the blood-brain
barrier. By depleting tryptophan levels, researchers can quantify and measure the effects
of lower tryptophan levels on cognition. The most common means of accomplishing
depletion is by ingesting a mixture of amino acids (prepared as a drink) containing all the
essential amino acids except for tryptophan. The balanced, or placebo, condition in such
studies sees the addition of L-tryptophan to the depletion mixture. In studies that include
acute tryptophan augmentation, a larger dose of tryptophan is added to the mixture than
that added for the balanced drink. At this point, a note on the terminology used within
the literature is necessary as there are several terms that are used almost interchangeably
when referring to acute tryptophan depletion (e.g., ATD, protein-loading) or to acute
tryptophan augmentation (e.g., ATA, carbohydrate-loading). For parsimonious reasons,
the remainder of this paper will employ the term ‘depletion’ to denote ‘acute tryptophan
depletion’ or ‘protein-loading’, and the term ‘augmentation’ will be used to refer to
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‘acute tryptophan augmentation’ or ‘carbohydrate-loading’. The term ‘balanced’ will be
used in reference to the ‘balanced condition’.
Among the first to examine the effects of acute tryptophan depletion were S. N.
Young and colleagues (S. N. Young, Smith, Pihl & Ervin, 1985), who found marked
decreases in free and total plasma tryptophan levels following ingestion of the depletion
mixture, and drastic increases following ingestion of the balanced drink. This method
has since been employed by numerous researchers who have found similar results when
examining the effects of depletion on total and/or free plasma tryptophan levels (e.g.,
Hughes et al., 2003; Schmitt et al., 2000). With evidence that this protocol produced
reliable alterations in plasma and total free tryptophan levels, attention was turned to the
effects such manipulations would have on mood and cognition given that alterations in
plasma tryptophan levels would presumably result in an alteration in brain serotonin
production and release.
In order to examine the effects of depletion on memory and learning, Park and
colleagues (1994) recruited 12 male participants and randomly assigned them to a
depletion or to a balanced group. Both researchers and participants were blind to the
drink composition, and all participants took part in both conditions separated by a
minimum of 7 days between test sessions. On both occasions, participants were provided
with a 52 g amino acid drink (S. N. Young and colleagues (1985) employed a 100 g
protocol), and blood samples were drawn both before ingesting the drink and
approximately 4 hours later, just prior to commencing the neuropsychological testing.
The domains of executive functioning, visual/visuospatial pattern learning and memory,
attention, and working memory were tested using the Cambridge Neuropsychological
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Test Automated Battery (CANTAB), a computerized neuropsychological test battery.
Participants also completed visual analogue scales to measure their perceived level of
sadness, anxiety, irritability, concentration, and energy levels, along with a computerized
test of autobiographical memory. Researchers found that total free and plasma
tryptophan levels were lowered following the depletion condition, but remained the same
following the balanced condition. Overall, it was found that although neither mood nor
autobiographical memory was affected by depletion, certain types of learning and
memory (i.e., learning and remembering new rules and visuospatial pairings) were
reduced by depletion. In addition, neither attention nor working memory showed any
effect of depletion. The authors concluded that low tryptophan levels result in poor
consolidation of information in memory and thus lower scores on measures of long-term
memory (LTM) and learning.
The finding that depletion results in transient decreases in learning has been
corroborated by several others. For instance, using the same protocol as S. N. Young’s
group (S. N. Young et al., 1985), Rogers and colleagues (1999) found reductions in
visual discrimination learning following depletion (compared to a balanced condition),
with participants demonstrating marked difficulty learning new stimulus-reward pairings.
In this study, participants’ ability to shift attention to now-relevant stimuli dimensions
remained intact. In addition, both total and free tryptophan levels were lowered by the
depletion but not by the balanced protocol. These results were interpreted to suggest that
cortical and subcortical regions undergo a change in neuromodulation that is affected by
serotonin (Rogers et al., 1999).
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Transient decreases in LTM have also been noted by Riedel and colleagues
(1999), who examined mood and cognition in tryptophan-depleted participants with and
without a family history of depression. Using S. N. Young’s protocol (1985), Riedel and
colleagues found that, compared to a balanced condition, depletion resulted in lower
scores on tests of LTM. More specifically, reductions in delayed recall and recognition
response time and sensitivity were apparent 6 hours after ingesting the drink. No effects
were found on perception, motor function, or short-term memory 6 or 24 hours after the
initial drink, despite participants receiving 10 g booster portions 7, 11 and 13 hours after
the initial ingestion of the drink and the low-tryptophan meals at lunch and dinnertime.
Further, although no differences were found between groups with and without a family
history of depression on the neurocognitive tests, depletion did produce lower moods in
those with a family history of depression, a finding similar to that of Benkelfat and
colleagues (1994). It should be noted, however, that 7 female participants (four of whom
were in the depletion condition) withdrew from Riedel’s study due to nausea induced by
the amino acid drink (three of whom vomited). This point highlights the fact that the
amino acid mixture is not only extremely potent, but also highly unpalatable, which
increases the odds of protocol-induced confounds within the study. For instance, it is
possible that even mild or unreported nausea may affect cognitive performance, making it
more difficult to discern true effects from those produced by objectionable testing
procedures. The disagreeable taste of the amino acid mixture has been reported by
several other researchers (e.g., Greenwood, Lader, Kantameneni, & Curzon, 1975;
Hughes et al., 2000; Park et al., 1994; Riedel et al., 1999), many of whom have tried to
improve its taste by mixing flavoured concentrates or chocolate syrup into the drink.
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Nonetheless, regardless of the palatability of the protocol, the literature seems to suggest
that depletion results in reductions in LTM and has the potential to influence mood,
particularly in those who are susceptible to depression (Benkelfat et al., 1994).
The effects of depletion on attention, however, are not as clear. For instance,
using the same amino acid mixture employed by Park’s group (1994), Coull and
colleagues (1995) examined the effects of depletion on emotional selective attention as
measured by a focused attention task and an attentional searching task. On both tasks, the
words “left” or “right” served as targets, and the distractors were words selected from
four groups of words with emotional valence (e.g., “choke” or “panic”). The attentional
searching task added a component of compatibility such that compatible trials were those
in which the target word “left” (or “right”) appeared on the left side (or the right side,
respectively) of the computer screen; incompatible trials were those in which the targets
did not match the side of the screen on which they were presented (i.e., the word “left”
appeared on the right-hand side of the screen). As with other studies employing acute
tryptophan depletion, participants took part in both the depletion and the balanced
conditions, with no less than 1 week between testing sessions. On both occasions, testing
began 4 hours after ingesting the drink. The authors concluded that depletion did not
affect focused attention, but they reported shorter response latencies when stimuli were
incompatible on the attentional search task; emotional valence did not affect this
relationship (Coull et al., 1995).
These findings are at odds with those of Schmitt and colleagues (2000), who
administered a comprehensive neuropsychological battery to determine the effects of
depletion on executive functions, memory, language, processing speed, mood, and
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attention. They used the 100 g protocol and administered a 10 g maintenance dose 6
hours later. All participants took part in both the depletion and balanced conditions,
which were separated by at least 7 days; blood samples were collected at multiple times
on both days. Overall, Schmitt’s group found that although depletion did not affect
planning (bolstering the findings of Park et al., 1994), processing speed, or divided
attention, it did produce significant improvements in both auditory and visual focused
attention. A possible reason for the divergence in findings is that whereas Coull and
colleagues (1995) utilized the same amino acid mixture as Park’s group (52 g), Schmitt’s
group utilized the protocol employed by S. N. Young and colleagues (100 g) and
included maintenance doses. It is likely that the greater dose of each amino acid, as
found in the 100 g mixture, results in greater “depletion” of tryptophan as the levels of
the other LNAAs increase and crowd out tryptophan for transport across the blood-brain
barrier. The higher dose of amino acids ostensibly results in greater cognitive changes.
Schmitt’s group reports that, compared to the balanced condition, plasma tryptophan
levels dropped 64% from baseline and the tryptophan:LNAA ratio fell by 33% from
baseline 9 hours after ingesting the drink. Coull’s group, on the other hand, did not report
the drop in plasma tryptophan levels attained by their manipulation. However, as Coull
employed the same protocol as Park and colleagues, it is likely that plasma and total free
tryptophan was similarly drastically decreased. Of note, however, is that neither Park’s,
Coull’s, nor Schmitt’s group altered the amount of the amino acid mixture based on
participants’ body mass. Indeed, it seems that the norm within the literature is to provide
all participants, regardless of gender or body mass, with the same quantity of the amino
acid mixture (but see Fischer et al., 2002). While it is not doubted that these variables
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may affect the degree to which tryptophan levels are altered, the fact that most studies do
not control for these confounds makes generalization of these findings quite difficult.
Schmitt’s group also found that verbal fluency scores improved 5 hours following
ingestion of the depletion mixture (compared to baseline measures), supporting the notion
that serotonin is important for proper frontal lobe functioning. This conclusion is based
on the fact that verbal fluency tasks result in increased activation in the frontal lobes
during imaging studies (Brannen et al., 2001). Further, Schmitt’s results corroborated
Park’s (1994) assertion that serotonin reduces certain aspects of learning and memory as
they found evidence of decreased LTM memory in light of spared short-term memory
and retrieval abilities. An interesting point, however, is that Schmitt and Park both found
reductions in LTM despite using different volumes of the amino acid mixture (100 g
versus 52 g, respectively), suggesting that decreases in LTM are robust findings
regardless of the degree of serotonin depletion. Schmitt and colleagues point out,
however, that although Park’s group did find selective reductions in learning and memory
(as measured by the number of trials needed to learn spatial locations on a paired
associates learning task), they failed to find such effects on any of the actual memory
tests that were employed. Schmitt’s group suggests that this is due to the fact that the
memory tests utilized by Park’s group did not measure memory for material learned and
consolidated after a considerable delay. For this reason, Schmitt’s group makes the point
that, “[M]emory tests which do not incorporate delayed assessment or do not require
long-term storage of new information are likely to fail to detect memory deficits of acute
tryptophan depletion” (p. 27).
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Few of the studies discussed thus far have included a neuropsychological test
battery as comprehensive as that employed by Hughes and his colleagues (2003) in their
efforts to examine the effects of tryptophan depletion on mood and cognitive functioning.
In contrast to Schmitt’s group (2000), whose battery contained several computerized tests
and experimental tasks, Hughes’ battery assessed a wide range of domains, including
attention and executive functioning, verbal learning and memory, visuospatial learning
and memory, and mood, using both paper-and-pencil and CANTAB tests. A group of 20
males were tested using the 52 g drink protocol; each participant took part in both the
depletion and the balanced conditions, with no less than 7 days between testing sessions.
On each test day, blood samples were drawn at four separate times, and testing began 4
hours after ingesting the initial drink. Analysis of the blood assays showed that there
were no significant between group differences in baseline measures of either total plasma
or free tryptophan levels. For the depletion condition, both total plasma and free
tryptophan decreased over time, remaining at depletion levels of 60.7% and 56.9% at 330
minutes, respectively. For the balanced condition, however, total tryptophan increased
by 33.6% at 240 minutes, but was depleted to a level of 6.8% below baseline by 330
minutes. Free tryptophan levels were increased by 71.8% at 240 minutes, but had
reduced to 28.5% by 330 minutes time. Taken together, these findings demonstrate that
the manipulation successfully altered total plasma and free tryptophan levels.
Nonetheless, test results showed that the tryptophan manipulation failed to produce any
decline in cognitive functioning or any changes in mood. These findings stand in stark
contrast to the literature discussed previously in that several researchers have detected
poorer performance within these same domains. Bolstering Hughes’s findings, however,
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are those of Shansis and colleagues (2000) who similarly found no effect of depletion on
mood, attention, and memory using a healthy male sample. Shansis’ team suggested that
the discrepancy between their findings and those of others (e.g., Park et al., 1994) could
be due to the testing instruments employed. That is, Park’s group used the Cambridge
Neuropsychological Test Automated Battery, which is known to be sensitive to subtle
neuropsychological (i.e., cognitive) changes (Shansis et al., 2000), whereas Shansis used
paper-and-pencil tests. However, unlike Shansis’ group, Hughes’ group employed three
of the same measures from the battery employed by Park’s group: the Tower of London,
Attentional Set-shift, and the Paired Associates Learning tests. Thus, while it is possible
that Shansis did not select measures that are sensitive enough to detect subtle cognitive
changes brought on by depletion, it does not explain why Hughes, who administered the
same protocol as Park and who also had a larger sample size than Park, found no
significant results. As Hughes and colleagues point out, the failure to measure delayed
memory or recognition, the degree of tryptophan (and thus serotonin) depletion or
disruption, and any individual differences in the degree of sensitivity to depletion,
including gender or body mass, or some combination of these factors may be responsible
for the inconsistency of findings.
Regardless of the contradictory findings, the common factor between all of the
studies discussed thus far is that they have only examined depletion in comparison to a
balanced condition; that is, not a single one of these studies employed an augmented
condition. The administration of an augmented condition is important as it enables us to
learn about what happens when we raise tryptophan concentrations to abnormally high
levels and the effects that this has on cognitive functioning. To overcome this gross
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oversight, Luciana and colleagues (2001) conducted one of the only studies found for this
review that examined cognitive functioning by employing both a depletion and an
augmentation condition (no balanced condition was used). Using S. N. Young’s (1985)
100 g amino acid protocol, participants took part in both conditions, separated by a
minimum of 7 days. Assessing the domains of working memory, executive functioning,
short-term memory and attention, and motor speed and accuracy, Luciana’s group found
several interesting differences between the depletion and the augmented groups. For
instance, although both conditions lowered participants’ scores of positive affect (as
measured by the PANAS; Watson, Clark, & Tellegen, 1988), the depletion group
exhibited faster response times on the Grooved Pegboard Test, more digits correct on the
backward trial of the Digit Span test, and better ability at processing sad affective content
compared to the augmented group. Conversely, although the augmentation group
exhibited decreased motor coordination (as evidenced by the number of drops on the
Grooved Pegboard Test), they made fewer errors of omission on a letter-cancellation test.
No discernable differences were found between the two groups on the Digit Span forward
trial, Spatial Span, verbal fluency, or spatial working memory. In both the depletion and
augmentation conditions, total plasma tryptophan concentrations were significantly
lowered and raised, respectively, compared to baseline levels. Overall, the authors
concluded that augmentation results in transient reductions in affective and verbal
working memory (as measured by the Digit Span Backward trial), as well as decreased
motor-coordination while sparing (and even enhancing) immediate vigilant attention.
Taken together, Luciana’s group concluded that these findings are consistent with the
notion that increased serotonin activity results in a reduction of the flow of information,
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leading to declines in motor coordination, working memory, and short-term attention.
Perhaps more importantly, results of this study demonstrate that just as depletion effects
performance, so too does augmentation, highlighting the necessity of researchers
including an augmented condition in future research to further our understanding of the
effects of augmentation on neuropsychological performance.
Overall, it is clear that there is considerable controversy and contradiction within
the literature on the effects of depletion and augmentation. This seems to be related to the
following factors: a) the tests selected for use in the study, many of which do not always
correspond with the instruments most widely used in clinical settings; b) the use of amino
acids, which often result in adverse effects such as nausea or vomiting; c) gender ratios,
which are rarely equal, especially as many studies only include males or provide no
information on gender distributions; and d) high attrition rates and small sample sizes,
making generalization of test results difficult. In an attempt to address some of these
issues (e.g., nausea and small sample sizes), researchers have begun to look to other
methods of altering tryptophan (and thus serotonin) levels, the most common of which is
the administration of carbohydrate-rich, protein-poor meals.
Dietary Manipulations
The effect of diet on brain serotonin levels is also unclear as there are many
factors influencing whether tryptophan will increase brain serotonin production or
release. As discussed previously, merely ingesting tryptophan-rich foods does not
necessarily alter brain- serotonin levels as it could get metabolized before it can cross the
blood-brain barrier, or prevented from easily crossing the blood-brain barrier due to
competition from the other LNAAs. This is because the volume of the LNAAs also
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increase due to the ingestion of dietary proteins, thereby reducing the tryptophan:LNAA
ratio. Ingesting carbohydrates in a protein-poor meal, however, appears to avoid both
issues by increasing insulin, thereby sweeping the LNAAs into the surrounding tissues
and allowing tryptophan to easily cross the blood-brain barrier to aid in the synthesis of
serotonin.
Using the dietary method of altering tryptophan levels, Markus and colleagues
(1998) studied the effects of carbohydrate-rich meals (designed to augment tryptophan
levels) in comparison to protein-rich meals (designed to deplete tryptophan levels) on
mood and memory in stress-prone participants during a stress-inducing task. Participants
were divided into two groups, high-stress (n = 24) and low-stress (n = 24), based upon
their scores on the Inadequacy Scale of the Dutch Personality Inventory (Luteijn, Starren,
& van Dijk, 1975). All participants were randomly assigned to start with either the
carbohydrate-rich/protein-poor meal, or the protein-rich/carbohydrate-poor meal. Each
participant took part in both conditions, which were separated by a 4-week period. On
each testing day, participants ate breakfast upon arriving at the testing site, followed by a
snack 1.25 hours later. Lunch was served 45 minutes after consumption of the snack.
The test battery, which was administered 1.5 hours after lunch, was preceded by the
collection of a blood sample. The battery consisted of the Profile of Mood States, a stress
induction task (a mental arithmetic task completed during noise interference), and a
computerized memory scanning task measuring accuracy and response times. The first
main effect Markus’s group reported was that the ingestion of the carbohydrate-rich diet
increased the tryptophan:LNAA ratio, rising from 0.074 on the protein-rich test day to
0.105 on the carbohydrate-rich day. They also reported that regardless of stress group,
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the carbohydrate-rich meal resulted in slower reaction times on the computerized
memory task. The authors concluded that the ingestion of carbohydrates increased brain
tryptophan levels, and thus that the synthesis and activity of brain serotonin was also
increased. They noted that this, in turn, resulted in slowed response times. Thus, their
prediction that a carbohydrate-rich meal would protect stress-prone people from
deteriorations in mood and cognitive performance in the face of a stressful task was met.
Markus and colleagues assert that increased serotonin synthesis and activity likely
mitigated the stress-response of the high stress group by increasing their sense of control
in an otherwise uncontrollable situation (the stress-induction task). The general
conclusion to be drawn from this study, however, is that carbohydrate-loading increased
the tryptophan:LNAA ratio in a similar manner as the amino acid protocol, and
neurocognitive effects were observed as a result. Thus, it seems that the dietary method
can be used as an alternative to the amino acid protocol as a means of altering the rate of
production and release of serotonin.
The utility of manipulating diet to measure the effects of varying macronutrients
on performance and mood has been shown by many other researchers. For instance, to
study the effects of tryptophan augmentation, Lieberman et al., (2002) provided 143 US
Army soldiers with one of three carbohydrate drinks: 6% by volume, 12% by volume, or
a placebo mixture, all of which looked and tasted identical. This was a between-subjects
study, with each soldier assigned to only one condition. No blood samples were collected.
The soldiers engaged in several physically demanding tasks throughout the day while
wearing vigilance monitors (specialized watches). When soldiers heard the monitors
beep, they had to respond as quickly as possible by pressing a button on the monitors.
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Response times were utilized as an indication of vigilance. Profile of Mood States mood
questionnaires were also completed at three separate times throughout the day. The
authors found dose-related increases in sustaining vigilance and alertness, such that those
in the 12% per volume group performed the best and those in the placebo group
performed the worst, declining in vigilance at every designated test period. Dose-related
effects were also found for confusion on the Profile of Mood States, wherein those in the
placebo group scored as more confused than either of the carbohydrate groups, with the
12% group being the least confused. The authors conclude that during times of sustained
physical activity, carbohydrates aid in the maintenance of vigilance and enable optimal
cognitive functioning.
The finding that carbohydrates enhance attention and decision times, however,
has not been replicated by all researchers. In a study by Fischer and colleagues (2002),
participants were randomly assigned to one of three dietary groups: highcarbohydrate/low-protein (i.e., augmentation), low-carbohydrate/high-protein (i.e.,
depletion), or a balanced condition. All participants took part in each condition, with
exactly 1 week separating each test condition. In each case, the cream-like meals were
identical in taste, texture, and colour. Blood samples were collected and the cognitive
domains of motor performance, information processing, short-term memory and
peripheral attention were assessed. Overall, the authors found that cognitive
performance, especially short-term memory, was greatest following the high-protein meal
or the balanced meal, whereas the high-carbohydrate meal resulted in the poorest
performance, producing only transient improvements in attention and decision times.
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Neither the carbohydrate nor the protein meal affected peripheral attention, which the
authors credited to a lack of sensitivity of the measure employed.
However, comparing protein (a depletion method) and two carbohydrate meals
(one high in starch and one high in sugar, designed to augment tryptophan levels), Smith,
Leekam, Ralph, and McNeill (1988) found that the carbohydrate meals resulted in slowed
response times to peripheral targets whereas the protein meal resulted in greater
distractibility on a centralized target-detection task. In addition, there were no overall
effects of meal composition on attention or mood. Taken together, these findings suggest
that protein increases vigilance and alertness compared to carbohydrates.
It has been found, however, that the effects of carbohydrates on performance
differ depending on age and gender. For instance, Spring, Maller, Wurtman, Digman,
and Cozolino (1983) examined the effects of protein and carbohydrates on a group of
younger (aged 18-39 years) and older (aged 40-65 years) participants, each of whom
were assigned to one of four groups: high-protein breakfast, high-protein lunch, highcarbohydrate breakfast, or high-carbohydrate lunch. Utilizing the Stanford Sleepiness
Scale, the Profile of Mood States, visual analogue mood scales, an auditory response time
task and a dichotic shadowing task measuring information processing of sustained and
selective attention, they found significant effects for meal type, gender, and time of the
meal. That is, those who consumed the high-protein meal performed with greater
accuracy on the dichotic shadowing task, whereas there was no effect of meal on the
auditory response time task. However, compared to the protein meals, the carbohydrate
meals produced a greater feeling of sleepiness in women than in men, and a greater sense
of calmness in men than in women. Furthermore, the protein meal resulted in those in the
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older age group feeling more tense and less calm if it was ingested at breakfast time,
whereas performance was worse on the dichotic shadowing task (i.e., sustained selective
attention) following carbohydrates at lunchtime. The authors concluded that the
consumption of a high-carbohydrate lunch affected concentration in older participants,
likely resulting from faltering attention.
In an older sample of adults, however, Kaplan, Greenwood, Winocur, and
Wolever (2001) found that carbohydrates, as well as protein and fat, improved several
aspects of cognition in individuals 61-79 years of age. In this study, each participant took
part in all four conditions, ingesting one drink (protein, carbohydrate, fat or placebo, 300
mL each) every 3-7 days. Within 15 minutes of consuming the drink, participants were
administered three verbal memory tests: a list-learning task (testing immediate recall),
and both an immediate and a delayed paragraph recall test. As fillers during the delay
period, the Trail Making Test (Reitan, 1958) and an attention task were completed. All
three drinks (save for the placebo) were found to improve delayed paragraph recall, with
a trend towards improved immediate recall. More specifically, the carbohydrate drink
was found to improve performance on the Trails task and delayed paragraph recall in
men, whereas the protein drink resulted in greater immediate paragraph recall and the fat
drink improved attention. Since all three drinks aided in increasing memory, the authors
concluded that all three macronutrients likely exert different effects upon cognitive
function.
Thus, it should be clear that the neuropsychological effects of tryptophan are
varying and contradictory, especially when differing methodologies (i.e., amino acid
protocol or dietary protocol) and manipulations (i.e., depletion or augmentation) are
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considered. For instance, recall that Coull and colleagues (1995) found no effect of
depletion on attention using the 52 g amino acid protocol, whereas Schmitt’s group
(2000) found that focused attention improved with the ingestion of a depletion 100 g
protocol drink. Luciana and colleagues (2001) found that a 100 g augmentation mixture
resulted in better attention than a 100 g depletion mixture. However, Hughes’s team
(2003) found that depletion using the 52 g protocol had no effect on any domain of
cognitive functioning. Within the dietary manipulation literature, Markus’s research
group (1998) found that carbohydrates reduced response times, a finding in direct
contradiction to that reported by Lieberman’s group (2002). Despite such
inconsistencies, however, there do appear to be several relatively reliable findings due to
tryptophan manipulation. It appears that depletion, produced either via the amino acid
protocol or the carbohydrate manipulation, is related to declines within the areas of LTM
(Park et al., 1994; Riedel et al., 1999; Rogers et al., 1999) and mood (in susceptible
individuals) (Luciana et al., 2001; Riedel et al., 1999; but see Hughes et al., 2003 and
Shansis et al., 2000), with mixed results for effects on attention (Coull et al., 1995;
Hughes et al., 2003; Lieberman et al., 2002; Schmitt et al., 2000; Shansis et al., 2000),
response time (Lieberman et al., 2002; Markus et al., 1998) and verbal fluency (Schmitt
et al., 2000). Conversely, augmentation seems to result in transient reductions in
affective and verbal working memory, as well as motor coordination, while enhancing
immediate vigilant attention (Luciana et al., 2001) (see Table 1 for summary of findings
in the literature).
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Table 1
Summary of Selected Findings Within the Literature
Research Group

Manipulation
Method

Design

Conditions
Employed

Effect of

Findings

Park et al., 1994
n = 12 M

amino acid

within

depletion &
balanced

depletion

- no effect on mood
- lower scores on LTM

Rogers et al., 1999
n = 31 (15 M)

amino acid

between

depletion &
balanced

depletion

- reductions in visual discriminant
- intact ability to shift attention

Riedel et al., 1999
n = 27 (12 M)

amino acid

mixed

depletion &
balanced

depletion

- reductions in LTM scores
- lower mood in those with family
history of depression

Coull et al., 1995
n = 12a

amino acid

within

depletion &
balanced

depletion

- no effect on attention

Schmitt et al., 2000
n = 20 (10 M)

amino acid

within

depletion &
balanced

depletion

- no effect on planning, processing
speed or divided attention
- improvements in auditory and
focused attention
- delayed improvements in verbal
fluency
- reductions in LTM scores

Hughes et al., 2003
n = 20 M

amino acid

within

depletion &
balanced

depletion

- no reductions on scores in any
neuropsychological domains
- no reductions in mood scores
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Shansis et al., 2000
n = 12 M

amino acid

within

depletion &
balanced

depletion

- no reductions in mood, attention or
memory scores

Luciana et al., 2001
n = 19a

amino acid

within

depletion &
augmentation

depletion
vs.
augment.

- faster response times
- improvements in working memory
- improvements in processing sad
affect

augment.
vs.
depletion

- reductions in affective processing
- reductions in verbal working
memory
- decreased motor coordination
- enhanced vigilant attention

Markus et al., 1998
n = 48 (13 M)

diet

mixed

depletion &
augmentation

augment.

- slower response times

Lieberman et al., 2002
n = 143 M

diet

between

augmentation &
balance

augment.

- improvements of vigilance &
attention
- lower scores on confusion ratings

Fischer et al., 2002
n = 15 M

diet

within

augmentation,
depletion &
balanced

depletion
& balanced

- improvements in STM

augment.

- transient improvements in attention
and response times
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Smith et al., 1988
n = 11 (5 M)

diet

within

augmentation
& depletion

augment.

- slower response times

Spring et al., 1983
n = 184 (129 M)

diet

between

augmentation
& depletion

augment.

- greater feeling of sleepiness in
women
- greater feeling of calmness in men
- poor performance on dichotic
shadowing task (at lunch only)

depletion

- greater accuracy on dichotic
shadowing task
- greater feeling of tenseness and
reduction in feelings of calmness
in older adults (at breakfast only)

augment.

- improved delayed paragraph recall
- improvements in Trail Making Test

depletion

- improved delayed paragraph recall
- greater immediate paragraph recall

balanced

- no effect

fat

- improved delayed paragraph recall
improved attention

Kaplan et al., 2001
n = 22 (11 M)

a

diet

= no gender information provided

within

augmentation,
depletion,
balanced & fat
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Purpose and Hypotheses of the Present Study
The purpose of this study is to examine the effects of tryptophan on
neuropsychological performance. Thus, the following hypotheses have been made:
Hypothesis 1: Depletion will result in lower scores on measures of LTM;
Hypothesis 2: Depletion will result in lower mood scores;
Hypothesis 3: Augmentation will lead to lower scores on measures of working
memory;
Hypothesis 4: Augmentation will result in functional improvements within the
areas of attention and vigilance;
Hypothesis 5: The balanced group will score higher than the depletion group on
verbal LTM and on mood indices, and higher than the augmentation
group on verbal working memory;
Hypothesis 6: The balanced group will score lower than those in the augmentation
group on tests of attention and vigilance;
Exploratory analyses will also be conducted in order to examine any group differences
that may arise on items comprising the composite attention and working memory scores,
as well as any differences on the individual items of the PANAS.
The benefits of employing a dietary manipulation outweigh those of the amino
acid protocol for several reasons. First, it is easy to attain the necessary materials – they
are all readily available at any local grocery store. Second, it is affordable for most
researchers and requires no special equipment or access to resources. With the amino
acid protocol, each individual amino acid powder must be purchased separately and then
mixed in the appropriate amounts. Using the dietary method, foods can be purchased
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fresh, and possibly even in bulk, and stored in a refrigerator until needed. Third, it is
better tolerated by participants, with lower chances of experiencing ill-effects (e.g.,
nausea, vomiting, etc.). Fourth, it is less aversive (Vered et al., 2001) given that
participants are taking part in an activity (eating food) not typically associated with stress
and anxiety. Lastly, it has potentially important implications for improving transient or
occasional cognitive, physiological, or affective problems, including furthering our
understanding of “emotional eating”.
Unlike the present study, the majority of research within the literature does not
include an augmented, a depleted and a balanced meal condition (e.g., Coull et al., 1995;
Park et al., 1994; Rogers et al., 1999). Although Fischer and colleagues (2002) similarly
employed all three conditions in the form of “cream-like” meals, all 15 of their
participants were male. As the present study included both males and females, it will
enable us to better tease apart the effects of tryptophan on neuropsychological
performance for both males and females. What is more, many studies within the
literature (e.g., Fischer et al., 2002; Rogers et al., 1999; Smith et al., 1988) do not include
a comprehensive neuropsychological battery comprised of tests and measurements that
are widely used within clinical settings; the present study does include such a battery,
allowing for greater ecological validity. The present study also included the
administration of commonly consumed foods, as opposed to the potent and potentially
aversive amino acid mixtures used by some researchers (e.g., Riedel et al., 1999; Schmitt
et al., 2000), allowing for further ecological validity. Lastly, although the majority of the
research within the literature has employed within-subjects designs (e.g., Hughes et al.,
2003), many have noted high attrition rates due to repeated testing sessions or reactions
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to the amino acid protocol (e.g., 26% attrition rate in Riedel et al., 1999). Further,
although a within-subjects design allows for comparison within the same participant
across all three conditions, thereby eradicating such between-subject confounds as
individual differences, it does introduce the possibility of such confounds as practice
effects due to repeated testing, test expectancy, order effects (of test condition), fatigue
and attrition, as mentioned previously. By employing a mixed design with betweensubjects test variables, the present study avoided those pitfalls, thereby enabling the
collection of data from a larger sample with a lower attrition rate and fewer confounds
due to repeated testing.
The benefits and strengths of employing a dietary manipulation to investigate the
effects of tryptophan manipulation on neuropsychological performance will help
elucidate the role played by tryptophan on cognitive functioning.

Method
Participants
Participants were recruited in two ways. The primary method involved recruiting
undergraduate students enrolled in a psychology course at the University of Windsor who
had signed up for the online participant pool. These students received course credit in
exchange for taking part in this study. A list of students who had signed up for the pool
and who met our criteria for Body Mass Index (BMI) range (greater than 18.5, the lower
cut-off for ‘underweight’, and less than 29.9, the upper cut-off for ‘overweight’) was
emailed to the researcher. Those students were then sent an email advertisement for the
study (see Appendix B for Study advertisement). This advertisement explained that in
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order to take part in the testing session, participants must first complete an in-person
screening interview, after which time they may elect to sign up for the testing session if
they are eligible to do so. The screening session of the study was worth a total of 0.5
course credits and the testing session was worth a maximum of 5.5 bonus points,
provided the participant completed the entire session. Those who were interested
contacted the researcher and an appointment was set up to take part in the screener (see
Appendix C for study screener). The secondary method of recruitment was comprised of
posters which were placed throughout the campus community inviting students from
other faculties to take part in the screener, with the option of signing up for the study
should they be eligible (see Appendix D for poster advertisement). Those who were
interested in taking part contacted the researcher and in return were sent the email
advertisement of the study. If upon reading the email advertisement they were still
interested in participating, an appointment was made to take part in the screening session.
Of note, these participants were not eligible to earn bonus points towards their course(s).
Thus, this was a two-part study consisting of a screening session (lasting approximately
half an hour) and a testing session (lasting approximately 5.5 hours). All participants
who signed up for and successfully completed the testing session, regardless of the
recruitment method, were given the option of having their name entered into a draw to
win 1 of 2 gift cards each valued at $50 CAD to either Devonshire Mall or Future Shop
(the winners had the option of choosing their reward). Ethics approval was gained by the
University of Windsor Research Ethics Board and informed consent was obtained from
all participants before completing both the screener and the testing session (see Appendix
E for the test screener consent form and Appendix F for the testing session consent form).
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A total of 103 participants were screened for inclusion in this study, of which 82 were
eligible to take part in the testing session. Of those deemed eligible, 73 participants
successfully completed the testing session. Participants were split across conditions in
the following manner: 25 in the Augmented group (17 female, 8 male), 25 in the
Balanced group (17 female, 8 male), and 23 in the Depleted group (16 female, 7 male)
(see Procedures for details on group assignment). All participants in this study regularly
ate breakfast and lunch, were not colour blind, and had no motor problems. None of the
females were pregnant or lactating. Complete demographic information for each group
can been seen in Table 2.
Design
This study employed a double-blind, mixed design. Pre- and post-test measures
of working memory (the Digit Span – backward trial) and affect (PANAS; Watson, Clark
& Tellegen, 1988) served as within-subject variables to assess the success of the
tryptophan manipulation (depletion, augmentation or balanced). All other test measures
were between-subject variables. A maximum of 30 days separated the screening and
testing sessions.
Procedures
Screening Session. All participants who signed up for the screen came into the
laboratory and, after signing an informed consent form, completed an initial screening
interview with the author (see Appendix C). During this interview, participants were
assessed for suitability for inclusion in the study according to the following criteria:
absence of food allergies (especially peanuts); confirmation of a body mass index (BMI)
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Table 2
Demographic Information for Each Condition
Variable

Augmented

Balanced

Depleted

(N = 25)

(N = 25)

(N = 23)

21.6 (3.1)

22.6 (3.38)

21.3 (2.51)

Females

21.4 (2.92)

22.5 (3.13)

20.6 (2.00)

Males

22.1 (3.72)

22.9 (4.09)

23.0 (2.89)

Female

17 (68)

17 (68)

16 (69.6)

Male

8 (32)

8 (32)

7 (30.4)

Yes

7 (28)

9 (36)

8 (34.8)

No

18 (72)

16 (64)

15 (65.2)

Age M (SD)

Gender N (%)

Screeners N

103

Ineligible

17

Declined Test Session

3

No Show

1

Completed/Eligible
Testers N

82
82

No Shows

3

Cancellations

4

Administration Errors

2

Final Sample

73

ESL N (%)
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Education M (SD)

15.0 (2.5)

15.4 (2.36)

15.11 (2.22)

Female

14.9 (2.64)

15.7 (2.40)

14.4 (1.89)

Male

15.3 (2.31)

14.69 (2.27)

16.6 (2.29)

BMI M (SD)

22.4 (2.57)

22.56 (2.88)

22.70 (3.02)

Female

22.0 (2.48)

22.0 (2.95)

21.8 (2.69)

Male

23.4 (2.64)

23.75 (2.48)

24.6 (2.98)

Female

126.7 (13.9)

136.88 (17.5) 131.56 (14.00)

Male

167.4 (28.9)

165.88 (21.4) 167.29 (11.69)

Not at all

1

1

0

Minimal (walking to school)

12

8

1

Quite (3-5 times/week)

4

6

14

Very (6+ times/week)

0

2

1

Not at all

0

0

0

Minimal (walking to school)

2

5

1

Quite (3-5 times/week)

5

2

5

Very (6+ times/week)

1

1

1

5

2

4

Weight (lbs) M (SD)

Physical Activity Level (weekly) N
Female

Male

Frequency of Food Consumption N
Female
Fast (0-2 hours)
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Average (3-5 hours)

11

14

12

Slow (6+ hours)

1

1

0

Fast (0-2 hours)

2

0

1

Average (3-5 hours)

4

6

5

Slow (6+ hours)

2

2

1

Female

3.24 (4.06)

6.12 (5.12)

4.63 (3.48)

Male

5.38 (4.31)

5.00 (4.66)

8.14 (4.67)

Female

1

0

0

Male

0

0

0

Female

0

0

0

Male

0

0

0

Female

6

4

2

Male

2

1

0

Female

1

1

0

Male

1

1

2

10

5

8

Male

Beck Depression Inventory – II
(BDI - II) Score M (SD)

History of Depression N

History of Anxiety N

Family History of Depression N

Smoker N

Birth control use (female) N
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Hours of sleep/night M (SD)
Female

6.88 (1.38)

7.79 (1.03)

7.50 (1.26)

Male

7.06 (1.05)

7.56 (1.08)

6.86 (1.11)

Low (0-1 drinks/day)

13

14

14

Medium (2-3 drinks/day)

4

2

2

High (4 drinks/day)

0

1

0

Low (0-1 drinks/day)

5

5

4

Medium (2-3 drinks/day)

2

2

3

High (4 drinks/day)

1

1

0

Amount of caffeine (daily) N
Female

Male
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between the values of 18.5 and 29.9; absence of chronic or current physical illness,
including gastrointestinal disorders such as Crohn’s disease, irritable bowel syndrome, or
lactose intolerance as these conditions have been shown to impede absorption of nutrients
(Murray, 1998); no neurological, endocrine or metabolic disorders; no current medication
use (including SSRIs, MAOIs, narcotics, anti-psychotics, anxiolytics, or stimulants); no
irregular diets (i.e., no ‘fad’ diets or skipping meals) or eating disorders; and no current
episode of acute anxiety or depression. The Beck Depression Inventory – II (BDI-II;
Beck, Steer, & Brown, 1996) was administered to measure current levels of depression.
If a participant had a BDI score of 30 or greater (indicating severe depression), follow-up
questions were asked as to the nature and severity of symptoms, including the likelihood
of them hurting themselves or others. Any participant who scored in this range would
have been provided with appropriate referrals to the Windsor Regional Hospital Mood
and Anxiety Clinic, the Windsor Mood Disorders Self-Help Group, or the Student
Counseling Centre on campus; this information was also listed on the consent forms, of
which participants kept a copy. If anyone was currently suicidal or thinking about
committing suicide, they would have been referred to the Community Crisis Centre (there
is a telephone in the laboratory available for such use). Of note, no participant obtained a
score of 30 or greater, and as a precaution, the author pointed out the referral information
to any participant who obtained a score of 10 or greater. Furthermore, suicidal ideation
was not endorsed by any participant. History of anxiety or depression, family history of
mental illness, and diagnoses of diabetes were also documented, as was the typical
amount of caffeine, alcohol and tobacco consumed daily, and the average number of
hours of sleep per night. Information was also obtained about the participant’s level of
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physical activity, frequency of food consumption, type and frequency of food cravings,
and use of oral birth control (for women).
At this point, if a participant was deemed eligible to continue after the screen, the
participant was given the option of signing up for the testing session. To take part in the
testing session, participants must have agreed to fast 12 hours prior to initiation of testing.
They were informed that on the day of testing, they would be provided with breakfast,
lunch and two snacks. They were also informed that the session would begin at 9 am and
would last approximately 5 hours, although the actual testing would only take place
during the last 1.5 hours of this 5 hour period. Participants were told that in the time
between breakfast and the commencement of testing, they would be required to remain in
the common waiting room (they were allowed to study, read, listen to music, and/or
entertain themselves with their laptops; sleeping was not allowed). Lastly, participants
were shown a list of foods they may be asked to eat when they come in to take part in the
study (this allowed for the screening and confirmation of food allergies and/or
sensitivities). If the participant agreed to these conditions, an appointment was made for
the participant to come back another day to take part in the study. Each participant was
instructed to abstain from alcohol consumption the day before testing, and to get a good
night’s sleep (ranging from 7-10 hours, or whatever is considered average for each
particular person) the night prior to coming in. Every effort was made to accommodate
the participant’s school schedule (i.e., essay due dates and exams) when booking the
testing session. Each participant thus came to the laboratory once for a screening session
and once for the testing session. The author was responsible for conducting the screening
sessions with participants, as well as for the quasi-randomization of participants into each
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of the three meal conditions (augmented, balanced, or depleted tryptophan), matched for
BMI and gender. In order to achieve quasi-randomization, BMI scores were split into
lower (18.5-21.5), middle (22-25.5) and higher (26-29.9) scores for both males and
females, with the aim of recruiting an equal number of males and females from each
range of scores. In other words, the aim was to obtain an equal number of lower-male,
lower-female, middle-male, middle -female, higher-male and higher-female participants
for inclusion in this study. For example, if the first participant was a middle-male, he
might randomly have been assigned to the Augmentation condition. Thus, the next
middle-male would have been randomly assigned to either the Depletion or the Balanced
condition. The third middle-male will thus be assigned to whichever condition is still
empty for that gender and BMI range. The same process was repeated for female
participants. Within each gender, an equal number of participants from each BMI range
were assigned to each meal condition. As condition assignment was completed by the
author and not by the research assistants who administered the neuropsychological test
battery, the maintenance of a double-blind research design was thus ensured. A total of
103 participants were screened for this study, 82 of whom met eligibility criteria for
inclusion in the testing session.
The meals for each participant were put together the night before each testing day
by the author and labeled according to a master menu key (known only to the author),
thereby ensuring that the research assistants administering the test battery were blind to
the condition to which participants had been assigned. On the day of testing, the author
provided participants with their meals and snacks, as well as with fresh copies of the
PANAS at the designated times. The author was also responsible for ensuring that
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participants completed their entire meal, and for removing all food trash from the waiting
room (to ensure that the research assistants could not inadvertently deduce to which
condition participants were assigned). The author informed participants that they were
not to divulge any information to the research assistant with whom they were paired
regarding the foods that were consumed. Participants were run either one or two at a
time, depending on recruitment and availability of the research assistants. Although each
participant worked with a separate research assistant once the testing started at 12:30 pm,
participants were together in the common waiting room during the time between
breakfast and the commencement of the testing (i.e., from 9 am until 12:30 pm). The
author was responsible for checking in with participants during this wait period. A total
of three research assistants were utilized in this study.
Testing Session. On the testing day, participants arrived at the laboratory by 8:45
am. Once they had signed the informed consent, they were quickly surveyed to ensure
they had met with the previously discussed pre-conditions for taking part in the test
session (namely: fasted for 12 hours, avoidance of alcohol and drugs the previous day, a
minimum of 6 hours sleep and no caffeine since the previous day). This brief screen was
conducted with each participant, one-on-one, by the author (on days when two
participants were being run concurrently, a research assistant would conduct this brief
screen with one of the participants). Upon confirmation that these conditions were met,
the participant was administered a brief measure of attention (the Digit Span) and was
then brought into the waiting room. Once in the waiting room, the participant filled out
the first PANAS while their breakfast was prepared and served at 9 am. Immediately
after breakfast and again after the first snack, which is provided at 10:15 am, each
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participant filled out a PANAS. Lunch was provided at 11 am, after which the PANAS
was completed for a fourth time. Given that research has shown that several hours are
required for plasma and free tryptophan levels to reach peak depletion (e.g., Benkelfat et
al., 1994), all participants completed the neuropsychological battery at 12:30 pm, 1.5
hours after the provision of lunch (3.5 hours after the first meal was consumed). This is
in line with Markus’s methodology. The fifth PANAS was completed just prior to the
administration of the test battery. The test battery took less than 1.5 hours to complete,
after which time participants completed the sixth and final PANAS, followed by the
second and final administration of the Digit Span. Taken together, the PANAS and the
Digit Span (backward condition) served as within-subject indicators of the effectiveness
of the tryptophan manipulation, enabling pre- and post-test comparisons in affect and
cognitive performance. At this point, all participants were provided with the option of a
final snack to replete tryptophan levels and to help offset any possible reactions to
tryptophan augmentation or depletion (see Table 3 for schedule of events). Water was
available ad libitum. Of the 82 participants deemed eligible to take part in this study, 3
failed to show up on the day of testing, 4 cancelled their testing session, and 2
administration errors resulted in a total of 73 participants successfully completing the
testing session. Participants were split across conditions in the following manner: 25 in
the Augmented group (17 female, 8 male), 25 in the Balanced group (17 female, 8 male),
and 23 in the Depleted group (16 female, 7 male).
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Table 3
Schedule of Events
Time

Activity

Administered by

8:45 am

Arrive at lab, consent, pre-screen

Author

8:50 am

Complete pre-test

Author

8:55 am

Complete PANAS

Author

9:00 am

Breakfast is served

Author

9:20 am

PANAS is completed

Author

10:15 am

Snack is served

Author

10:30 am

PANAS is completed

Author

11:00 am

Lunch is served

Author

11:20 am

PANAS is completed

Author

12:25 pm

PANAS is completed

Author

12:30 pm

Neuropsychological test battery begins

RA

2:00 pm

Final PANAS is completed once

Author

neuropsychological test battery has finished
2:05 pm

Final snack is served

Author
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Dietary Manipulations
The meals created for each of the three conditions were modeled after the diets
provided by Markus and colleagues (1998) (see Appendix G for composition of meals
and snacks). As Markus’s group did not provide the exact amount of each food provided
to participants, instead citing only the total amount of carbohydrates, protein, fat and
calorie intake in each meal, all meals for this study were created and analyzed by the
author using the NutritionData website (NutritionData, 2009). This website enables the
user to input the amount and type of food and creates a recipe label listing the total grams
of carbohydrates, protein, fat, calories, and other nutritional facts about the foods
contained therein. In this way, it was possible to replicate the menus created by Markus’s
group so as to obtain the same carbohydrate:protein ratios (see Table 4 for macronutrient
content of each condition). Thus, the ratios employed in the present study are in keeping
with those employed by Markus such that the augmentation meal in the present study
contained 18.2 times more carbohydrates than proteins, and the depletion meal in the
present study contained 1.47 times more carbohydrates than proteins. As Markus’ group
did not employ a balanced meal, the balanced meal in the present study was devised to
have a carbohydrate:protein ratio between those used in the augmentation and depletion
meals. Thus, the balanced meal has 8.37 times more carbohydrates than proteins. The
final snack, composed of a pineapple cup and a yogurt cup, was chosen as these foods are
known natural sources of tryptophan (Murray, 1998; Schmitt et al., 2000).
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Table 4
Macronutrient Content of Each Condition
Augmented
Carbohydrates
Total grams
% of meal
% RDA

Meal Type
Depleted

Balanced

200
67
67

57
19
19

174
58
58

Total grams
% of meal
% RDA

11
15
22

39
45
78

21
2
42

Total grams
% of meal
% RDA

11
18
17

23
36
35

26
40
0.4

Calories
Total grams

931

881

988

Protein

Fat

Note: Macronutrient content of these meals based on a 2,000 calorie diet. The
Recommended Daily Allowance (RDA) for each macronutrient, based on a 2,000 calorie
diet for males and females aged 4 and over as indicated by the Canada Food Inspection
Agency (“Chapter 6”, n.d.), is as follows: Carbohydrates = 300 g; Protein = 50 g; Fat =
65 g. All meals were modeled after those used by Markus and colleagues (1998) and
were created and analyzed using the NutritionData website (NutritionData, 2009).
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Neuropsychological tests administered
The following is a list of the neuropsychological test measures that were utilized
in this study, organized by test domain. A brief description of each test is provided,
along with the scoring criteria that were employed. The interested reader is directed to
Lezak et al., (2004) for further detail regarding these measures.

Executive Functioning
Verbal Fluency (‘F’, ‘A’, ‘S’ + Animals; Benton, 1968)
The FAS is a measure of verbal fluency that assesses language generation and
executive functions. Participants were instructed to list as many different words as
possible in one minute that start with a specific letter while abiding by the following
rules: no names or proper nouns (e.g., Brenda or Baltimore), no numbers, and no variants
of a word (e.g., bank, banks, banked). For each of the three letters, participants were
allotted one minute to respond. The total score was the total number of correct words
(i.e., non-perseverative words that did not break any of the rules) for all three letters,
combined into a single score. On the semantic fluency task, participants were instructed
to name as many different animals as they could in one minute (e.g., mammals, reptiles,
birds, insects, etc.). The total score on the semantic trial was the total number of real
animals produced in one minute that were not perseverative. In both the phonemic and
semantic conditions, rule breaks were coded as responses that were a number, a name or
proper noun, or that constituted a variation of a previously stated word (e.g., paint,
paints); perseverative responses were coded when a word was repeated more than once.
Test-retest reliability for the FAS is quite high, over r = .70 for both the phonemic and the
semantic trials (Basso, Bornstein, & Lang, 1999; Harrison, Buxton, Husain, & Wise,
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2000). With regards to validity, the FAS is highly correlated with other measures of
verbal fluency (e.g., the Controlled Oral Word Association Task, which uses the letters
‘C’, ‘F’, ‘L’), ranging from .85 to .94 across varying populations and settings, including
healthy controls (M. J. Cohen & Stanczak, 2000; Lacy, Gore, Pliskin & Henry, 1996).
Stroop Color-Word Test (SCWT; Golden, 1978; Stroop, 1935)
Although it is often utilized as a measure of selective attention, the Stroop is
considered a measure of cognitive control as it requires the inhibition of pre-potent (i.e.,
automatic) responses, forcing participants to ignore task-irrelevant stimuli. The version
of the Stroop employed in this study (Golden, 1978) consisted of three separate trials:
word reading (black ink); colour naming (red, blue and green ‘X’s), and the colour-word
reading interference task (e.g., the word “red” written in blue ink). On this latter task,
participants were required to ignore the typed word and to name the colour of the ink in
which the words were typed. Participants were allotted 45 seconds for each of the three
trials. Scores were calculated for each individual trial, producing a Word Score, a Color
Score and a Color-Word Score. An overall interference score was also derived by
subtracting the participant’s age and education predicted color-word score from the actual
color-word score achieve by the participant. The interference score indicates the degree
to which participants are able to inhibit pre-potent responses. Test-retest reliability has
been reported at r = .86 for the Word trial, at r = .82 for the Color trial, and at r = .73 for
the Color-Word trial (Golden, 1975). Chafetz and Matthew (2004) report moderate to
high validity, and there is a moderate correlation between the Interference score and other
measures of prepotent response inhibition (e.g., time of the stop-signal task, r = .56; May

Tryptophan

69

& Hasher, 1998) and attention (r = .31 with errors of omission on continuous
performance tasks; Weinstein, Silverstein, Nader & Turnbull, 1999).
Emotional Stroop (paper-and-pencil)
The emotional Stroop employed in this study followed the same principles as the
Stroop Color Word Test, with the exception that the words listed in the latter two trials
were emotionally salient. Modeled after the 1978 Golden version of the Stroop, four
trials were administered: reading of neutral words (e.g., hat, swim, book); colour naming
of neutral words; colour naming of negative words (e.g., disaster, failure, pathetic); and
colour naming of positive words (e.g., happy, smile, clean). Each trial contained 100
words. For the latter three trials, participants were required to name the colour of the ink
in which the words were printed. A total of 45 seconds was allotted for each trial. Scores
were calculated for each individual trial, producing a Word Score, a Color Score and a
Color-Positive Word Score, and a Color-Negative Word Score. An overall total
interference score was also derived by subtracting the participant’s combined score for
the Positive and the Negative Word Scores from the combined Word and Color Score.
In creating the emotional Stroop test used in this study, a review of the literature
provided information pertaining to the appropriate word parameters to employ. Larsen,
Mercer, and Balota (2006) analyzed the lexical characteristics of words used in emotional
stroop experiments. From the studies they analyzed that utilized negative, positive, and
neutral conditions, we chose to use the neutral and positive word lists from Compton,
Heller, Banich, Palmieri, and Miller (2000). Since these lists contained 12 words, we
eliminated two words in order to fit our format (i.e., 10 positive, 10 negative and 10
neutral words). Since the negative word list from Compton’s study included words of a
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threatening nature, as opposed to a purely negative emotional nature, we created our own
negative word list by utilizing the online MRC Psycholinguistic Database
(http://www.psy.uwa.edu.au/mrcdatabase/uwa_mrc.htm) (Coltheart, 1981). We limited
our word search to match the lists employed by Compton and Larsen’s groups in terms of
word length, number of syllables, concreteness, imageability, and familiarity. All words
were one syllable and 3-6 letters long. The concreteness, imageability, and familiarity
ratings for the positive word list used in Compton’s study were 359, 435, and 609,
respectively, whereas the ratings for the neutral word list were 373, 442, and 624,
respectively. Limits in the Psycholinguistic database were set at 100 higher and lower
than these ratings. The concreteness, imageability, and familiarity ratings for the
negative word list created for this study were 358, 436, and 540, respectively. These
ratings were similar to those of the neutral and positive lists used by Compton’s group.

Attention/Concentration
Digit Span (DS; from the Wechsler Adult Intelligence Scale –Third Edition (WAIS-III);
Wechsler, 1997)
The Digit Span is a measure of auditory attention span and working memory. In
this task, participants were required to listen to and repeat an aurally presented string of
numbers that increased in length with each successive trial. The task was discontinued
following errors on both digit strings within a trial. The task was then completed in a
backward condition wherein participants were required to repeat a string of aurally
presented numbers backwards (i.e., in the reverse sequence as was presented). The
backwards condition, which taps into the domain of working memory, is thus the harder
of the two conditions. Discontinuation on the backward condition occurred when both
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digit strings within a trial were incorrect. The total number of digits correctly recalled in
both the forward and the backwards trials were calculated by simple summation of
correct responses, resulting in a total forward score, a total backward score, and an
overall total score. Scores range from 0-16 on the forward condition, and from 0-14 on
the backward condition. Scores on the backward condition were employed as pre- and
post-test measures of the tryptophan manipulation as there is evidence in the literature
that this task is sensitive enough to differentiate between tryptophan augmentation and
deletion (e.g., Luciana et al., 2001). The reliability of the Digit Span subset is high (r =
.90). Digit Span correlates the best with the Letter-Number Sequencing subtest from the
WAIS-III (r = .57), and demonstrates a moderate correlation with the Verbal Scale (r =
.51) (Sattler, 2001).
Letter-Number Sequencing (from WAIS-III; Wechsler, 1997)
Letter-number Sequencing is a measure of working memory and attention that
involves the aural presentation of complex auditory material (letters and numbers) that
the participant must mentally manipulate and reproduce according to specific criteria
(i.e., letters in alphabetical order, followed by numbers in numerical order). There is no
time limit on this task, and discontinuation occurred when all three trials of an item are
incorrect. The total number of correct trials was calculated. The reliability of the LetterNumber Sequencing subtest is high (r = .82), demonstrating a moderate correlation with
the Verbal Scale of the WAIS-III (r = .62). Of the other subtests comprising the WAISIII, Letter-Number Sequencing best correlates with Digit Span (r = .57) (Sattler, 2001).
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Digit Symbol – Coding (from WAIS-III; Wechsler, 1997)
Digit Symbol – Coding is a task of visual attention and working memory. In this
task, participants were required to re-code a series of symbols using the key-code
provided at the top of the page. This is a timed task, and discontinuation occurred after
two minutes had lapsed. The total number of correctly recoded symbols served as the
score for this task. The Digit Symbol – Coding subtest of the WAIS-III is reliable (r =
.84) and demonstrates a moderate correlation with the Performance Scale (r = .50)
(Sattler, 2001).
Ruff 2 & 7 Selective Attention Test (Ruff & Allen, 1996)
The Ruff 2 and 7 Selective Attention Test is a selective visual cancellation task
that assesses the difference between automatic and controlled visual search (i.e.,
processing speed). In this task, participants were presented with 20 blocks of stimuli,
each of which consisted of either three rows of letters (automatic search) or three rows of
numbers (controlled search). Participants were instructed to cross off (with a pen) all of
the 2’s and 7’s that they could within a 15 second block of time. At the end of each 15
second period of time, participants were instructed to stop and to continue with the next
block of stimuli. This task takes a total of 5 minutes to complete and is scored according
to both speed and accuracy of automatic and controlled search. Thus, for the letter trials,
the following scores were derived: Automatic Detection Speed (i.e., total number of
correct hits), Automatic Detection Errors (i.e., the total number of errors) and Automatic
Detection Accuracy scores (calculated in the following manner: Automatic Detection
Speed divided by the sum of the Automatic Detection Speed score plus the Automatic
Detection Errors score, multiplied by one hundred). For the digit trials, scores were
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derived for Controlled Search Speed (i.e., total number of correct hits), Controlled Search
Errors (i.e., the total number of errors), and Controlled Search Accuracy (i.e., Controlled
Speed score divided by the sum of Controlled Search Speed score plus Controlled Search
Errors, multiplied by one hundred). Total Speed and Total Accuracy scores, as well as
Speed Differences, Accuracy Differences, and Total Difference were also calculated by
adding or subtracting speed and accuracy scores, respectively. Ruff and Allen (1996)
report that Speed scores yield higher test-retest reliability than do Accuracy scores;
Lemay, Bedard, Rouleau, and Tremblay (2004) found a .85 correlation between Speed
scores. Although content validity is mainly based on theoretical grounds (Strauss,
Sherman, and Spreen, 2006), it has been reported that Digit Symbol, which also assesses
processing speed, is the test most highly correlated with the Ruff 2 & 7 (r = .35-.40) and
in normal samples it is not correlated with other tests designed to measure attention (e.g.,
Digit Span, Stroop; Ruff & Allen, 1996).
Trail Making Test (Trails A & B; Reitan, 1958)
The Trail Making Test is a speeded visual attention task involving simple
sequencing of numbers. On the first trial (Trails A), participants were instructed to
connect the numbers on the page as quickly as they could without taking their pen off of
the page. The second trial (Trails B) was essentially the same task save for the fact that it
entails alternating between letters and numbers, making it the more complex of the two
tasks. This is a timed test requiring participants to connect the circles of letters (or letters
and numbers) as quickly as possible. The total time required for each condition served as
the score on each trial. Dikmen, Heaton, Grant, and Temkin (1999) report reliability for
both Trails A (.79) and Trails B (.89) as adequate to high, respectively. There is a modest
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correlation between Trails A and B (r = .31-6), a range that is thought to reflect the
greater cognitive demand of the latter as opposed to the former trial (Heilbronner, Henry,
Buck, Adams, & Fogle, 1991).

Memory
California Verbal Learning Test - II (CVLT-II; Delis, Kramer, Kaplan, & Ober, 2000)
The CVLT-II is an aurally presented list learning task requiring the participant to
learn and recall verbal information immediately after presentation. There are five
learning trials, in which the list is repeated each time after which the participant must
reproduce as many words from the list as possible. An interference trial was
administered, followed by Short-Delay Free Recall and Short-Delay Cued Recall trials.
After a 20 minute delay, Long-Delay Free Recall, Long-Delay Cued Recall, and LongDelay Recognition trials were administered. Thus, scores were calculated for: Trials 1-5
Recall Total Correct; List B Free Recall Correct; Short-Delay Free Recall; Short-Delay
Cued Recall; Long-Delay Free Recall; Long-Delay Cued Recall; Free Recall Intrusions;
Cued-Recall Intrusions; Total Intrusions; Total Repetitions; Long-Delay Recognition;
Long-Delay Recognition False Positives; and Long-Delay Forced Choice Recognition
Accuracy. According to the test manual, reliability is high (r = .80-.89) for Trials 1-5
Recall Total Correct, Short- and Long-Delayed Free Recall, and Total Recognition. The
test manual also reports validity scores ranging from .60-.69 for Free-Recall Intrusions to
.80-.89 for Long-Delayed Recognition False Positives.
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Rey-Osterrieth Complex Figure Test (R-OCFT; Rey, 1941; Osterrieth, 1944)
The R-OCFT measures a participant’s ability to accurately copy a complex figure
onto a sheet of paper. Successful completion requires that participants be able to
accurately perceive and synthesize the numerous components of the figure. After the
copy trial, immediate (3 minute delay) and delayed (25-35 minute delay) recall trials
were administered to assess the integration, memory and synthesis of the figure.
Participants also completed a recognition trial to help determine whether performance
was affected by difficulties with perception, synthesis, or retrieval of complex visual
information. Thus, scores were calculated for Immediate Recall, Delayed Recall,
Recognition Total Correct, Copy, and Time to Copy, as well as for Recognition True
Positives, Recognition False Positives, Recognition True Negatives and Recognition
False Negatives. Meyers and Meyers (1995) report reliability scores of r = .76 for
Immediate Recall, of r = .89 for Delayed Recall, and of r = .87 for Recognition Total
Correct. According to Strauss and colleagues (2006), the R-OCFT is a valid measure of
visual-construction (via the copy trial) and memory (recall and recognition trials).

Mood/Affect
Positive and Negative Affect Scale (PANAS; Watson, Clark, & Tellegen, 1988)
The PANAS is a self-report inventory comprised of both a negative affect and a
positive affect subscale. Each scale consists of 10 items, and participants were required
to rate (on a 5-point scale) how well each descriptor described them at that particular
moment. Examples of negative descriptors are irritable, distressed, guilty, or scared;
positive descriptors include such items as determined, strong, enthusiastic, or proud.
Watson (1988) reported correlations of between -. 12 to -.26 for the PANAS scales,
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indicating that the negative affect and the positive affect scales are independent of one
another. With regards to validity, Watson (1988) stated that “[a]ll of the scales are
reasonably convergent with other measures of the same factor, and one must conclude
[that the NA and PA] scales have comparable correlates and lead to similar conclusions”
(p. 138). Discriminant validity between the NA and PA scales has also been reported,
with correlations in the range of r = -.48 (Warr, et al., 1983) to r = .54 (Watson, 1988).
Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996)
The BDI-II is a self-report inventory consisting of 21 items, each of which is
scored on a four-point scale. Indecisiveness, Mood, and Sense of Failure are examples of
items on the scale, each of which pertains to a particular symptom of depression. The
scores for each item were summed together to arrive at a total score; lower scores
translate into lesser degrees of depression. A score of 30 or greater indicates severe
depression. If a participant scored in this range, follow up questions were asked by the
researcher as to the nature and severity of symptoms, including the likelihood of the
participant hurting him or herself or others. No participants scored in this range. As a
precaution, all participants who scored 10 or above were provided with referrals to the
appropriate services, all of which have their contact information listed on the consent
form signed by the participant. If anyone had of endorsed the suicide item, they would
have been walked over to the Student Counseling Centre at the CAW by the researcher.
No one endorsed this item. The BDI-II was only administered as part of the screening
procedures in order to ensure no current depression; it was not administered during the
testing session.
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Results
Prior to analyses, all variables were examined for accuracy of data, missing
values, normality and outliers. Of the 73 participants who completed this study, five
participants failed to complete one of the six PANAS forms and thus these participants
with missing data were excluded from analyses relevant to the PANAS; all other analyses
contained data from all 73 participants. Data was screened for multivariate outliers using
Mahalanobis’s distances, and none were found. All assumptions of analyses of variance
(ANOVA), multivariate analyses of variance (MANOVA) and repeated measures were
met (or corrected for). Raw test scores were used in all analyses, and data was analyzed
using SPSS for Windows Version 17 (SPSS Inc., Chicago, IL, USA).
A correlation matrix was conducted in order to examine the relationship between
the background variables (e.g., age, education, physical activity level, BDI score, etc.)
and all cognitive and affective measures. Results of this analysis can be seen in Table 5.
As can be seen from Table 5, several key measures did not correlate with any
background variables (e.g., CVLT Long Delay Recall, Rey-O Delayed Recall); every
background variable correlated with at least one test measure.
As we were unable to recruit equivalent numbers of males and females, it was unclear
whether there were any gender differences on the background variables of English as a
Second Language (ESL), eating frequency 1 , level of physical activity 2 or BMI. This was
an important consideration as many researchers within the field have collected data only
1

‘Eating frequency’ is the term used in this document to refer to the average number of hours between
eating each meal or snack as reported by the participant during the screening session.
2
Levels of physical activity was measured via self-report by each participant during the screener. A 4point Likert scale was utilized, enabling participants to report their levels of physical activity during a
typical week as either “Not at all” (i.e., no exercise of any kind), “Minimal” (e.g., walking to school),
“Quite” (physical activity 3-5 times per week), or “Very” (physical activity 6 or more times during the
week). See Appendix C for more detail.
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Table 5
Correlations Between Background Variables and Tests Comprising Predictions and Composite Scores a.
Test

Age

Educb.

BMIc

Weight
(lbs)

Height
(in.)

Eating
Freq.d

Sleep
(hrs)

BDIe

Physical
Activity f

1. CVLT-II g Long Delay Recall

.22

.28

.18

.12

-.03

-.10

-.09

-.17

-.04

2. Rey-O Delayed Recall

.12

.20

.21

.10

-.07

.18

-.16

-.03

-.22

3. Stroop Interference

.09

.09

-.14

-.11

.01

-.06

.10

.00

-.20

4. Trails A

-.25* -.20

-.28*

-.33**

-.19

.16

.25*

-.05

.16

5. Trails B

-.13

-.06

-.10

-.20

-.16

.07

.14

.07

.13

6. Ruff 2 & 7 Total Speed

.25*

.29*

.22

.31**

.23

-.05

-.02

.02

-.20

7. Ruff 2 & 7 Total Accuracy

.12

.15

-.24

-.05

.14

-.12

-.08

-.11

-.40

8. Digit Symbol Coding

.01

.09

-.07

-.08

-.00

-.32**

.15

-.15

-.14

9. Letter Number Sequencing

.01

-.04

-.02

.09

.14

-.23

.00

-.09

-.25

-.08

-.10

-.08

-.02

.07

-.24*

.15

.08

-.10

11. EStroop Negative Interference -.06

.04

-.08

-.22

-.21

-.35**

-.10

-.21

-.12

12. Digit Span 2 Total

.24*

.05

.13

.11

-.02

.07

-.26*

-.34

10. EStroop Positive Interference

.30*
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Educb.

BMIc

Height
(in.)

Eating
Freq.d

Sleep
(hrs)

BDIe

Physical
Activity f

-.05

.05

.05

-.17

-.16

.17

.13

-.13

.05

-.22

-.32

-.18

-.06

.09

-.17

.16

-.17

-.34

.13

.03

.13

.16

.20

-.22

.04

.13

.08

.04

.03

.10

.11

.13

-.24

.05

.07

18. Positive PANAS 3

-.02

-.04

.01

.15

.20

.07

-.21

.10

.11

19. Positive PANAS 4

-.01

.00

-.11

.04

.15

.14

-.30*

.11

.13

20. Positive PANAS 5

.04

.04

.01

.12

.16

.06

-.34** .16

.13

21. Positive PANAS 6

.04

.50

-.05

.08

.18

.01

-.24

.11

.17

22. Negative PANAS 1

-.14

-.18

.07

.12

.14

.02

-.13

.58**

.20

23. Negative PANAS 2

-.09

-.12

.08

.06

.02

.09

-.09

.51**

.10

24. Negative PANAS 3

-.15

-.17

.16

.08

-.04

.04

-.18

.58**

.20

25. Negative PANAS 4

-.12

-.16

.07

.09

.07

-.03

.03

.58**

.13

26. Negative PANAS 5

-.12

-.19

.11

.08

.02

-.04

-.05

.54**

.15

Test

Age

13. FAS h Total

.33** .20

14. Working Memory

.27*

.17

.08

15. Attention

.11

.16

16. Positive PANAS i 1

.20

17. Positive PANAS 2

.17

Weight
(lbs)
.05
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Test

Age

Educb.

27. Negative PANAS 6

-.08

-.11

BMIc
.09

Weight
(lbs)
.08

Height
(in.)

Eating
Freq.d

.05

.04

Sleep
(hrs)
-.01

BDIe
.49**

80

Physical
Activity f
.06

** p < .01, * p < .05
a
Collapsed across gender; b Education (years); c Body Mass Index; d Eating Frequency = average time (hrs) between each meal and/or
snack; e Beck Depression Inventory - II score; f biserial correlation conducted on dichotomized (i.e., ‘low’ and ‘high’) variable; g
California Verbal Learning Test-II; h ‘F’, ‘A’, ‘S’ verbal fluency test; i Positive And Negative Affect Scale. Note. All PANAS
correlations excluded participants with missing data (n = 68).
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on males (e.g., Fischer et al., 2002; Hughes et al. 2003; Lieberman et al., 2002; Park et
al., 1994) or females (e.g., Nabb & Benton, 2006). Thus, examining each gender
separately allowed us to better compare our findings to those in the literature.
Looking at each gender separately, ESL proportions did not differ for females
[χ²(2, N = 50) = .01, p =.994] or males [χ²(2, N = 23) = 1.10, p =.577]. With regards to
eating frequency, it had been suggested by Craig (1986) that the amount of time between
each meal is likely to influence the effect of the manipulation on performance in that
those with a faster metabolism may have a different peak level of augmentation or
depletion than those with a slower metabolism. For this reason, a chi-square analysis was
also conducted on eating frequency, demonstrating no significant group differences for
either females [χ²(4, N = 50) = 2.60, p =.627] or males [χ²(4, N = 23) = 2.63, p =.622].
The chi-square analysis examining the proportions of physical activity levels across meal
types for females, however, violated the assumption of expected frequencies, with more
than 20% of the cells having an expected cell count of less than 5, thus rendering this
analysis uninterpretable. Examination of the chi-square table illustrated that the lowest
(i.e., ‘Not at all’) and highest (i.e., ‘Very’) categories of physical activity for each meal
condition were the cells with expected frequency counts of less than 5.
This analysis was repeated for the males, with the same result being obtained.
The assumption of expected frequencies was violated, as all nine cells had an expected
cell count of less than 5, again rendering the analysis uninterpretable. Examination of
cell counts in the chi-square table, it is evident that the lowest category (i.e., ‘Not at all’),
which was not endorsed by any males, and the highest category (i.e., ‘Very’) of physical
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activity for each meal condition were the cells that violated the assumption of expected
frequencies most gravely.
Since the values in the ‘Not at all’ and ‘Very’ categories for both the females and
the males rendered the analyses uninterpretable due to their low levels of endorsement,
we collapsed across these more extreme activity levels to instead create two categories of
physical activity. The ‘low’ category was generated by collapsing across the ‘Not at all’
and the ‘Minimal’ levels of activity, whereas the ‘high’ category was created by
collapsing across the ‘Quite’ and the ‘Very’ levels of activity. By doing so, the chisquare analysis of physical activity levels no longer violated the assumption of expected
frequencies for females. Levels of physical activity (using these dichotomized ‘low’ and
‘high’ physical activity levels) were significantly disproportionate across meal conditions
for females [χ²(2, N = 50) = 16.86, p =.000]. The Augmented group had a greater
proportion of participants within the ‘low’ level of physical activity (n = 13, 76.5%),
whereas the Depleted group had a greater proportion of participants within the ‘high’
category of physical activity (n = 15, 93.8%) (see Table 6).
A chi-square analysis examining levels of physical activity (using the
dichotomized ‘low’ and ‘high’ physical activity levels) was also conducted for the males
and demonstrated a violation of the assumption of expected frequencies. Since more than
20% of the cells had an expected cell count of less than 5, the analysis was
uninterpretable (see Table 7).
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Table 6
Chi-square Results for Proportion and Percent Total of Dichotomized Physical Activity
Levels by Meal Type for Females

Meal

Physical Activity Levels
Low
High
Count (%)
Count (%)

Augmented

13 (76.5)

4 (23.5)

Depleted

1 (6.3)

15 (93.8)

Balanced

9 (52.9)

8 (47.1)
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Table 7
Chi-square Results for Proportion and Percent Total of Dichotomized Physical Activity
Levels by Meal Type for Males

Meal

Physical Activity Levels
Low
High
Count (%)
Count (%)

Augmented

2 (25.0)*

6 (75.0)

Depleted

1 (14.3)*

6 (87.5)*

Balanced

5 (62.5)*

3 (37.5)

*expected cell count of less than 5.
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When BMI was analyzed separately for each gender, no significant difference
emerged between meal types for either the females [F(2, 47) = .02, p =.985, partial η2=
.00] or the males [F(2, 20) = .43, p =.656, partial η2= .04] (see Table 8 for group means
and SDs).
Overall, no gender differences were found for ESL or eating frequency. Levels of
physical activity, although significant for the females when dichotomized into ‘low’ and
‘high’ levels of activity, was not significantly correlated with any of the variables on
which the predictions were based. Thus, despite there being an unequal proportion of
levels of physical activity among female participants in Augmented and Depleted
conditions (respectively), it does not appear that this difference was great enough to
influence test scores. For this reason, level of physical activity is excluded from all
further analyses. For exploratory purposes, however, all female analyses were repeated,
examining low- and high-activity level participants separately on each test measure. The
results were largely the same. The only significant difference was on the EStroop
Positive Interference for the high-activity females [F(2, 24) = 3.84, p =.036, partial η2=
.24]. Post-hoc comparisons showed a significant difference between those in the
Augmented group (M = 12.00, SD = 4.24; n = 4) and those in the Depleted group (M =
2.80, SD = 7.04; n = 15). With regards to BMI, when taken together with the results of
the correlation matrix and above mentioned ANOVA, results of these analyses indicate
that the BMI distribution is equal between meal groups and the difference is thus not
large enough to influence test scores. For this reason, BMI was excluded from further
analyses. This is in keeping with the norm within the literature in that researchers may
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Table 8
Mean and Standard Deviation of BMI Scores by Gender and Meal Type
BMI Score
Female

Male

Meal Type

M

SD

M

SD

Augmented

21.97

2.48

23.38

2.64

Depleted

21.84

2.69

24.64

2.98

Balanced

22.00

2.95

23.75

2.48
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control for BMI when recruiting participants (e.g., Markus et al., 1998; Nabb & Benton,
2006), but they do not include it in subsequent analyses.
Effects of the Tryptophan Manipulation
Working memory and self-report affect indices have been found to be sensitive
measures in previous studies examining the effects of tryptophan manipulation on
neuropsychological performance (e.g., Kanarek & Swinney, 1990; Lieberman et al.,
2002; Luciana et al., 2001). For this reason, the Digit Span Backwards scores and the
PANAS NA and PA scores over time were employed to serve as indicators of the
effectiveness of the tryptophan manipulation. In order to assess whether the dietary
method of tryptophan manipulation successfully altered levels of circulating tryptophan
in females, a one-way ANCOVA of meal type (augmentation, depletion, or balanced)
was conducted on the Digit Span Backward Time 2 raw scores, with the Digit Span
Backward Time 1 raw score entered as a covariate. There was no main effect of meal
type [F(2, 46) = .61, p =.549, partial η2= .03]. As expected, however, Digit Span
Backward Time 1 score was a significant covariate [F(1, 46) = 24.54, p =.000, partial η2=
.35]. An identical analysis was conducted for the male participants. As with the females,
there was no main effect of meal type [F(2, 19) = .34, p =.713, partial η2= .04], but Digit
Span Backward Time 1 score was a significant covariate [F(1, 19) = 15.04, p =.001,
partial η2= .44]. These results indicate that there were no significant between group
differences for either females or males on the Digit Span Backward Time 2 score, one of
the two pre- post-test measures selected to examine the effectiveness of the manipulation
(see Table 9 for mean scores on Digit Span Backward 2 scores split by gender and meal
type).
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Table 9
Mean and Standard Deviation of Test Scores on Digit Span Backward 2 Scores by
Gender and Meal Type
Digit Span Backward 2 Scores
Female
Male
SD
M
SD

Meal Type

M

Augmented

8.47

2.27

8.63

2.62

Depleted

8.19

2.51

8.71

2.56

Balanced

7.29

2.42

7.50

2.73
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In order to determine whether mood scores changed over time as a function of the
manipulation, a repeated measures ANOVA of meal type on the NA scale of the PANAS
(administrations 1 through 6) was conducted for each gender separately. For the females,
Mauchly’s test indicated that the assumption of sphericity had been violated for the main
effect of NA, χ²(14) = 60.28, p =.000. Thus, degrees of freedom were corrected using
Greenhouse-Geisser estimates of sphericity (ε = .65 for the main effect of NA). The
main effect of NA was not significant [F(3.24, 149.23) = 1.23, p =.301, partial η2= .03],
nor was the main effect of meal type [F(2, 46) = .08, p =.923, partial η2= .00]. The
interaction between NA and meal type was also not significant [F(10, 230) = .42, p
=.936, partial η2= .02].
These analyses were repeated for the males. As with the females, Mauchly’s test
indicated that the assumption of sphericity had been violated for the main effect of NA,
χ²(14) = 54.57, p =.000. Thus, degrees of freedom were corrected using GreenhouseGeisser estimates of sphericity (ε = .50 for the main effect of NA). The main effect of
NA was not significant [F(2.52, 40.24) = 4.00, p =.019, partial η2= .20], nor was the main
effect of meal type [F(2, 16) = .51, p =.611, partial η2= .06]. The interaction between NA
and meal type was also not significant [F(10, 80) = 1.14, p =.343, partial η2= .12] (see
Table 10 for mean NA scale scores split by gender and condition).
An identical set of repeated measures ANOVAs were conducted examining the
effect of meal type on the PA scale of the PANAS (administrations 1 through 6) for each
gender. For the females, Mauchly’s test of sphericity indicated that the assumption of
sphericity had been violated for the main effect of PA, χ²(14) = 34.48, p =.002. Thus,
degrees of freedom were corrected using Greenhouse-Geisser estimates of sphericity (ε =

Tryptophan
Table 10
Mean and Standard Deviation of Test Scores on Negative Affect (NA) Scale by Gender
and Meal Type
NA Scale Scores
Female
Meal Type

M

Male
SD

M

SD

NA Scale 1
Augmented

12.69

4.25

14.17

5.91

Depleted

12.56

3.48

12.83

3.66

Balanced

12.47

4.35

15.57

4.04

NA Scale 2
Augmented

11.50

2.76

12.17

2.48

Depleted

12.44

4.46

12.17

3.25

Balanced

11.76

4.76

12.86

2.48

NA Scale 3
Augmented

12.38

3.14

12.67

3.08

Depleted

12.44

3.03

12.17

3.37

Balanced

11.71

2.95

12.86

1.95

NA Scale 4
Augmented

11.88

3.69

12.17

1.94

Depleted

12.13

2.47

11.83

2.56

Balanced

12.18

3.19

12.29

1.80
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NA Scale Scores
Female
Meal Type

M

Male
SD

M

SD

NA Scale 5
Augmented

12.06

2.79

12.67

2.66

Depleted

12.00

2.16

11.50

1.52

Balanced

12.00

2.96

13.00

2.31

NA Scale 6
Augmented

12.19

4.02

12.33

2.34

Depleted

13.31

5.21

13.67

3.61

Balanced

12.47

2.18

16.57

6.90

91

Tryptophan

92

.76 for the main effect of PA). There was no significant main effect for PA [F(3.80,
174.93) = 1.69, p=.157, partial η2= .04]. The main effect of meal type was also not
significant [F(2, 46) = .59, p =.599, partial η2= .03]. There were no significant
interactions between PA and meal type [F(10, 230) = .17, p =.998, partial η2=.01].
These analyses were repeated for the males. As with the females, there was no
significant main effect for PA [F(5, 75) = .95, p =.455, partial η2= .06]. The main effect
of meal type was also not significant [F(2, 15) = .66, p =.530, partial η2= .08]. There
was, however, a significant interaction between PA and meal type [F(10, 75) = 2.19, p
=.028, partial η2= .23]. Post-hoc comparisons indicate that there was a near-significant
difference between meal types on the fourth administration of the PA, t(15) = -2.13, r =
.48, with those in the Augmented group scoring lower than those in the Depleted group.
As this value is equal to the established p = .05 cut-point for a significant finding and is
only present on one of the six PANAS administrations, it is likely that this result is
spurious and not meaningful (see Table 11 for mean PA scale scores split by gender and
condition).
Overall, these analyses indicate that there were no significant between group
differences for males or for females on pre- and post-test affective scores as measured by
the PANAS NA and PA scales.
Hypothesis 1: Depletion will result in lower scores on measures of LTM.
An ANOVA was conducted examining the effect of meal type on the CVLT
Long-delay Free Recall scores for females. There was no significant main effect of meal
type on the total number of words recalled during the long-delay free recall [F(2, 47) =
.13, p =.882, partial η2=.01]. An identical analysis was conducted for the male
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Table 11
Mean and Standard Deviation of Test Scores on Positive Affect (PA) Scale by Gender
and Meal Type
PA Scale Scores
Female
Meal Type

M

Male
SD

M

SD

PA Scale 1
Augmented

26.69

5.75

29.50

6.57

Depleted

23.75

6.95

31.00

6.60

Balanced

23.76

7.01

32.14

9.19

PA Scale 2
Augmented

26.38

2.27

26.17

8.89

Depleted

23.38

9.16

30.80

6.14

Balanced

23.53

7.15

31.14

9.23

PA Scale 3
Augmented

26.56

7.66

28.83

10.76

Depleted

24.56

7.62

34.80

4.09

Balanced

24.35

7.37

31.00

12.52

PA Scale 4
Augmented

26.63

8.50

24.00*

8.67

Depleted

24.25

6.66

35.00

4.90

Balanced

25.12

7.21

31.29

10.13
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Meal Type

M

PA Scale Scores
Female
SD
M

Male
SD

PA Scale 5
Augmented

25.88

8.45

28.50

7.79

Depleted

24.69

8.30

36.80

5.50

Balanced

24.41

9.10

30.00

7.57

PA Scale 6
Augmented

28.38

8.29

31.33

6.53

Depleted

25.75

8.42

32.60

3.78

Balanced

25.76

10.65

29.00

12.82

*p =.05
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participants. The assumption of homogeneity of variance was violated, however,
necessitating the use of the Brown-Forsythe F correction for unequal group sizes; the
Brown-Forsythe correction is a robust test of the equality of means. Using this
correction, the main effect of meal type on total words recalled was not significant [F(2,
12.07) = .73, p =.493, partial η2= .07].
An identical ANOVA was also conducted to examine the effect of meal type on
Rey-O Delayed Recall scores for females. The main effect of meal type on the number
of elements correctly recalled during the long-delay recall trial was not significant [F(2,
47) = .22, p =.806, partial η2= .01]. This same analysis was conducted for the male
participants, wherein a significant main effect of meal type was found [F(2, 20) = 5.21, p
=.015, partial η2= .34]. Post-hoc comparisons indicate that males in the Depleted
condition scored significantly higher on the Rey-O Long Delay subtest than did those in
the Balanced condition (see Table 12 for mean scores on the CVLT Long Delay Free and
the Rey-O Long Delay split by gender and meal type).
Taken together, the prediction that depletion would result in lower scores on
measures of LTM was not met. In fact, males in the Depleted group scored significantly
higher than did males in the Balanced condition and higher (though not significantly)
than those in the Augmented condition on Rey-O Long Delay Recall, a measure of
visuospatial LTM.
Hypothesis 2: Depletion will result in lower mood scores.
This prediction was tested by conducting a repeated measures ANOVA with the
NA and PA scores from all six administrations of the PANAS. Although this measure
was used to assess the efficacy of the tryptophan manipulation, it was also employed in
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Table 12
Mean and Standard Deviation of Test Scores on the CVLT Long Delay Free Recall and
the Rey-O Long Delay by Gender and Meal Type
Test
Female
Meal Type

M

Male
SD

M

SD

CVLT-Long Delay
Augmented

13.65

2.18

11.63

4.14

Depleted

13.38

2.34

13.14

2.12

Balanced

13.24

7.05

13.13

1.55

Rey-O Long Delay
Augmented

21.88

7.15

21.06 c

4.28

Depleted

20.50

5.68

25.21a

5.71

Balanced

20.65

7.05

16.63 b

5.44

a

p <.05 Significantly different from b but not significantly different from c; b is not
significantly different from c.
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examining the prediction that tryptophan depletion will lower mood scores as it directly
measures changes in self-reported affect throughout the testing session. The prediction
was also assessed by conducting an ANOVA with the Positive and Negative Interference
scores for the Emotional Stroop.
As detailed in the repeated measures ANOVA described in the Effects of the
Tryptophan Manipulation section, four analyses were conducted looking at the NA and
PA scales of the PANAS for each gender separately. There were no significant main
effects for NA or for meal type, nor were there any significant interactions between NA
and meal type for either the females or the males. For the PA analysis, no significant
main effects were found for PA or for meal type for either gender, nor were there
significant interactions between PA and meal type for females. There was, however, a
significant interaction between PA and meal type for the males on the 4th administration
of the PANAS. This interaction, although significant, is not interpretively meaningful.
An ANOVA of meal type on Emotional Stroop Negative Interference scores was
conducted for each gender. No significant main effect was found for meal type on
negative interference scores for females [F(2, 47) = .11, p =.899, partial η2= .01], or for
males [F(2, 20) = .14, p =.874, partial η2= .01].
An identical set of analyses were conducted using the Positive Interference score
of the Emotional Stroop. The main effect of meal type on positive interference scores
was not significant for females [F(2, 47) = .79, p =.459, partial η2= .03], or for males
[F(2, 20) = .02, p =.985, partial η2= .00] (see Table 13 for mean scores on the Positive
and Negative EStroop test split by gender and meal type).
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Table 13
Mean and Standard Deviation of Test Scores on the Negative and Positive EStroop by
Gender and Meal Type
Test
Female
Meal Type

M

Male
SD

M

SD

EStroop Negative Interference
Augmented

10.06

6.18

5.38

5.55

Depleted

9.31

6.67

4.43

5.38

Balanced

8.88

9.24

3.88

6.45

EStroop Positive Interference
Augmented

5.35

6.97

1.50

6.55

Depleted

3.06

6.88

1.86

4.10

Balanced

6.29

8.64

2.00

6.37
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Taken together, these analyses indicate that the prediction that those in the
Depletion group would score lower on measures of mood was not met.
Hypothesis 3: Augmentation will lead to lower scores on measures of working memory.
To assess this prediction, participants’ total raw scores for Letter-number
Sequencing, verbal fluency and Digit Span (total score on the second administration)
were converted into z-scores which were then averaged to arrive at a composite working
memory score for each participant. An ANOVA was conducted examining the effect of
meal type on the working memory composite scores for females. There was no
significant main effect of meal type on working memory scores [F(2, 47) = 1.29, p =.286,
partial η2= .05]. The same analysis was conducted for males, indicating that the main
effect of meal type on working memory scores was not significant [F(2, 20) = .18, p
=.837, partial η2= .02] (see Table 14 for mean scores on the working memory composite
split by gender and meal type). Thus, the prediction that those in the Augmented
condition would obtain lower scores on measures of working memory was not met.
Hypothesis 4: Augmentation will result in functional improvements within the areas of
attention and vigilance.
To test this prediction, a composite attention score was created for each
participant. This was done by converting raw scores for the measures of attention into zscores and averaging them to arrive at a composite attention score for each participant.
The following tests were included in this composite score: Digit Span total score (from
the second administration); Letter-number Sequencing total score; Digit-symbol Coding
total score; Ruff 2 & 7 Total Speed and Total Accuracy scores; Trails A time; and Trails
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Table 14
Mean and Standard Deviation of Test Scores on the Working Memory Composite by
Gender and Meal Type
Working Memory Composite Score
Female
Male
SD
M
SD

Meal Type

M

Augmented

.13

.64

.03

.92

Depleted

-.01

.89

.29

.86

Balanced

-.27

.63

.04

1.04
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B time. An ANOVA of meal type on composite attention scores was conducted for the
females. Results of this analysis revealed no significant main effect of meal type on
attention composite scores [F(2, 46) = .10, p =.904, partial η2= .00]. The same analysis
was conducted for the males, again revealing no significant main effect of meal type on
attention composite score [F(2, 19) = .80, p =.464, partial η2= .08] (see Table 15 for mean
attention composite scores split by gender and meal type). Thus, the prediction that
Augmentation would result in functional improvements in attention and vigilance was not
met.
Hypothesis 5: The balanced group will score higher than the depletion group on LTM
and on mood indices, and higher than the augmentation group on working memory.
These hypotheses, which were tested via the analyses for Hypotheses 1 through 3
(detailed above), were not met as neither females nor males in the Balanced group
obtained statistically significant higher scores than those in the Depleted or Augmented
groups on these measures. Females in the Balanced group did not score higher than the
females in the Depletion group on the CVLT Long-delay Free Recall [F(2, 47) = .13, p
=.882, partial η2= .01]. Similarly, there were no significant group differences between
females on the Rey-O Delayed Recall [F(2, 47) = .22, p =.806, partial η2= .07]. Scores
on the CVLT Long-delay Free Recall were also not significantly different between males
in the Balanced and Depleted groups [F(2, 12.07) = .73, p =.493, partial η2= .01]. Scores
on the Rey-O Delayed Recall, however, were significantly different between males in the
Balanced and Depleted groups [F(2, 20) = 5.21, p =.015, partial η2= .34], with those in
the Depleted group obtaining higher scores than those in the Balanced group (see Table
12 for mean scores). Overall, the prediction that the Balanced group would score higher
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Table 15
Mean and Standard Deviation of Test Scores on the Attention Composite by Gender and
Meal Type
Attention Composite Score
Female
Male
SD
M
SD

Meal Type

M

Augmented

-.00

.54

.10

.39

Depleted

.03

.48

-.02

.35

Balanced

.06

.37

-.17

.49
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than the Depleted group on measures of LTM was not met. In fact, males in the
Balanced group scored significantly lower than those in the Depleted group on the Rey-O
Delay Recall, a measure of visuospatial LTM (see Hypothesis 1 for further details).
The hypothesis that those in the Balanced group would obtain higher scores in
the mood indices was also not met. Neither the females [F(2, 46) = .08, p =.923, partial
η2= .00] nor the males [F(2, 16) = .51, p =.611, partial η2= .06] in the Balanced group
scored higher than those in the Depletion group on the NA scale of the PANAS.
Similarly, there were no group differences on the PA scale for the females [F(2, 46) =
.59, p =.599, partial η2= .03] or for the males [F(2, 15) = .66, p =.530, partial η2= .08].
Females in the Balanced group also failed to score higher than the Depletion group on the
Emotional Stroop Negative [F(2, 47) = .11, p =.899, partial η2= .11] or Positive [F(2, 47)
= .79, p =.459, partial η2=.03] Interference trials. Similarly, males in the Balanced group
failed to score higher than those in the Depletion group on either of the Negative [F(2,
20) = .14, p =.874, partial η2= .01] or Positive [F(2, 20) = .02, p =.985, partial η2= .00]
Interference trials of the Emotional Stroop (see Table 13 for mean scores). Taken
together, these analyses demonstrated that the Balanced group did not score higher than
the Depletion group on mood indices (see Hypothesis 2 for further details).
The hypothesis that those in the Balanced group would score higher than those in
the Augmented group on measures of working memory was also not met for either the
females F(2, 47) = 1.29, p =.286, partial η2=.05] or the males [F(2, 20) = .18, p =.837,
partial η2= .02] (see Table 14 for mean scores; see Hypothesis 3 for further details).
Overall, hypotheses made in Hypothesis 4 were not met as neither the females nor
the males in the Balanced group obtained statistically significantly higher scores than

Tryptophan

104

those in the Depleted group on measures of LTM and mood, and they did not obtain
statistically significant higher working memory scores than those in the Augmented
groups.
Hypothesis 6: The balanced group will score lower than those in the augmentation group
on tests of attention and vigilance.
As discussed in the ANOVA of meal type on attention composite scores detailed
in Hypothesis 4, neither the females [F(2, 46) = .10, p =.904, partial η2= .00] nor the
males [F(2, 19) = .80, p =.464, partial η2=.08] in the Balanced group obtained a lower
score on tests of attention and vigilance than did those in the Augmented group (see
Table 15 for mean scores; see Hypothesis 4 for greater details). Thus, this hypothesis
was not met as there were no statistically significant between group differences on the
attention composite.
Exploratory Analyses
Exploratory analyses were also conducted in order to assess whether there were
any group differences on the other cognitive measures comprising the composite scores
or on the individual items of the PANAS. As the nature of exploratory analyses is to
examine whether any findings emerge that would warrant further exploration in future
research, no corrections for multiple comparisons were conducted; we were more
concerned with Type II error (i.e., sensitivity) than with Type I error (i.e., specificity) (S.
Miller, personal communication, March 17, 2010). In keeping with previous analyses,
females and males were analyzed separately.

Tryptophan

105

In an exploratory way, the individual items of the PANAS were analyzed in order
to examine the individual affects (e.g., upset, interested, enthusiastic) captured by the
PANAS. As initial exploratory analyses, a MANOVA was conducted for each gender
examining the effect of meal type on the difference scores for each item. The difference
scores were created by subtracting the score on PANAS Time 6 from the score on
PANAS Time 1 for each individual item, resulting in 20 difference scores, one for each
item on the PANAS. No significant between group differences emerged for females for
any of the items (see Table 16).
This analysis was repeated for the male participants. A significant between group
difference was found for males on the Excited difference scores [F(2, 16) = 3.81, p
=.044, partial η2= .32] (see Table 17). Post-hoc comparisons indicate that the Excited
item was significantly different between the Balanced and Depleted groups, t(16) = 2.51,
p =.023, r =.47.
In order to determine whether or not the individual items on the PANAS were in
fact stable and reliable across time, test-retest reliability analyses were conducted on the
NA scale as prior research has found the NA scale to be the most sensitive to tryptophan
manipulation. These analyses, which were conducted on the Balanced group,
demonstrated that the NA is in fact stable over time, r = .78, p <.01. Further examination
revealed that the Excited item is also reliable over time, with an average correlation of r
=.72 (when collapsed across gender) or of r =.80 (when only males are included). As
difference scores have an inherently greater degree of error in them compared to repeated
measures analyses, it was unclear whether there was, in fact, a change in excitement
levels over time. For this reason, a repeated measures ANOVA was conducted on meal
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Table 16
MANOVA for Each PANAS Item for Females
PANAS Item

df

F

partial η2

p

Interested

2

.22

.01

.807

Distressed

2

2.29

.09

.113

Excited

2

.08

.00

.921

Upset

2

.14

.01

.870

Strong

2

.27

.01

.767

Guilty

2

.24

.01

.791

Scared

2

.04

.00

.965

Hostile

2

.97

.04

.386

Enthusiastic

2

.22

.01

.801

Proud

2

.19

.01

.827

Irritable

2

1.44

.06

.248

Alert

2

.40

.02

.674

Ashamed

2

.18

.01

.839

Inspired

2

.03

.00

.966

Nervous

2

.76

.03

.474

Determined

2

.25

.01

.784

Attentive

2

.54

.02

.588

Jittery

2

.02

.00

.982

Active

2

.85

.04

.432

2
46

.05

.00

.951

Afraid
Error
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MANOVA for Each PANAS Item for Males
PANAS Item

df

F

partial η2

p

Interested

2

.23

.03

.794

Distressed

2

.95

.12

.408

Excited

2

3.81

.32

.044

Upset

2

1.75

.18

.206

Strong

2

1.44

.15

.266

Guilty

2

.84

.10

.449

Scared

2

.61

.07

.556

Hostile

2

2.02

.20

.165

Enthusiastic

2

1.30

.14

.301

Proud

2

2.58

.24

.107

Irritable

2

1.01

.11

.385

Alert

2

.31

.04

.739

Ashamed

2

.26

.03

.777

Inspired

2

.68

.08

.521

Nervous

2

1.16

.13

.338

Determined

2

1.30

.14

.300

Attentive

2

.22

.03

.809

Jittery

2

1.22

.13

.321

Active

2

1.16

.13

.340

2
16

1.10

.12

.358

Afraid
Error

107

Tryptophan

108

type on Excited scores for all 6 times (male participants only). Mauchly’s test of
sphericity indicated that the assumption of sphericity had been violated for the main
effect of Excited, χ²(14) = 27.72, p =.017. Thus, degrees of freedom had been corrected
for using Greenhouse-Geisser estimate of sphericity (ε = .65 for the main effect of
Excited). There was no significant main effect for Excited [F(3.24, 51.88) = .53, p =.677,
partial η2= .03]. The main effect of meal type was also not significant [F(2, 16) = 2.64, p
=.102, partial η2= .25], nor was the interaction between Excited and meal type [F(10, 80)
= 1.49, p =.158 , partial η2= .16] (see Table 18 for mean Excited scores by meal type over
time).
Although the overarching omnibus analysis was not significant, post-hoc
comparisons were examined for exploratory purposes to see if any trends existed within
the data. Post-hoc comparisons indicate that the Excited item was significantly different
between the Augmented and Depleted groups on Time 4, t(16) = -2.74, p =.015, r = 0.75,
Time 5, t(16) = -2.14, p =.048, r = 0.47, and on Time 6, t(16) = -2.12, p =.050, r = 0.47.
These post-hoc comparisons indicate a trend wherein those in the Depleted group
experienced a fairly modest, but linear, increase in excitement level over time, whereas
excitement was lowered between administration two through four before increasing
drastically by the sixth administration for those in the Augmented group. Participants in
the Balanced condition demonstrated a subtle decrease in excitement levels over time
(see Figure 2 for mean Excited scores by meal type over time).
Taken together, these analyses suggest that there is a trend between meal type and
level of excitement, indicating that those in the Depleted group experienced an increase
in level of excitement as the study progressed, whereas those in the Augmented group
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Table 18
Mean and Standard Deviation of Excited Item Over Time for Males

Meal Type

Administration
M
SD
Excited 1

Augmented

2.00

.63

Depleted

3.00

.89

Balanced

3.14

1.07
Excited 2

Augmented

2.50

.84

Depleted

3.00

1.27

Balanced

3.00

1.16
Excited 3

Augmented

2.17

1.33

Depleted

3.17

.41

Balanced

3.00

1.29
Excited 4

Augmented

1.83

.98

Depleted

3.50

.55

Balanced

2.71

1.38

109

Tryptophan

Meal Type

M

Administration
SD
Excited 5

Augmented

2.50

.84

Depleted

3.67

.82

Balanced

2.71

1.11
Excited 6

Augmented

2.50

.84

Depleted

3.67

.52

Balanced

2.57

1.27
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Figure 2. Mean Excited scores by meal type over time.
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experienced a dip in excitement levels followed by a steady increase in excitement
towards the latter half of the testing session. The subtle decrease in excitement
experienced by the Balanced group over time was not statistically significant. These
findings may provide some limited evidence for the effect of the manipulation.
Oneway ANOVAs were conducted on all other tests and measures employed in
this study in order to examine the effect of meal type on neuropsychological and
emotional performance; females and males were analyzed separately. As can be seen in
Table 19, the only significant result was found for male participants on the Ruff 2 & 7
Total Speed subtest [F(2, 20) = 4.68, p =.022, partial η2= .32]; all other analyses failed to
reject the null hypothesis. Post-hoc Bonferroni comparisons on the Ruff 2 & 7 Total
Speed subtest revealed significant differences in mean time scores between the
Augmented and Balanced groups but not between the Augmented and Depleted groups,
or between the Balanced and Depleted groups. The Augmented group obtained a mean
speed score of 112.50 (SD = 16.44), the Balanced group obtained the fastest speed score,
with a mean score of 88.38 (SD = 17.44), and the Depleted group obtained a mean speed
score of 104.86 (SD = 13.91). There was no significant difference in time scores between
the Augmented and the Depleted group, or on any other measures for either females or
males.
Discussion
In this study, the effects of tryptophan manipulation on cognitive functioning and
affective state were examined. More specifically, a dietary method of tryptophan
manipulation was employed in order to assess any differences in performance produced
by tryptophan augmentation as compared to tryptophan depletion or balanced tryptophan
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Table 19
ANOVAs on the Effect of Meal Type on All Test Measures Examined in Exploratory
Analyses, Separated by Gender
Test

df

F

partial η2

p

Digit Symbol Coding
Female
Male

2, 47
2, 20

.13
1.26

.01
.11

.878
.305

FAS
Female
Male

2, 47
2, 20

.71
1.16

.03
.10

.495
.334

Letter Number Sequencing
Female
Male

2, 47
2, 20

.87
.22

.04
.02

.425
.808

Stroop Interference
Female
Male

2, 44
2, 18

.25
.15

.01
.02

.783
.865

Ruff 2 & 7 Total Accuracy
Female
Male

2, 46
2, 19

.86
2.00

.04
.17

.428
.163

Ruff 2 & 7 Total Speed
Female
Male

2, 46
2, 20

.12
4.68

.01
.32

.890
.022

Trails A Time (sec)
Female
Male

2, 47
2, 20

3.16
2.01

.12
.17

.052
.160

Trails B Time (sec)
Female
Male

2, 47
2, 20

.66
1.03

.03
.09

.521
.374

Digit Span 2 Total
Female
Male

2, 47
2, 20

.98
.24

.04
.02

.383
.787
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levels. Although the cognitive measure of pre-test/post-test differences (Digit Span
Backwards) failed to detect any significant between group differences for either males or
females, there were marginally significant group differences in positive affect between
males in the Augmented and Depleted group. These differences in PA levels seem to be
primarily driven by the trend in excitement levels between males in the Augmented and
Depleted conditions over time. Group differences were also found for the males on a
visuospatial measure of long-term memory, as well as on a measure of attention and
concentration. Results of this study support the hypothesis that dietary manipulations
aimed at altering tryptophan levels had an effect on some cognitive tests and positive
affect, at least with regards to males.
Did the manipulation affect affect?
Of all the measures employed in this study, it was believed that the PANAS
would be the most sensitive to tryptophan manipulation and it can thus be viewed as a
check on the efficacy of the manipulation. Although no significant results emerged on
the NA scale for either the males or the females, indicating that participants reported no
change in negative affect, a marginally significant finding emerged for males on the PA
scale, but not for females. More specifically, it was found that on the fourth
administration of the PANAS (which was administered immediately after lunch), males
in the Depleted group scored higher on the PA scale than did males in the Augmented
group. As only one of the six administrations demonstrated a near-significant effect of
meal type, with all others being not significant, it is likely that this finding is spurious and
not interpretively meaningful. Thus, despite this trend, no meaningful results emerged
on either the NA or the PA scale for either the females or the males, indicating that
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participants reported no increase or decrease in overall negative or positive affect. This
finding was somewhat unexpected as it was predicted that negative affect (i.e. NA scale
scores) would be affected, whereas a subtle change in positive affect was actually found.
The results of the study by Luciana and colleagues (2001), however, are the
opposite as they found that tryptophan depletion resulted in transient decreases in
negative affect, and a lowering of positive affect, whereas tryptophan augmentation had
no effect on negative affect, but lowered positive affect. Their findings seem to indicate
that positive affect can be decreased by either augmentation or depletion of tryptophan,
whereas the effect on negative affect is transient at best. This is in contrast to the finding
by several researchers that negative affect is most affected by augmentation of
serotonergic transmission (and thus, presumably, tryptophan; e.g., Bodkin et al., 1997;
Shelton & Brown, 2000; Shelton & Tomarken, 2001), which would indicate that
increased serotonin likely plays a role in reducing feelings of general distress (Dichter et
al., 2005). Reviewing the literature on the effects of tryptophan manipulation on mood
and affect, however, illustrates that there is no consensus within the field. For instance,
many researchers have found no effect of tryptophan manipulation on mood (e.g.,
Hughes et al., 2003; Park et al., 1994; Shansis et al., 2000; Smith et al., 1988), whereas
many others have found that tryptophan depletion lowers mood (e.g., Benkelfat et al.,
1994; Luciana et al., 2001; Riedel et al., 1999; Schmitt et al., 2000; Spring et al., 1983;
Young et al., 1985).
One possible reason for the lack of an effect of tryptophan manipulation on NA
scores in the present study is that perhaps the manipulation was not as strong as expected.
Another possibility is that the inclusion of a macronutrient-manipulated breakfast, lunch
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and snack for each participant lessened (or even perhaps eradicated) the effects of
tryptophan manipulation on negative affect. For instance, many of the studies within the
literature include only a macronutrient-manipulated breakfast or lunch and few include
snacks (e.g., Fischer et al., 2002; Riedel et al., 1999; Spring et al., 1983; Wurtman et al.,
2003). This makes comparison between studies difficult as each study will thus report
differing amounts of carbohydrates, proteins, fats and calories in their meals. For
instance, Wurtman and colleagues employed breakfasts in their study and reported a total
of 175.70 calories for the high carbohydrate meal, and 34.29 calories for the high protein
meal. In the present study, those in the Augmented condition (i.e., high carbohydrate
condition) ingested 931 calories in total, whereas those in the Depleted condition (i.e., the
high protein condition) consumed a total of 881 calories. Since the present study
included two meals and a snack, the calorie intake was thus much higher, making it
difficult to determine whether the manipulation was too weak, or whether there were too
many competing macronutrients for subtle differences in affect to emerge.
An alternative possibility for the lack of an effect of tryptophan manipulation on
negative affect is that perhaps macronutrient content does not exert a strong influence in
the first place, which would consequently make detecting changes difficult. In line with
this notion, Teff, Young and Blundell (1989) reported that a carbohydrate meal
containing as little as 4% protein will counteract the rise in availability of tryptophan to
the brain that would otherwise occur. However, in a study that sampled lumbar
cerebrospinal fluid from 3 normal pressure hydrocephalus patients, Teff, Young,
Marchand, and Botez (1989) found that neither carbohydrates nor protein, ingested 2.5
hours prior to lumbar puncture, resulted in significantly altered levels of central nervous
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system tryptophan or serotonin. While it is possible that this conclusion was the result of
either too little time elapsing between treatment and measurement of the effect, by the
small sample size, or by the sample characteristics (i.e., normal pressure hydrocephalus
patients), it does raise the question of how much of a given macronutrient is required to
influence tryptophan or serotonin levels in the brain and spinal cord, and over what time
is this change detectable? In a more recent study by Lindseth, Petros, Jensen, Lindseth
and Fossum (2006) that examined the effects of macronutrients on the flight performance
of pilots, it was found that a high-fat diet resulted in significantly better performance than
the high-carbohydrate, high-protein or control diets. Furthermore, they concluded that
when on the high-protein diet, pilots performed the worst. These contradictory findings
suggest that the effects of protein (or carbohydrates) on tryptophan availability are not
straightforward. In the present study, the Augmented group had 15% of its total caloric
intake comprised of protein, whereas the Balanced meal only had 2% of it’s calories
coming from protein. In consideration of the findings by Teff, Young and Blundell, the
Balanced group should have displayed some effect of tryptophan manipulation given that
there was not enough protein to quash the emergence of tryptophan-driven effects.
Regarding the statement by Teff, Young, Marchand, and Botez, however, both groups
should have demonstrated some effect of tryptophan based solely on the premise that
protein content does not appear to matter. Fischer and colleagues (2002) had concluded
that their lack of tryptophan-related findings was due to a protein content in the meals
that was still too high, based on the idea that even 4% protein would abolish effects; the
same could possibly be said for the present study regarding the Augmented group.
However, we are not convinced that this is the case in the present study as there appears
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to be no clear consensus on how much protein is required, if any at all, to erase
tryptophan-mediated effects on affect (or cognition). Further, S. N. Young (1993) states
that, “[s]ince few meals eaten by humans will contain less than 4% protein, serotoninmediated changes in behaviour after carbohydrate meals are unlikely to be a normal
physiological phenomenon” (p. 240).
A final possible reason for the lack of findings of an effect of tryptophan
manipulation on NA scores pertains to screening criteria as it seems likely that the
exclusionary criteria used during recruitment would play a critical role in the outcome.
For instance, previous studies have found differing effects of tryptophan manipulation on
mood when studying those with a family history of depression (e.g., Riedel et al., 1999),
personal history of mood disorder (e.g., Price, Charney, Delgado & Heninger, 1991; S. N.
Young, 1993), stress level (e.g., Markus et al., 1998), and even age or gender (Spring et
al., 1983). The present study employed very rigorous exclusionary criteria which makes
it possible that it over-controlled for potential confounding factors, thereby decreasing the
likelihood that any effect would emerge. While this certainly reduces the likelihood of
making a Type I error, it begs the question as to whether the over-stringent controls made
it difficult for more subtle effects to be detected (i.e., Type II error). Reviewing the
literature, it is clear that there is no standard set of exclusionary criteria for this line of
research. For example, the requirements for many studies were merely being ‘healthy’
and free from medication/drug use (e.g., Blum et al., 1992; Coull et al., 1995; Park et al.,
1994). Some studies did not list exclusion criteria at all, only stating that participants
were interviewed about their medical and/or psychiatric history (e.g. Lyons & Truswell,
1988; Wurtman et al., 2003). On the other hand, some studies employed very strict
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controls similar to those used in the present study (e.g., Luciana et al., 2001; Riedel et al.,
1999; Schmitt et al., 2000) and still found effects of the tryptophan manipulation on
affect (and cognition). All of these studies, however, employed within-subjects designs
and all (with the exception of Fischer and colleagues, 2002) utilized an amino acid
tryptophan depletion protocol. The present study utilized a mixed design with a dietary
manipulation of tryptophan. Thus, it is possible that the use of strict exclusionary
criteria, in conjunction with the mixed design and dietary tryptophan manipulation
employed in the present study, prevented the emergence of affective differences. The
mechanism behind such action, however, is still unclear as there are others within the
literature who found effects of tryptophan using a dietary manipulation, including those
who employed between-subject designs but who did not utilize strict exclusionary criteria
(e.g., Spring et al., 1983). Thus, there is some degree of interplay between these three
factors (controls, design and mode of manipulation) that influences whether or not effects
on mood are detected. As more research is conducted within this field, a consensus
should begin to emerge that will indicate which methods and controls provide the most
accurate and replicable results as to the effect of tryptophan on positive and negative
affect.
With regards to specific affects comprising the NA and the PA scales, exploratory
repeated measures analyses of individual affects on the PANAS detected a trend for
males, indicating group differences in levels of excitement on the fourth, fifth and almost
the sixth administrations; no significant group differences were found for either gender
on any of the individual affects. More specifically, it was found that those in the
Depleted group demonstrated a fairly linear (albeit modest) increase in excitement over
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time, whereas those in the Augmented group demonstrated a dip in excitement from
administration two through four before experiencing a drastic increase in excitement by
time six. A limitation of exploratory analyses is that the risk of committing a Type I error
(i.e., of finding a result that is not really there by rejecting the null when it is actually
true) is increased. It is possible that this is the case in the present study as it is difficult to
interpret, from a theoretical perspective, the reason for increased excitement levels in
males in the Augmented and Depleted conditions, the two conditions in which
participants received opposite carbohydrate:protein proportions in their meals, whereas
those in the Balanced condition demonstrated a minor decrease in excitement levels.
Since this finding was not predicted from the outset and does not have a theoretical basis
to support it, any interpretation must be handled with caution. Regardless, one possible
explanation is that perhaps it is not the macronutrient content per se, but rather the
ingestion of greater than normal amounts of dietary components (i.e., carbohydrates or
proteins) that is driving this finding, which could also explain why those who received a
balanced diet demonstrated a minor decrease in level of excitement. This decrease would
not be surprising when one considers that participants were in the lab from 8:45am until
roughly 2pm, a span of approximately 5 hours, during which time it would seem
plausible that activity levels and the degree of alertness would decrease. It is difficult to
maintain a high level of arousal over an extended period of time, so the body naturally
begins to lower its degree of arousal in response. In the current sample, however, the
average score (collapsed across gender and meal type) on the Alert item at time 6 was
3.43 (out of 5), indicating a ‘Moderate’ degree of alertness, which is actually slightly
higher than the average rating of 2.75 (out of 5) that indicated only a ‘Slight’ degree of
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alertness at the start of the study. In a similar vein, scores on the Active item did not
decline over time, with an average score of 2.24 (out of 5) on the sixth administration,
compared to an average score of 2.68 (out of 5) on the first administration. These results
show that in fact, a minor increase in levels of alertness and activity were found over
time, not the expected decrease.
With regards to why the Excited item would be most sensitive to the
manipulation, as opposed to the PA scale in general, it has been reported by Watson,
Clark and Carey (1988), that “[p]ositive affect is a dimension reflecting one’s level of
pleasurable engagement with the environment” (p. 347). Excitement can also be seen as
a pleasurable state of being – we get excited about events to come, or about things we are
presently experiencing. As to why there would be differing levels of excitement over
time for the different meal types, however, is somewhat more difficult to understand.
Recall that in the present study significant differences between the Augmented and the
Depleted group were found for level of excitement at Time 4, Time 5 and almost at Time
6 (for males only), with those in the Depleted group displaying the greatest levels of
excitement at all times. More specifically, Time 4 represents the fourth administration of
the PANAS, which was completed immediately after lunch, and Time 5 (i.e., the fifth
administration) was immediately before the test battery began. Immediately after lunch,
those in the Augmented group experienced the lowest levels of excitement which might
be explained by the finding that carbohydrate-rich foods result in decreased feelings of
dysphoria, alertness and general distress, and increased feelings of calmness
(Christensen, 1993; Christensen, Krietsch, & White, 1989; Pühringer, Wirz-Justice, Graw,
LaCoste & Gastpar, 1976; Spring et al., 2008). Recall that carbohydrate consumption
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leads to increased insulin secretion which acts to draw the large neutral amino acids
(LNAAs), with the exception of tryptophan, into the surrounding tissue. This action
enables tryptophan to pass through the blood brain barrier with little competition, where
5-HTP synthesis occurs, which is immediately converted into serotonin. This process
results in increased serotonin synthesis and activity within the limbic system, including
the amygdala and the prefrontal cortex, which in turn produces a feeling of calmness and
even euphoria (Pühringer, et al., 1976). It is also known that 5-HTP raises endorphin
levels in the brain and endorphins act as the body’s natural defense against pain and
stress of all kinds (physical, psychological, and emotional) (Murray, 1998). Thus, greater
levels of 5-HTP in the brain result in more endorphins being released, which in turn
decreases feelings of stress (Murray, 1998). This decrease in stress could in turn result in
decreased levels of excitement.
Conversely, the (male) Depleted group in the present study experienced higher
levels of excitement over time than did the Augmented group, which seems indicative of
greater sympathetic nervous system arousal. In the present study, the depleted meal was
composed of the lowest level of carbohydrates and the highest level of protein (57 g of
carbohydrates and 39 g of protein, compared to 200 g of carbohydrates and 11 g of
protein in the Augmented condition); thus, it should be expected that the effects of the
depleted meal would be opposite to those of the augmented meal. The finding that those
in the Depleted group experienced the highest levels of excitement over time could be
interpreted to indicate that protein increases one’s level of excitement. Ingestion of
protein has also been linked with self-reported ratings of happiness. For instance, Verger,
Lagarde, Batejat and Maitre (1998) stated that participants reported feeling happier after
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consuming a protein meal than after a ingesting a protein-free meal. However, a study by
DeCastro (1987) reported the opposite result from protein consumption. In his study he
had participants keep a detailed food diary for 9 consecutive days and found that over the
9-day period those who reported a protein-rich diet also reported greater overall levels of
depression. Reconciling these divergent findings is difficult and likely stems from
differing samples, designs and methodologies.
As should be clear, the findings pertaining to the relationship between protein,
carbohydrates and mood are not entirely straightforward as several researchers have
noted that although ingestion of simple carbohydrates leads to increased feelings of
energy in the short-term (e.g., Blouin et al., 1991; Thayer, 1987), in the long-term they
result in increased feelings of fatigue and lower energy levels (e.g., D. P. Wyons & I.
Wyons, unpublished data). Further, as discussed earlier, protein has been found to
influence feelings of happiness and depression (DeCastro, 1987; Verger et al., 1998). In
the present study, participants in the Augmented condition consumed carbohydrates for
an extended period of time (breakfast, lunch and a snack), resulting in decreased
excitement levels following the morning snack. The Depleted group, however, exhibited
a subtle increase in excitement levels over time. By contrast, those in the Balanced
group, whose meals contained carbohydrate:protein ratios between those ingested by the
other two groups, demonstrated a minor decrease in excitement over time. While it is not
clear from the literature exactly what effect specific macronutrients have on excitement
levels, it has generally been found that increases in negative mood typically follow the
consumption of lunch (Craig, 1986; Kanarek, 1997). This conclusion was supported by
males in the Augmented condition of the present study. Nonetheless, these
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interpretations must be made with caution as there are many factors that can influence
these findings, including the size of the meal, it’s caloric and macronutrient content,
whether the participant is a habitual breakfast-eater, and whether the foods ingested were
similar to those normally consumed by participants at home (Kanarek, 1997; Lloyd,
Rogers, Hedderley, & Walker, 1996). It is evident that further research within the area of
the effects of specific macronutrients on individual affects is needed before a clearer
picture can begin to emerge.
Overall, the effect of macronutrients on specific affects or scales is not clear
within the literature. For instance, Lieberman and colleagues (1983) found that
tryptophan resulted in reduced alertness, as measured by the Visual Analogue Mood
Scale (VAMS), whereas scores on the fatigue-inertia scale of the POMS were increased
and scores on the vigor-activity scale of the POMS were decreased. In a later study
conducted by Lieberman (Lieberman et al., 2002), carbohydrates were found to increase
alertness and decrease scores on the confusion scale of the POMS. These results seem
contradictory in light of the fact that carbohydrate consumption has been shown to
increase tryptophan levels in the blood (e.g., Fernstrom & Wurtman, 1971) and has been
found to increase alertness by some researchers (Lieberman et al., 2002) and to decrease
alertness by others (Lieberman et al., 1983). Thus, the results of Lieberman’s respective
studies seem to indicate that tryptophan both increases and decreases levels of alertness.
Taken together, the results of the present study and those in the literature highlight the
need for more research examining not just positive and negative affect on the whole, but
specific affects as well, so that a greater understanding of the influence of tryptophan on
mood and affect can begin to emerge.
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Did the manipulation affect cognitive functioning?
In an attempt to determine the effect of tryptophan manipulation on cognitive
functioning, the present study employed measures aimed at testing the domains of
memory (specifically long-term memory), attention/concentration, and executive
functioning. The Digit Span Backwards was also utilized as a measure of the
effectiveness of the manipulation as there is some evidence within the literature that it is
sensitive enough to detect the effects of tryptophan manipulation (Kanarek & Swinney,
1990; Luciana et al., 2001). The present study, however, failed to replicate these
findings. This result in and of itself does not necessarily indicate that the tryptophan
manipulation did not work, but rather it may indicate that Digit Span Backwards may not
be sensitive enough to detect these effects. This issue of test sensitivity has also been
raised with regards to difficult to measure constructs such as attention. It has been
suggested that paper-and-pencil tests such as those employed in the present study may
not be sensitive enough to detect subtle changes in cognitive functioning produced by
altered levels of brain tryptophan (e.g., Hoyland, Lawton & Dye, 2008; Shansis et al.,
2000). This argument does not hold in light of the fact that the CANTAB battery, which
is known to be sensitive to subtle neuropsychological changes and which was employed
by Hughes’s group (2003) and Park and colleagues (1994), has also failed to reliably
detect tryptophan-induced changes in cognitive performance. Park’s group found that
low levels of tryptophan resulted in poor consolidation of information, which in turn
resulted in lower scores on measures of long-term memory and learning. Conversely,
despite utilizing the exact same depletion methodology as Park, employing many of the
same CANTAB tests, and recruiting a larger sample size, Hughes’s group failed to find

Tryptophan

126

any significant effects of tryptophan depletion on neuropsychological performance,
including long-term memory. Thus, it appears that even tests deemed to be highly
sensitive to subtle changes in cognitive function, such as those produced by tryptophan
manipulation, fail to produce replicable results. Hoyland and colleagues (2008) go one
step further by stating that “[i]t is feasible that commonly employed tasks may be
inadequate measures of performance that mask real effects” (p. 74). In their review of
the macronutrient effects of food on cognition, they concluded that task difficulty seems
to be the best indicator of task sensitivity in that tasks that require the greatest cognitive
load are most sensitive to macronutrient manipulations.
Regardless, significant group differences were found on a visuospatial measure of
LTM. It was predicted that those in the Depletion group would score lower on measures
of LTM. This prediction was in part supported by the finding that males in the Depleted
group scored differently than the other two groups on LTM measures. The prediction
that they would score lower, however, was not met as males in the Depleted group scored
significantly higher than did males in the Balanced group on the Rey-O long delay recall;
no effect was found for the males on the verbal LTM test, or for females on either the
verbal or the visuospatial measure of LTM. The finding for the males on the Rey-O was
somewhat unexpected for the simple reason that most researchers only measure verbal
LTM (e.g., Kaplan et al., 2001; Riedel et al., 1999; Schmitt et al., 2000), whereas those
that do employ visuospatial measures of LTM (e.g., Hughes et al., 2003; Shansis et al.,
2000) find no effect of meal type. Both Hughes and Shansis, however, employed a
within-subject design and used the amino acid protocol for altering tryptophan levels.
The present study employed a mixed-design, and used a dietary manipulation for
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tryptophan. Thus, it is possible that the difference in findings could be related to
methodology. In particular, it seems to bolster the notion broached earlier that extreme
amounts of specific macronutrients could influence cognitive functioning, as the
Depleted group, who ingested low levels of carbohydrates but high levels of protein,
performed significantly better than those in the Balanced group, who did not receive
greater-than-normal amounts of protein (or carbohydrates). Indeed, Kaplan and
colleagues (2001) state that “the ingestion of energy, regardless of source, appears to
improve memory” (p. 691). They found that carbohydrates, protein and fat intake all
improved delayed paragraph recall in their sample of elderly adults (aged 61-79),
although protein in particular enabled participants to recall more details during the delay
recall than on the immediate recall trial. Why this would be so is somewhat unclear. It is
known, however, that protein-containing foods increase phenylalanine, from which
tyrosine is synthesized (Curzon, 1985). Tyrosine, in turn, is the precursor to dopamine,
norepinephrine and epinephrine, the latter two of which are known for their excitatory
effect in readying the body for activity and for increasing alertness (Kolb & Whishaw,
1996; Spring, 1986). According to Lieberman and colleagues (1983), however, “tyrosine
appears to have little or no effect on rested, unstressed volunteers” (p. 246). Dopamine,
on the other hand, plays a role in memory by way of dopaminergic connections between
the basal ganglia and substantia nigra (Kolb & Whishaw, 1996). Thus, it could be that
the findings by Kaplan’s group are mediated by dopaminergic processes. Memory
impairments for nonverbal stimuli, such as objects or drawings, however, are known to
result from damage to the right temporal lobe and surrounding areas, including the
amygdala, hippocampus, and prefrontal cortex (Kolb & Whishaw, 1996). As discussed
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earlier, the hippocampus in particular plays a role in spatial memory as the memory and
perceptual systems are closely linked (Zola & Squire, 2000). The thalamus also plays a
role in memory in that connections between the temporal and prefrontal cortices pass
through the thalamus. Neocortical and brainstem systems, including acetylcholine,
serotonin and norepinephrine systems, all provide input to the temporal lobe and other
regions involved in memory processes (Kolb & Whishaw, 1996). Together, these
processes can lead to greater LTM for visuospatial information.
During exploratory analyses, a significant between-group difference was also
found for males on the Ruff 2 & 7 Selective Attention Test, with those in Augmented
group obtaining a faster speed score than those in the Balanced group; no difference was
found for females. A possible explanation for the findings with males could be due to
cerebellar function, as this area of the brain, although primarily thought of for its motor
control, is involved in speed of information processing (Botez et al., 1985). It does this
through its non-motor pathways, connecting to the thalamus and receiving input from the
frontal, parietal and superior temporal cortices (Schmahmann & Sherman, 1998). These
pathways also influence working memory (Desmond et al., 1997), as well as general
memory and learning (Nyberg, 1998). Together, these functions are all required in order
to successfully complete the Ruff 2 & 7, as the speed with which the task is completed
also requires being able to keep the rules of the task in working memory during
completion. The majority of the serotonergic innervation to all layers of the cerebral
cortex, including temporal, parietal, frontal and cerebellar cortices, comes from the dorsal
raphe nuclei (Graeff, 1997; Molliver, 1987). Thus, a reduction to the amount of
serotonin available to the structures would likely result from lesions to these cerebellar
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pathways. Although it has been reported in the literature that the speed of information
processing slows as a result of such lesions (e.g., Botez et al., 1985), it is not yet clear
whether this outcome is due to decreased tryptophan or due to some other process
influenced by such lesions. For instance, Smith and colleagues (1988) found that
response times to peripheral stimuli on a visual search task were slowed following a high
carbohydrate lunch (i.e., increased tryptophan), whereas those in the high-protein
condition (i.e., reduced tryptophan) experienced greater distractibility to non-relevant
stimuli. These results do not concur with those of the present study, which found faster
response times for those in the Augmented (i.e., increased tryptophan) condition
compared to those in the Balanced and Depleted conditions. An important difference
between these studies, however, is that although both employed a dietary method of
manipulating tryptophan, Smith’s group utilized a within-subject design, whereas the
present study used a mixed-design. Furthermore, the present study analyzed each gender
separately, whereas the study by Smith did not, resulting in a total sample size of 23
males in the present study, versus a mixed sample of 11 participants (5 males, 6 females)
in the latter study. Regardless, the effect of tryptophan manipulation on visual search
tasks is not unanimous within the literature. For instance, Fischer and colleagues (2002)
reported transiently improved attention following carbohydrate consumption (although
they concluded that the balanced and protein conditions resulted in better overall
cognitive performance), whereas several groups have failed to find any effect of
augmented or depleted tryptophan (Hughes et al., 2003; Luciana et al., 2001; Shansis et
al., 2000). As with Smith’s group, the studies that failed to detect any between-group
differences all employed a within-subjects design. As has been discussed previously,
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reconciling the results of the present study with the findings in the literature is difficult
due to the utilization of differing methods of manipulation and different research designs.
Thus, there are several possible reasons for such discrepancies between the
present study and those reported in the literature. For instance, as has been discussed
earlier, there appears to be no real consensus within the field as to the best way to
manipulate tryptophan levels. There is ample evidence, as presented above, to suggest
that at least within those studies that found significant results, the amino acid protocol is
equally effective as the dietary (carbohydrate-loading) method at altering tryptophan
levels. However, even among researchers using the same method, there is little
consistency with regard to dose, with researchers employing macronutrient protocols
ranging from 25g to 100g (e.g., Ford, Scholey, Ayre, & Wesnes, 2000; Green, Taylor,
Elliman, & Rhodes, 2001; Hughes et al., 2003; Park et al., 1994; S. N. Young et al.,
1985). Within the dietary literature, there is even less consistency with regards to dose or
type of manipulation, with some studies employing carbohydrate or macronutrient drinks
(e.g., Kaplan et al., 2001; Lieberman et al., 2002), some utilizing full meals or foods (e.g.
Markus et al., 1998; Smith et al., 1988; Spring et al., 1983), and still others using creamlike pastes or puddings (e.g., Fischer et al., 2002; Teff, Young & Blundell, 1989). To
further complicate matters, there is evidence that the time of day in which the protocol is
administered, in conjunction with the age and gender of participants, also influences
results (e.g., Craig, 1986; Spring et al., 1983). Researchers have also employed different
delay periods between administration of the depletion method and testing session, which
may also influence results. For instance, although Benkelfat and colleagues (1994) found
that 5 hours are needed for tryptophan levels to reach their peak level of depletion
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following the amino acid protocol, some researchers have tested participants 2 to 24
hours after the manipulation (e.g., Coull et al., 1995; Markus et al., 1998; Reidel et al.,
1999; Schmitt et al., 2000), whereas others have tested participants only 15-30 minutes
after ingestion of the macronutrient drinks (e.g., Kanarek & Swinney, 1990; Kaplan et al.,
2001). Furthermore, some researchers have employed the use of maintenance doses
throughout the testing session (e.g., Schmitt et al., 2000), and others still have made use
of practice sessions in order to obtain baselines measures of performance (e.g., Fischer et
al., 2002; Luciana et al., 2001; Riedel et al., 1999). It has been postulated by Hoyland
and colleagues (2008) that the inability of researchers to successfully and consistently
replicate the findings reported in the literature is likely due to these issues of varying
methodologies. In other words, the paucity of research that employs the same tests and
means of manipulation could be the very thing that is hindering progress within this field
of research.
Bellisle (2001) and others have pointed out that there are a myriad of other factors
that can influence test results. For instance, motivation, arousal, previous learning, time
of day, fatigue, and individual characteristics and abilities could all lead to discrepant
findings. Craig (1986) posits that both the quantity and the quality (i.e., the
carbohydrate:protein ratio) of the meal is also important, as is the “nature and
disposition” (p. 163) of the person consuming the meal, such that a person accustomed to
eating large meals will be less affected by the macronutrient components of a large meal
than would a be person who usually eats smaller meals. Further, he states that the
amount of time between each meal is also likely to influence the outcome as someone
who is hungry is likely to be more affected than is someone who is not hungry. This
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reasoning could be extended to include metabolic rate, as someone with a fast
metabolism, who is used to eating more frequently, would likely react differently than
would someone with a slower metabolism. Nonetheless, metabolism is a variable not
often accounted for within the literature (but see Smith et al., 1988) and is typically
excluded from analyses. Although the present study failed to detect any group
differences for females or for males with regards to the average amount of time between
each meal or snack (i.e., the eating frequency variable), it cannot be concluded that this
variable is unimportant. In the present study, participants were asked during the
screening session how many hours typically pass between each meal or snack, which is
admittedly an inaccurate measurement of metabolic rate, especially as participants
reported guessing how many hours passed as they could not pin down the exact amount
of time (on average) between each meal. This could be a promising area of investigation
as metabolism would influence the digestion speed of the meals consumed such that
someone with a faster metabolism may have a different window of opportunity in which
to measure cognitive or affective changes than would someone with a slower metabolic
rate.
Individual differences in neurotransmitter synthesis and activity would also
presumably influence the effectiveness of tryptophan manipulation in that higher or lower
baseline levels would result in greater or lesser amounts of depletion or augmentation.
Along these lines, Steckler and Sahgal (1995) suggest that different and overlapping
neurotransmitter systems, such as the cholinergic and serotonergic systems, exert
different effects on cognitive processes and that manipulating availability of
neurotransmitters in one system could influence the other. In other words, a
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compensatory process could emerge with one system taking over the function(s) of the
incapacitated system until normal functioning is reestablished. This could become even
more apparent when individual differences in these systems get taken into account.
Lastly, results of the present study also suggest that demographic variables may
influence results to some degree and on some tests, a finding echoing that of Spring and
colleagues (1983). Unlike the finding by Sambeth and colleagues (2007), who stated that
females carried the effect for results of tryptophan manipulation on (verbal) LTM, the
present study only found results for males (on visuospatial LTM). With regards to other
demographic variables, it seems that the present study is one of the first to include
demographic variables in the analyses. Certain variables, such as ESL status, BMI, and
eating frequency, were found to exert no influence on test results. However, eating
frequency, as discussed earlier with regards to metabolic rate, was not a well-designed
measure so the results from this analysis are not entirely conclusive. Level of physical
activity, however, did demonstrate some influence on cognitive performance for the
females. It is possible that if data had been collected on a larger sample of males, and an
interval level scale used instead of an ordinal scale, more significant findings would have
emerged. Future research should be sure to employ continuous measurements of physical
activity, as well as metabolic rate and other key variables, in order to ensure more
accurate analyses of factors potentially influencing the effect of tryptophan manipulation
on cognitive and affective measures.
Strengths of the Current Study
This study has several notable strengths, the first of which is the inclusion of an
augmented condition. The majority of the studies in this field of research employ only a
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depletion condition and a control (or, balanced) condition (e.g., Coull et al., 1995; Park et
al., 1994), whereas the present study included both a depleted and an augmented
condition, in addition to a balanced condition, in order to facilitate greater understanding
of any between-groups difference that could emerge. What is more, our stratification of
participants allowed us to ensure that all three groups were comparable in terms of the
age, education level, BMI, eating frequency, ESL status, and gender ratios of the
participants. Had we failed to do so, we may have missed finding important differences
between the Augmented and Balanced conditions on the Ruff 2 & 7 Speed task and
between the Depleted and Balanced conditions on the Rey-O delay recall task. Thus, had
other studies employed all three levels of manipulation, perhaps more findings would be
present within the literature.
Another strength to the present study is that our test battery was a fairly
comprehensive assessment of cognitive functioning, consisting of reliable and wellvalidated measures that are commonly used clinically. Our inclusion of a visuospatial
measure of LTM, a task often omitted from the test battery of other researchers, enabled
the detection of group differences between males in the Depleted and Balanced
conditions.
A final strength to the present study, compared to many studies in the literature,
pertains to the sample collected. We obtained roughly the same female to male ratio in
each of the three meal conditions (approximately 2:1, respectively), whereas many past
studies have included only male (e.g., Hughes et al., 2003; Park et al., 1994) or only
female participants (e.g., Nabb & Benton, 2006). While it might be argued that the
sample employed in the present study was too small, there are several findings within the

Tryptophan

135

literature that support the sample size and gender split utilized. A mega-analysis by
Sambeth and colleagues (2007) was conducted on nine studies employing acute
tryptophan depletion in order to investigate the effects of tryptophan depletion on
declarative LTM and the mediating variables of age, gender and serotonergic
dysregulation. Their results indicate that tryptophan depletion results in lower scores on
measures of delayed (and, to some degree, immediate) recall, but that the effect is larger
for women. Further, they noted that gender was the only variable found to be a factor of
serotonergic vulnerability. The difference in tryptophan levels between the depletion and
control conditions was 9.90 for females (effect size = .60), but only 4.13 for males (effect
size = .29). They calculated that the sample size required for a power of .8 (deemed a
large effect size, according to Cohen, 1992) is 19 for females, but 74 for males. This
female sample size is not altogether dissimilar from that collected in the present study
(Augmented = 17 females; Balanced = 17 females; Depleted = 16 females; total female n
= 50). Cohen (1992) states that for a three group ANOVA with a large effect size (.8)
using alpha at .05, a total of 21 participants per group are required; this number is less
than that collected in the present study, provided we collapse across gender (Augmented,
n = 25; Balanced, n = 25; Depleted, n = 23) . If gender is considered (i.e., a six group
ANOVA), a total of 14 participants per meal and gender group would be needed (Cohen,
1992). The present study has more than 14 participants in each meal condition (collapsed
across gender), but admittedly fewer than 14 males per meal condition when gender is
taken into account. There are, however, more than 14 females in each condition.
Further, as discussed by Sambeth’s group (2007), the effect of tryptophan manipulation is
carried by females, not males, which suggests that our current female sample size is
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likely adequate. This point is particularly relevant as the mega-analysis by Sambeth and
colleagues (2007) only included studies that employed verbal measures of LTM. As the
present study found effects for males on a measure of visuospatial LTM, our smaller
male sample size is likely not an issue. Lastly, examination of the sample sizes of other
between-subject studies within the literature that employed a dietary manipulation of
tryptophan reveals that most contain cell sizes that are either comparable to, or much
smaller than, those in the present study (for both males and females). For example,
Vered (2001) reported cell sizes of between 4 and 6, Rogers and colleagues (1999) report
cell sizes of between 7 and 8, and Markus’s group (1998) reports cell sizes ranging from
6 to 18. Other, larger studies, such as Spring and colleagues (1982) do not explicitly state
their cell sizes, only informing the reader that their 184 participants were split into 4
groups, that 129 were male, 55 were female, and that 81 were aged 18-36, whereas 103
were aged 40-65. Similarly, Lieberman’s group (2002) collected a total sample size of
143 male participants randomly assigned to three groups, but does not indicate the exact
number of participants per condition, leaving the reader to speculate that approximately
47 participants were in each condition. Lastly, Nabb and Benton (2006) report that they
collected data on 189 female participants who were then split into 8 groups with between
23 and 25 participants each. Overall, these studies indicate that the sample size of the
present study is at least comparable to, if not greater than, the standard reported within
the literature which, when taken together with the findings of Sambeth’s group and the
established power analyses of Cohen (1992), indicate the adequacy of the sample in the
present study. Thus, the sample size in this study may be considered a relative strength in
comparison to many studies (particularly those employing a between-subjects design),
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but also a weakness in terms of Cohen’s established levels of adequate power (but only
with regard to the males).
Regardless, what is of interest is that unlike Sambeth and colleagues’ (2007)
findings that females carry the effect for tryptophan depletion lowering verbal LTM, the
present study found that males carried the effect for tryptophan depletion improving
visuospatial LTM. This finding is perhaps due to gender effects showing that males are
better at visuospatial tasks than are females (Burnett et al., 1982; Kaploun & Abeare,
2007; Lewis & Harris, 1990; Linn & Petersen, 1985; Peters et al., 1995) (although these
findings largely disappear when degree of hemispheric lateralization is taken into
account; e.g., Burnett, Lane & Dratt, 1982; Kaploun & Abeare, 2007; McGlone &
Kertesz, 1973; McGlone, 1980). It is also possible that the smaller sample of males
(compared to females in this study) made individual differences stand out more, allowing
them to influence results more than would be the case with a larger sample of males.
Lastly, it could be that these findings are the result of some peculiarity of the sample that
cannot be accounted for and that may not likely be replicated by other researchers.
Whatever the reason, future research should be sure to include equal numbers of men and
women in their sample as this appears to be an important factor in influencing results.
Overall, these factors indicate that our investigation was a strong test of the
hypothesis that dietary manipulation of tryptophan levels affects cognitive functioning
and affective processes.
Limitations of the Current Study
There are, however, some limitations to this study. First, in deference to the
within-subject design commonly found within the literature, the present study employed a
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mixed design. Although such a design does introduce inter-individual variability that
would otherwise be absent in a within-subject study, it does reduce the chances of test
expectancy and repeated testing influencing results, as well as enabling the recruitment of
larger sample sizes with lower attrition rates. This latter point is key as differences in the
findings of previous studies and the present one could be due to sample size of the males.
Thus, it could be that individual differences get disproportionately represented in small
within-subject studies due to the lack of variability within the sample itself. This could
be the reason for the results found for the PANAS PA and the trend in Excitement levels
for males in the present study. This problem is avoided by mixed designs employing
between-subject variables with larger samples.
Another limitation was that we were unable to draw blood assays in order to
assess for alterations in free and total plasma levels of tryptophan, resulting in the
inability to definitively discern whether or not the dietary manipulation successfully
altered circulating tryptophan levels. As several other studies reported in the literature,
however, have similarly failed to draw blood samples from participants (e.g., Kanarek &
Swinney, 1990; Lieberman et al., 2002; Smith et al., 1988; Spring et al., 1983), it was not
felt that this was a strong limitation. There are, in addition, several theoretical and
practical reasons for rightfully excluding the use of blood assays. For instance, although
sampling blood would enable us to determine whether the dietary manipulation
successfully altered circulating tryptophan levels, it does not allow us to definitively
determine whether the levels of tryptophan in the brain have been similarly altered.
Based on this data, we can infer that a change has occurred, but we have no way of
directly measuring brain tryptophan levels or the levels of its metabolites, including
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serotonin. One means of measuring tryptophan metabolism is to measure levels of 5HIAA (the end product of metabolized serotonin) in cerebral spinal fluid (CSF). It has
been assumed that CSF levels of 5-HIAA indicate how much serotonin has been
produced and released in that higher levels of CSF 5-HIAA would correlate with greater
serotonergic activity. For example, in a study by Carpenter and colleagues (1998), a
sample of 5 healthy participants (3 male, 2 female) underwent a tryptophan depletion
protocol (amino acid drink) and then had their lumbar CSF sampled every 15 minutes
over a 13.5 hour time span. The researchers utilized 5-HIAA as a measure of central
serotonin levels, and collected blood samples to measure plasma levels. Despite the
counterintuitive findings that a 92% drop in CSF 5-HIAA levels and an 85% decrease in
blood tryptophan levels occurred, no behavioural or mood changes were found following
tryptophan depletion. From these results, there can be no doubt that tryptophan levels
changed (at least in free-circulating blood levels), but whether these changes lead to
decreases in brain tryptophan or its metabolites, such as serotonin, is unclear. Further, it
is unclear as to whether such changes in blood serum tryptophan levels are even related
to CSF tryptophan levels. It has been found by several researchers (e.g., Perez-Cruet,
Chase & Murphy, 1974; S. N. Young et al., 1976), however, that it is not CSF tryptophan
levels, but rather free tryptophan blood serum levels, that correlate with CSF 5-HIAA.
Together, these findings suggest that CSF 5-HIAA levels can only be used to indirectly
estimate the degree of change in central nervous system tryptophan and serotonin levels
(Carpenter et al., 1998; Degrell & Nagy, 1990; Nishizawa et al., 1997). What is more,
Anderson and colleagues (1990) assert that since serotonin concentrations in CSF are
extremely low and the current methods available for detecting subtle changes in central
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(i.e., brain) CSF are imprecise, it is not clinically useful to assess central serotonin
activity via CSF analysis. Furthermore, Garelis, Young, Lal and Sourket (1974) assert
that lumbar CSF may include 5-HIAA from brain or spinal catabolism of serotonin,
highlighting the fact that lumbar CSF may not be directly related to brain (i.e.,
ventricular) CSF. Urinanalysis of 5-HIAA levels has also been utilized to detect
serotonergic production and release throughout the body. As discussed earlier, an adult
male human body contains approximately 10 mg of serotonin; roughly 1-2% of that 10
mg is found within the brain (Sirek & Sirek, 1970). Thus, 5-HIAA in urine could be
from tryptophan metabolism anywhere in the body, not just in the brain. Furthermore, 5HIAA is usually only found in very small quantities in urine as larger amounts are
indicative of carcinoid tumors (Feldman, 1986). Thus, it is clear that urinalysis of 5HIAA is an inadequate means of measuring brain tryptophan or serotonin as there is no
way to determine if the 5-HIAA is a result of central or peripheral tryptophan
metabolism.
Overall, it should be clear that although blood assays would enable one to ensure
whether or not a tryptophan manipulation actually altered serum levels of tryptophan
within the circulating blood, it is an inadequate measure of brain tryptophan levels.
Furthermore, there is no direct way to measure tryptophan or serotonin levels in the brain
as neither lumbar nor ventricular tryptophan or serotonin levels can directly assess the
availability of these substances in the brain. Taken together, these findings suggest that
employing blood assays as a measure of tryptophan levels in the brain is not necessarily a
requirement in this field of research as it is at best an indirect method of inference.
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Is Dietary Manipulation An Effective Means of Measuring Tryptophan Manipulation?
Although the present study did not detect as many effects of tryptophan
manipulation as would have been hoped, there are several reasons why it is felt that the
dietary method of tryptophan manipulation is worth pursuing. As discussed earlier, it is a
relatively inexpensive and a much more feasible means of manipulating tryptophan levels
(compared to the amino acid protocol), enabling more researchers who do not have large
research grants to implement this method. Purchasing fresh foods and bulk items is
relatively economical, even for those with small research budgets. This fact alone should
make it a much more appealing alternative to researchers looking to work within this
field of study. Using different samples and designs, several researchers have shown that
dietary methods of tryptophan manipulation do produce cognitive and affective changes
in participants (e.g., Fischer et al., 2002; Lieberman et al., 2002; Markus et al., 1998;
Smith et al., 1988). As more researchers employ this method, our knowledge about the
effects of dietary manipulations will continue to increase which will help bring about
some consensus within the field as to the appropriate amounts of each food, and other
methodological and research issues concerning the effects of tryptophan upon cognition
and affect.
Furthermore, it must be kept in mind that this line of research is still in its infancy.
While it is true that the backbone of this field of study arguably started in 1948 with the
isolation of serotonin, it has hopefully been made clear that no consensus has been
reached as to the appropriate design and method of this type of research. At present, the
literature is a veritable cornucopia of differing sample sizes and demographics,
methodologies (dietary or amino acid mixture), designs (within-, between-, and mixed-
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designs), and other possibly confounding variables that make it extraordinarily difficult to
arrive at consistent, replicable, and generalizeable results. As more researchers pursue
this line of study greater consensus will begin to emerge within the literature, which
should also help bring us closer to a unified theory.
It must also be kept in mind that this line of research is incredibly complex. All
research must take into account such variables as individual differences and other
confounding factors, but within this field of study there are a myriad of other factors that
could bear weight upon the outcome, such as inherent differences in macronutrient
metabolism and catabolism, as well as the production and activity of resulting
neurotransmitters. The interplay between different amino acids and macronutrients, as
well as between different neurotransmitters, may also influence whether or not effects of
the tryptophan manipulation are detected. In other words, the same manipulation may be
much stronger for one participant than for another, even though all other variables are
similar. For this reason, this field of study may be better suited to the examination of
manipulation responders versus non-responders. By investigating these two groups
separately, we may begin to get a better picture of what makes someone a responder
versus as non-responder, as well as the ways in which they differ cognitively and
affectively following tryptophan manipulation.
The importance of this line of research cannot be overstated. It is not just students
or patients that would benefit from a greater understanding of the effects of tryptophan on
neuropsychological performance. If consumption of everyday foods was found to result
in significant effects on cognition or affect, then it is possible that in our daily lives we
are inadvertently affecting our baseline level of functioning. What is more, we could
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unknowingly be exacerbating existing conditions or conditions to which we are
predisposed (e.g., depression). For instance, patients taking monoamine oxidase
inhibitors (MAOIs) for the treatment of depression must limit foods high in tyramine,
such as cheese, alcohol, and chocolate to prevent spikes in blood pressure that could lead
to stroke (McCabe, 1986). While it is not being argued that tryptophan, found in the
levels present in everyday food, exert the same effects as major antidepressant
medications, it could be that even trace amounts of tryptophan could interact with
medications taken for various conditions. It is possible that even small amounts of
tryptophan or other macronutrients could be enough to produce, without our even being
aware of it, variations in our day-to-day behaviour (including mood, cognition, and
physiological or metabolic states). Maier and Watkins (2000) have proposed a similar
idea regarding our immune systems, suggesting that since we are continuously coming
into contact with unknown pathogens, variations in our spontaneous “normal” behaviour
are caused by immune system responses. Further, they state that in response to immune
system activation, serotonin is released in the hippocampus, highlighting the complexities
of human neuropsychological function and the many factors that can influence them.
Overall, it should be clear that the complexities of this field of research make it
difficult to boil down results to one simple set of findings. The ease and accessibility of
employing a dietary manipulation of tryptophan in order to investigate the effects of
tryptophan manipulation on cognitive and affective outcomes should make this field of
study more appealing to researchers, and through increased research the complexities of
this area of research will begin to unravel.
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Summary and Future Directions
In conclusion, although no significant results were found for females, significant
effects were found for males on the Rey-O delay recall, and the Ruff 2 & 7 Total Speed
measure, as well as minor differences in PA and excitement levels over time. These
findings are relatively unique within the literature as few studies have found significant
results for PA (as opposed to NA), or for visuospatial LTM, especially for males.
Although some caution must be exercised in comparing the results of the present study to
those of within-subject studies, it is apparent that the current study found effects of
tryptophan manipulation that, to the best our knowledge, have not yet been reported
within the literature. Unlike Lieberman and colleagues (2002), the present study did not
find that carbohydrates resulted in increased vigilance in males, nor did it result in greater
sleepiness in women, or greater calmness in men (Spring et al., 1983). Furthermore, no
between-subject studies employing a dietary method of tryptophan manipulation found
any effect of tryptophan on visuospatial LTM or on tests of selected visual attention.
Hoyland and colleagues (2008) bolster the belief of the author that the lack of consensus
within the literature pertaining to the effects of tryptophan manipulation could at least in
part be due to the variability of research designs and methods, with too few studies
employing the same means of manipulating tryptophan or of measuring its effect. They
also suggest that different foods likely produce cognitive effects along differing
timelines, and thus it might be best if performance (on cognitive measures) was assessed
on multiple occasions following the manipulation in order to assess differences in
performance across time. Furthermore, there is a lack of consensus within the literature
as to whether manipulating tryptophan levels in healthy participants, such as in the
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present study and many others (e.g., Lieberman et al., 2002; Luciana et al., 2001; Riedel
et al., 1999), leads to findings as robust as those seen in psychiatric populations (e.g.,
Benkelfat et al., 1994; LeMarquand et al., 1998). Thus, a combination of participant
characteristics, sample size, method of manipulation and test sensitivity could all be
responsible for the lack of consistent findings within this field of research.
Future directions for this field of study should include the analysis of tryptophan
manipulation responsiveness (as suggested earlier), coding participants as either
responders or non-responders. This idea had occurred to the author of the present study
after completing data collection. However, as this was not an a priori analysis, it was
discovered that the data from the present study do not lend themselves to coding
participants as responders or not. For this type of analysis to be done, a greater range of
scores must be available on the pre- and post-test measures used to assess the
effectiveness of the manipulation. The PANAS and Digit Span Backwards scores did not
provide the ranges required to discern not only whether someone responded to the
manipulation, but also whether or not they responded in the predicted direction based on
their meal condition. Responder analyses were attempted, but they were deemed
meaningless as the categories for ‘responder’ or ‘non-responder’ were far too narrow,
making it impossible to accurately determine whether a participant did in fact respond to
the manipulation (in the manner predicted or not). Future studies should consider this
analysis from the start of their design conception and should detail exactly how they will
define and code for responsiveness in order to ensure an adequate range of scores is
attainable.
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Other, more technologically complex designs should also be considered for
future research. For instance, PET studies employing the injection of radio-labelled
tryptophan would also provide a wealth of information concerning whether exogenous
doses of tryptophan actually increase brain tryptophan (and therefore serotonin
production and release), and whether such changes are detectable via behavioural or
affective output. In a study by Perreau-Linck and colleagues (2007) using PET,
professional actors were instructed to self-induce a particular mood state (happy, sad or
neutral, counterbalanced across 3 testing days) and were then injected with radio-labelled
tryptophan (11C-labelled α-methy-L-tryptophan, a synthetic version of L-tryptophan that
crosses the blood-brain barrier and is used to estimate serotonin synthesis within the
brain). Although no changes were detected in free or total venous tryptophan levels, the
researchers found that serotonergic activity in the right anterior cingulate cortex was
positively correlated with self-induced happiness, whereas a negative correlation was
found between self-induced sadness and the subcallosal region of the right anterior
cingulate cortex. These results indicate that even though measurable levels of free
circulating tryptophan did not appear to change, changes to serotonin activity within the
brain were detected. In a similar vein, Praschak-Reider and colleagues (2004) conducted
a tryptophan depletion study using PET with 8 currently-remitted depressed patients.
Although they measured a drop of 86% in total tryptophan plasma following tryptophan
depletion, they failed to detect any changes in brain serotonin levels or activity. The
tryptophan depletion did, however, induce a transient relapse of depressive symptoms in
6 of their 8 participants, indicating that small changes in brain serotonin levels are
sufficient to induce short-term relapse in depressed patients normally being treated with
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SSRIs. Taken together, these studies seem to suggest that even small changes in brain
tryptophan or serotonin levels can lead to changes in activity in neuroanatomical
structures known to be implicated in mood. Future studies should include a more
comprehensive assessment of other neuropsychological functions, such as memory or
attention. Hoyland and colleagues (2008) suggests that the following tests seem most
consistently sensitive to macronutrient manipulation: the serial sevens task (a measure of
working memory); free word recall with delay trials (verbal LTM); and cued word recall
(verbal LTM). Thus, the inclusion of measures similar to these should be employed in
PET studies.
As a follow-up to the present study, a mixed-design study should be employed
with both between- and within-subject participants being recruited. Such a design will
allow the direct comparison of these two methods to help determine which is the stronger
design. This finding would guide researchers in deciding which design to utilize in future
research. A larger sample size for both between- and within-subject samples, with equal
gender ratios in each condition, should be obtained to further strengthen the findings of
the present study and to prevent possible power issues from confounding results. The
inclusion of additional sensitive measures, such as those suggested by Hoyland and
colleagues (2008), should also be employed to provide the widest net for catching any
between-group or between-condition effects of tryptophan manipulation on
neuropsychological performance.
Overall, through future research that employs the above-discussed methods of
measuring and assessing tryptophan and serotonin levels in the brain, a better
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understanding of the effects of tryptophan manipulation on neuroanatomical, cognitive
and affective functioning should begin to emerge.
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Appendix A
Glossary of Terms

CNS

Central Nervous System: the part of the nervous system comprised
of the brain and spinal cord that coordinates activities of the body.

LNAAs

Large Neutral Amino Acids: a term used to describe amino acids
that compete with each other for uptake into the brain and
subsequent neurotransmitter synthesis.

5-HT

The chemical name for the neurotransmitter 5-hydroxytryptamine
(aka: serotonin), the final end product of tryptophan metabolism.

5-HTP

The chemical name for 5-hydroxytryptophan, the amino acid
metabolite of tryptophan and the precursor to serotonin (5-HT).

5-HIAA

The chemical name of 5-hydroxyindoleacetic acid, the primary
metabolite of serotonin (5-HT) that is excreted in the urine.

Depletion

The term used to denote acute tryptophan depletion produced
either via the amino acid protocol drink, excluding the amino acid
tryptophan, or via dietary manipulations (i.e., protein-loading).

Augmentation

The term used to denote acute tryptophan augmentation produced
either via the amino acid protocol drink, with the inclusion of
increased amounts of the amino acid tryptopahn, or via dietary
manipulations (i.e., carbohydrate-loading).

Balanced

The term used to denote the balanced condition between acute
tryptophan depletion and acute tryptophan augmentation, produced
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either via the amino acid protocol drink, wherein the proportion of
LNAAs produces an equal effect as the amount of tryptophan on
plasma levels, or via dietary manipulations (i.e., the
carbohydrate:protein ratio produces an even balance between
LNAAs and tryptophan).
BMI

Body Mass Index: a measure of body fat based on weight and
height.
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Appendix B
Study Advertisement (Participant Pool)
Participant Pool Recruitment Statement – Effects of Food on Cognition
Hello,
My name is Kristen Kaploun and I am a PhD Candidate in the Clinical
Neuropsychology program here at that University of Windsor. I am contacting you in the
hopes that you are interested in taking part in my research study examining the effect of
food on cognition. This is a two-part study, requiring participants to first take part in a
screening session; it is this session for which I am now recruiting participants.
The purpose of this screen is to determine your eligibility for inclusion in the study
entitled, “The Effects of Food on Cognition”. This screening is completely non-invasive.
If you volunteer to participate, you will be asked to come into the laboratory for
approximately 30 minutes in order to complete a screening interview. During the
interview, you will be asked to provide information about your medical history and
general health, as well as other demographic criteria (e.g., age, gender, program of study).
The screen is worth 0.5 credits. If you are deemed eligible to continue, and you wish to
do so, a separate appointment will be set up for you to come in and take part in the testing
session. The testing session takes approximately 5.5 hours, during which time you
receive breakfast, lunch and two snacks. The testing session is worth 5.5 credits and the
chance to win one of two $50 gift cards (more information will be provided about the
study during the screening session).
If you are interested in taking part, please email me at: hodgesk@uwindsor.ca and
we can set up an appointment. The screening will take place in the basement of Chrysler
Hall South, Room 73.
I thank you in advance and I look forward to hearing from you.
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SCREENER
Effects of Food on Cognition

*Are you allergic to peanuts?

□

No
□ Yes
If Yes, please leave now _____________________________________

Date: ____________________
Age: _____
Sex: _____

ESL?: _____

Weight: ________
Height: ________
BMI: ________ (BMI category: ______________________)
•
•
•
•

Underweight = <18.5 (less than 17.5 = anorexia)
Normal weight = 18.5 - 24.9
Overweight = 25 - 29.9
Obesity = BMI of 30 or greater

Do you have any food allergies? □ No
If Yes: ______________

□

Yes

Chronic illnesses? (incl. Crohn’s disease, celiac disease, IBS, lactose intolerance)
•
•
•
•
•

__________________________________
__________________________________
__________________________________
__________________________________
□ Yes
Do you have diabetes? □ No

Current illnesses?
•
•
•

__________________________________
__________________________________
__________________________________

If ‘Yes’, Type I or II ?
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__________________________________

Current medications? (incl. birth control, vitamins, herbal supplements, allergy or
asthma meds)
•
•
•
•

__________________________________
__________________________________
__________________________________
__________________________________

Exclusionary: SSRIs, MAOIs, narcotics, anti-psychotics, anti-depressants, anxiolytics
(anti-anxiety)
Do you use any recreational drugs?
□ No □ Yes If Yes: _____________________________________
Hallucinogens:

PCP, angel dust, ketamine, Special K, LSD, acid,
MDMA/methamphetamine, ecstasy, mescaline, peyote, psilocybin
(mushrooms)

Frequency: _________________________
Pain Killers:

Codeine, opium, heroin, morphine, smack, Vicodin, methadone,
Dilaudid, Oxycodone/Oxycontin, Percodan

Frequency: _________________________
Tranquilizers:

Amount: ______________________

Marijuana, pot, weed, hashish, hashish oil

Frequency: _________________________
Steroids:

Amount: ______________________

Cocaine, coke, crack, amphetamines, methamphetamines, speed,
crystal meth, ice, crank, Ritalin, tobacco, caffeine

Frequency: _________________________
Marijuana:

Amount: ______________________

Benzodiazepines, Valium, Ativan, Diazepam, pentobarbital,
amobarbital, Seconal, roofies, Nembutal, barbituates, inhalants,
alcohol

Frequency: _________________________
Stimulants:

Amount: ______________________

Amount: ______________________

Any kind: _______________________________________

Frequency: _________________________

Amount: ______________________
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Any prescription?

□

No

Do you smoke?

□

No

□

Yes

□

Yes: _________________________________
Yes

If Yes: How many per day?_________
Is your diet irregular?

How long have you smoked? ________

□

No

□

Yes: ________________________________________

Does your weight tend to fluctuate? □ No
Have you ever / do you ever binge eat?

□

□
No

Yes

Range: _____________

□

Yes When last?_______

Have you ever been diagnosed with: Anorexia Nervosa
Bulimia
Do you usually eat breakfast?

□

No

□

Yes

Do you usually eat lunch?

□

No

□

Yes

Athleticism:

□

□ Quite
(3-5 time/wk)

Very
(daily)
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□
□

No
No

□
□

Yes
Yes

□ Minimal
□ Not at all
(e.g., walk to school) (e.g., drive to school)

Metabolic Rate: How often do you eat during a normal day (every X hours): ______
Do you eat more than most people at each meal?

□

No

□

Yes

What types of foods do you crave the most? ______________________________
Current Depression? □ No

□

Yes:_______________________________________________

Current Anxiety? □ No

□

Yes:_______________________________________________
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Family history of mental illness? (include who has what disorder)
•
•
•
•

__________________________________
__________________________________
__________________________________
__________________________________

History of stroke, seizures or other neurological impairments/injuries? (incl. age of
injury and most recent event)
• __________________________________
• __________________________________
• __________________________________
• __________________________________

How many hours of sleep do you get in a typical night? _______________________
Do you feel rested upon waking? ____________________________________
How much caffeine do you typically consume in a day?

□

Pop: ________

□

Coffee: ________

□

Decaf Coffee: _________

□

Decaf Pop: ______

□

Tea: ________

□

Decaf Tea: _________

□

Chocolate: ________

□

Hot Chocolate: ________

□

Energy Drinks: _________

□

Other: _________

Do you ever take caffeine pills? ______________________________________

Other:
Are you pregnant?

□

No

□

Yes

Stage of menstrual cycle (females only):

Last day: _______________________
First day: _______________________

General
How did you find out about this study? ___________________________________
¾ Recruitment method (circle one): Participant Pool

Poster
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What motivated you to take part in this study?
________________________________________________________________________
Are you a student?

□

No

□

Yes

If ‘Yes’, what is your Major? ____________________________________________
¾ What year are you currently in? ______________________
If ‘No’, what kind of work do you do? _______________________________________
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Appendix D
Study Advertisement (Community Sample)

INTERESTED IN THE EFFECTS OF FOOD ON
COGNITION?
Women and men 17 years or older are invited to participate
in a study exploring the effects of food on cognitive performance.
Participation is voluntary and confidential.
Participants will receive breakfast, lunch and two snacks, as well as the
chance to win 1 of 2 gift cards valued at $50 for a total of 6 hours of their
time (30 minutes for the pre-screening, and 5.5 hours for the testing session).
This study is being conducted by Kristen Kaploun, M.A., a clinical
neuropsychology doctoral student at the University of Windsor, and her
research advisor, Dr. Chris Abeare, Ph.D. The research study has received
ethics clearance from the University of Windsor Research Ethics Board.
For further information about this study, please contact Kristen at
hodgesk@uwindsor.ca.
Contact Kristen at:
hodgesk@uwindsor.ca

Contact Kristen at:
hodgesk@uwindsor.ca

Contact Kristen at:
hodgesk@uwindsor.ca

Contact Kristen at:
hodgesk@uwindsor.ca

Contact Kristen at:
hodgesk@uwindsor.ca

Contact Kristen at:
hodgesk@uwindsor.ca

Contact Kristen at:
hodgesk@uwindsor.ca

Contact Kristen at:
hodgesk@uwindsor.ca

Contact Kristen at:
hodgesk@uwindsor.ca

Contact Kristen at:
hodgesk@uwindsor.ca

Contact Kristen at:
hodgesk@uwindsor.ca
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Appendix E – Screener Consent Form

CONSENT TO PARTICIPATE IN SCREEN
To determine eligibility for participation in the study entitled, “The Effects of Food on Cognition”
Title of Study: The Effects of Food on Cognition
You are asked to participate in a research screen for a study conducted by Kristen Kaploun, MA
(student researcher) and Dr. Chris Abeare, PhD (faculty supervisor), from the Psychology
Department at the University of Windsor. This screen comprises a part of Kristen Kaploun’s PhD
Dissertation.
If you have any questions or concerns about the research, please feel free to contact Kristen
Kaploun at hodgesk@uwindsor.ca, or Dr. Chris Abeare at 519-253-3000, ext. 2231.

PURPOSE OF THE STUDY
The purpose of this screen is to determine your eligibility for participation in the study, “The
Effects of Food on Cognition”.

PROCEDURES
If you volunteer to participate in this screen, we would ask you to do the following things:
Screening Procedures:
Upon signing up for the study, you will be asked to come into the laboratory. Upon providing
informed consent, you will be asked to complete an initial screening interview. You will be asked
you will be asked to provide information about your medical history and general health, as well as
other demographic criteria (e.g., age, gender, program of study). If you are deemed eligible to
participate in the study and you wish to do so, a separate appointment will be made for you to
return to the lab to take part in the study. The screening session should last approximately 30
minutes and will take place one-on-one with the examiner in the basement of Chrysler Hall South,
Room 73. It is worth 0.5 credits.
Exclusionary Criteria:
Participants will be excluded if they meet criteria for any of the following:
- Obesity, Anorexia, or Bulimia (other eating disorders)
- Diabetes
- Food allergies
- Lactose intolerance
- Irritable Bowel Syndrome (IBS)
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- Crohn’s disease
- Celiac disease
- Other chronic illnesses (incl. Endocrine and metabolic disorders)
- Current depression
- Current anxiety
- Illicit drug use (e.g., marijuana, narcotics)
- Stimulants (incl. more than the equivalent of 5 cups of coffee/day, or 1 package of
cigarettes/day)
- Current medication use (incl. SSRIs, MAOIs, psychotropic medications, cold
medications such as Nyquil)
- History of neurological disorders/impairments

POTENTIAL RISKS AND DISCOMFORTS
All information provided is completely confidential. However, it is possible that by participating in
this screen, you may experience discomfort discussing medical and health matters. If so, you
may elect to skip certain questions and still remain in the screen.
If by taking part in this screener you experience certain negative feelings, such as anxiety,
sadness or worry, and you would like to talk to someone about these feelings, here is a list of
local resources that we encourage you to contact:
The Student Counseling Centre

CAW Student Centre
Room 293 2nd Floor
(519) 253-3000 Ext. 46160
Email: scc@uwindsor.ca

Windsor Regional Hospital Mood and Anxiety Clinic

(519) 257-5125

Windsor Mood Disorders Self-Help Group

(519) 979-5089

Community Crisis Centre

(519) 973-4435

POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
By participating in this screen, you will learn about the different variables that may influence the
effects of meal composition on cognitive performance. If you are deemed eligible to take part in
the study upon completion of the screen, you will learn more specific information regarding the
impact of food choices on cognition. The scientific community, society and those involved in
helping patients who experience transient or occasional cognitive, affective, or physiological
problems could benefit from a greater understanding of role played by various food components
on mood and cognition.

PAYMENT FOR PARTICIPATION
As a participant, you will earn 0.5 credits for participating in this screen. If you are deemed
eligible for taking part in the testing session and you wish to do so, you will be able to earn up to
an additional (and maximum of) 5.5 credits for completing the study (please note that credits
cannot be “banked” from one semester to another). If you are deemed eligible to take part in the
testing session, more information will be provided about the procedures, at which point you may
decide if you want to take part. Even if you chose to not take part in the testing session (i.e.,
upon hearing the details it is not of interest to you), you will still earn the 0.5 credits for taking part
in the screening session.

Tryptophan

191

CONFIDENTIALITY
Any information that is obtained in connection with this study and that can be identified with you
will remain confidential and will be disclosed only with your written permission. Your identity will
be known to the researcher for the purposes of scheduling and compensation only and any
information collected will be kept in file cabinets and locked up in the laboratory. Upon entering
the lab for the study screen, you will be assigned an ID number. This number is kept on a master
key alongside your name and contact information. All data that is subsequently collected will be
identifiable by ID number only. All data will be stored in cabinets and locked up in the laboratory;
the master key, which will be stored separately from all data, will also remain locked in the
laboratory. Data will be retained, locked away in this fashion, for at least two (2) years until the
study is completed and accepted for publication.

PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this screen or not. If you volunteer to be in this screen, you may
withdraw at any time. However, please note that if you decide to withdraw from the screen, you
will only be compensated for the time in which you participated (i.e., a maximum of 0.5 credits).
The investigator may withdraw you from this research if circumstances arise which warrant doing
so (for example, if you fail to follow test instructions, or if it is deemed unsafe for you to continue
to participate). As a participant in this study, you will have the option of removing your screening
data from the study.

FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS
Participants will have the option of learning the results of the study (not the screen) simply by
contacting the researcher. Those who are ineligible for participating in the study will be notified
and provided with the reason for their exclusion. Participants who complete the study may also
log onto the REB website and read the results of this study by selecting it from the available list.
Web address: http://www.uwindsor.ca/reb
Date when results are available: April 30, 2011

SUBSEQUENT USE OF DATA
This data will be used in subsequent studies.

RIGHTS OF RESEARCH SUBJECTS
You may withdraw your consent at any time and discontinue participation without penalty. If you
have questions regarding your rights as a research subject, contact: Research Ethics
Coordinator, University of Windsor, Windsor, Ontario, N9B 3P4; Telephone: 519-253-3000, ext.
3948; e-mail: ethics@uwindsor.ca

SIGNATURE OF RESEARCH SUBJECT/LEGAL REPRESENTATIVE
I understand the information provided for the screen for the study “The Effects of Food on
Cognition” as described herein. My questions have been answered to my satisfaction, and I
agree to participate in this screen. I have been given a copy of this form.
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______________________________________
Name of Subject
______________________________________
Signature of Subject

___________________
Date

SIGNATURE OF INVESTIGATOR
These are the terms under which I will conduct research.

_____________________________________
Signature of Investigator

____________________
Date
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Appendix F – Testing Session Consent Form

CONSENT TO PARTICIPATE IN RESEARCH – TESTING SESSION
Title of Study: The Effects of Food on Cognition
You are asked to participate in a research study conducted by Kristen Kaploun, MA (student
researcher) and Dr. Chris Abeare, PhD (faculty supervisor), from the Psychology Department at
the University of Windsor. This study comprises Kristen Kaploun’s PhD Dissertation.
If you have any questions or concerns about the research, please feel free to contact Kristen
Kaploun at hodgesk@uwindsor.ca, or Dr. Chris Abeare at 519-253-3000, ext. 2231.

PURPOSE OF THE STUDY
The purpose of this study is to determine the effects of different foods on cognitive performance.

PROCEDURES
If you volunteer to participate in this study, we would ask you to do the following things:
Testing Procedures:
On the day of testing, informed consent will be obtained along with a short intake survey. You will
have been randomly assigned to one of three conditions, each of which receive a different set of
meals. Upon completing the intake survey you will be provided with breakfast; lunch, and two
snacks will also be provided before the end of the testing session. Please note that you will not
have the option of refusing to eat some or all of the food provided during this study. If you do not
wish to eat some or all of the food that is provided, you are free to withdraw at any time. If you
chose to exercise this right, please note that you will only be compensated for the time in which
you participated (i.e., you will not receive the full 5.5 credits; please see ‘Participation and
Withdrawal’ section below for further details). One and a half hours following the provision of
lunch, you will complete the test battery, comprised of several paper-and-pencil measures aimed
at assessing various cognitive functions (e.g., attention). Indices of mood and affect will also be
administered upon arrival at the laboratory on the day of testing, after each meal, and upon
completion of the test battery.
The total length of time for participation will be approximately 5.5 hrs done in one sitting (the
actual testing session will last approximately 1.5 hours). During the waiting period, you must
remain in the waiting room (save for washroom breaks). You will be allowed to study, read,
watch a movie on the computer or play a board game; you will not, however, be permitted to eat
or sleep. Water will be provided upon request. This study will take place one-on-one with the
examiner in the basement of Chrysler Hall South, Room 73 (the same room as the screening
interview).
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Exclusionary Criteria:
Participants will be excluded if they meet criteria for any of the following:
- Obesity, Anorexia, or Bulimia (other eating disorders)
- Diabetes
- Food allergies
- Lactose intolerance
- Irritable Bowel Syndrome (IBS)
- Crohn’s disease
- Celiac disease
- Other chronic illnesses (incl. Endocrine and metabolic disorders)
- Current depression
- Current anxiety
- Illicit drug use (e.g., marijuana, narcotics)
- Stimulants (incl. more than the equivalent of 5 cups of coffee/day, or 1 package of
cigarettes/day)
- Current medication use (incl. SSRIs, MAOIs, psychotropic medications, cold
medications such as Nyquil)
- History of neurological disorders/impairments
POTENTIAL RISKS AND DISCOMFORTS
It is possible that by participating in this study, you may experience a mild alteration of your mood
(e.g., mild irritation or lowering of mood). Any such effects, if experienced at all, will be mild and
transient, consistent with what might occur had you skipped breakfast or lunch. The snack
provided upon completing the testing will help return your mood to baseline levels should any
deviation occur.
If by taking part in this study you experience certain negative feelings, such as anxiety, sadness
or worry, and you would like to talk to someone about these feelings, here is a list of local
resources that we encourage you to contact:
The Student Counseling Centre

CAW Student Centre
Room 293 2nd Floor
(519) 253-3000 Ext. 46160
Email: scc@uwindsor.ca

Windsor Regional Hospital Mood and Anxiety Clinic

(519) 257-5125

Windsor Mood Disorders Self-Help Group

(519) 979-5089

Community Crisis Centre

(519) 973-4435

POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
You will learn about the effects of meal composition on mood and cognitive performance. The
scientific community, society and those involved in helping patients who experience transient or
occasional cognitive, affective, or physiological problems could benefit from a greater
understanding of role played by various food components on mood and cognition.
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PAYMENT FOR PARTICIPATION
Participants will earn up to a maximum 5.5 course credits for participating in, and completing, this
study (please note that credits cannot be “banked” from one semester to another). The screening
session (completed previously) is worth 0.5 credits. Thus, by fully completing this study,
participants can earn up to a total of 6 credits (0.5 for the screening session, and 5.5 for the
testing session). Completion of the study will also deem the participant eligible for inclusion (if
s/he so wishes) in a draw to win 1 of 2 gift cards valued at $50 CAD to either Devonshire Mall or
Future Shop. Please refer below (“Participation and Withdrawal”) for information regarding
withdrawing from this study.

CONFIDENTIALITY
Any information that is obtained in connection with this study and that can be identified with you
will remain confidential and will be disclosed only with your written permission. Your identity will
be known to the researcher for the purposes of scheduling and compensation only and any
information collected will be kept in file cabinets and locked up in the laboratory. Upon entering
the lab for the study screen, you were assigned an ID number. This number is kept on a master
key alongside your name and contact information. All data that is subsequently collected will be
identifiable by ID number only. All data will be stored in cabinets and locked up in the laboratory;
the master key, which will be stored separately from all data, will also remain locked in the
laboratory. Data will be retained, locked away in this fashion, for at least two (2) years until the
study is completed and accepted for publication.

PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this study or not. If you volunteer to be in this study, you may
withdraw at any time. However, please note that if you decide to withdraw from the study, you
will only be compensated for the time in which you participated. In other words, if you completed
2 hours of the study, you will receive 2 credits; if you completed 4 hours, you will receive 4
credits. Also, choosing not to complete the testing session will deem you ineligible for inclusion in
the draw to win 1 of 2 gift cards valued at $50 CAD to either Devonshire Mall or Future Shop.
However, as a participant in this study, you may refuse to answer any questions you do not want
to answer and still remain in the study. The investigator may withdraw you from this research if
circumstances arise which warrant doing so (for example, if you fail to follow test instructions, or if
it is deemed unsafe for you to continue to participate). Lastly, in the event that you choose to
withdraw from the study, you will still receive the credits you earned for participating in the screen
(i.e., you will not be docked previously earned points). As an example, if you withdrew from the
study after 2 hours, you would have earned a total of 2.5 credits – 2 for the study, and 0.5 for the
screener completed previously. As a participant in this study, you will have the option of
removing your data from the study.

FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS
Participants will have the option of learning the results of the study simply by contacting the
researcher. They may also log onto the REB website and read the results of this study by
selecting it from the available list.
Web address: http://www.uwindsor.ca/reb
Date when results are available: April 30, 2011
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SUBSEQUENT USE OF DATA
This data will be used in subsequent studies.

RIGHTS OF RESEARCH SUBJECTS
You may withdraw your consent at any time and discontinue participation without penalty. If you
have questions regarding your rights as a research subject, contact: Research Ethics
Coordinator, University of Windsor, Windsor, Ontario, N9B 3P4; Telephone: 519-253-3000, ext.
3948; e-mail: ethics@uwindsor.ca

SIGNATURE OF RESEARCH SUBJECT/LEGAL REPRESENTATIVE
I understand the information provided for the study “The Effects of Food on Cognition” as
described herein. My questions have been answered to my satisfaction, and I agree to
participate in this study. I have been given a copy of this form.

______________________________________
Name of Subject
______________________________________
Signature of Subject

___________________
Date

SIGNATURE OF INVESTIGATOR
These are the terms under which I will conduct research.

_____________________________________
Signature of Investigator

____________________
Date
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Appendix G
Composition of tryptophan augmented (ATA), tryptophan depleted (ATD), and balanced
(B) meals and snacks.

Augmentation Meal
Breakfast
Bread – 1 slice (26 g)
Low-fat margarine – 1 tbsp (14 g)
Grape jam – 1 oz (28 g)
Tea – black decaf – 1 cup (8 fl oz) (237 g)
Sugar (in tea) – 2 tsp (4 g)
Grape juice – 1 cup (253 g)
Snack
Black coffee (decaf) – 1 cup (8 fl oz) (237 g)
Sugar (in coffee) – 2 tsp (4 g)
3 Musketeer candy bar – 1 2.13 oz bar (60
g)
Lunch
Bread – 1 slice (26 g)
Low-fat margarine – 1 tbsp (14 g)
Grape jam – 1 oz (28 g)
Grape juice – 1 cup (253 g)
Depletion Meal
Breakfast
Bread – 2 slices (26 g each)
Low-fat margarine – 1 tbsp (14 g)
Cheese – low-fat mozzarella – 1 oz (28 g)
Tea – black decaf – 1 cup (8 fl oz) (237 g)
Milk (in tea) – whole milk – 1 oz (28 g)
Snack
Coffee – decaf – 1 cup (8 fl oz) (237 g)
Milk (in coffee) – 1% milk – 1 oz (28 g)
Peanuts – roasted with salt – 1 oz (28 g)
Lunch
Bread – 2 slices (26 g each)
Low-fat margarine – 1 tbsp (14 g)
Roast beef – lean – 1 oz (28 g)
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Balanced Meal
Breakfast
Bread – 1 slices (26 g each)
Butter – salted – 1 pat (5 g)
Grape jam – 2 oz (28 g each)
Tea – black decaf – 1 cup (8 fl oz) (237 g)
Sugar (in tea) – 2 tsp (4 g each)
Snack
Black coffee (decaf) – 1 cup (8 fl oz) (237 g)
Sugar (in coffee) – 2 tsp (4 g)
Milk – 1% milk – 1 oz (28 g)
2 fun-size “3 Musketeers” candy bars (28 g)
Lunch
Bread – 2 slices (26 g each)
Peanut Butter (unsalted) – 1 oz (28 g)
Grape jam – 1 oz (28 g)
Grape juice – 1 cup (253 g)
Final Snack for all groups:
Yogurt cup
Pineapple fruit cup

All meals were modeled after those used by Markus and colleagues (1998). They were
created and analyzed using the NutritionData website (NutritionData, 2009). RDA
values based on a 2,000 calorie diet for males and females aged 4 and over as indicated
by the Canada Food Inspection Agency
(http://www.inspection.gc.ca/english/fssa/labeti/guide/ch6e.shtml#a6_3).
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